{
               "authors" : "Djoumbou Feunang, Yannick; Wishart, DS et al. 2017",
               "version" : "1.1",
            "desription" : "THIS IS A PARTIAL OF BioTransformerDB 1.1. THE COMPLETE VERSION WILL BE RELEASE UPON PUBLICATION OF OUR BIOTRANSFORMER PAPER. BioTransformerDB is a biotransformation database that describes the transformation of small molecules in humans. this is a first partial release, which will be updated very soon.",
             "copyright" : "BioTransformerDB is offered to the public as a freely acessible database. It is part of BioTransformer, a software tool for the prediction ofsmall molecule metabolism. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (BioTransformer) and the original publication (see citation). We ask that users who download portions of the database, or use the BioTransformer software, cite the BioTransformer reference in any resulting publications.",
              "citation" : "Djoumbou Feunang, Yannick - Cheminformatics Tools for Enabling Metabolomics, 2017; PhD thesis (University Of Alberta, Canada).",
    "biotransformations" : {
      "BIOTID0001" : {
                                    "Substrate" : {
                     "Name" : "(R)-halothane",
                   "SMILES" : "C(F)(F)(F)[C@H](Cl)Br",
                 "InChIKey" : "BCQZXOMGPXTTIC-SFOWXEAESA-N",
                 "BTMDB_ID" : "BTM0001",
              "PubChem CID" : "445258",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6; CYP3A4; CYP2B6; CYP2C9; CYP2D6",
                                "Reaction Type" : "Reduction of terminal aliphatic trihalide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1167",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "1-chloro-2,2,2-trifluoroethanide",
                       "SMILES" : "FC(F)(F)[CH-]Cl",
                     "InChIKey" : "JUKWCHLDFKRDHO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0002",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Spracklin, D.K. et al (1996); Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4; Drug Metab Dispos. 1996 Sep;24(9):976-83.|| (R2) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015 || (R3) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0002" : {
                                    "Substrate" : {
                     "Name" : "Dehydroxyzyleuton",
                   "SMILES" : "C1(=CC2=C(S1)C=CC=C2)[C@@H](NC(N)=O)C",
                 "InChIKey" : "CKVDCQYUEYONIA-ZETCQYMHSA-N",
                 "BTMDB_ID" : "BTM0003",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Thiohene S-oxidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0102",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dehydroxyzyleuton sulfoxide",
                       "SMILES" : "NC(=O)N[C@H](C1=CC2=C(C=CC=C2)S1=O)C",
                     "InChIKey" : "KGUIRZVMBWMQQZ-RWNHWRGESA-N",
                     "BTMDB_ID" : "BTM0004",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0003" : {
                                    "Substrate" : {
                     "Name" : "(-)-limonene",
                   "SMILES" : "[C@H]1(C(C)=C)CCC(=CC1)C",
                 "InChIKey" : "XMGQYMWWDOXHJM-SNVBAGLBSA-N",
                 "BTMDB_ID" : "BTM0005",
              "PubChem CID" : "439250",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19",
                                "Reaction Type" : "Allylic hydroxylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0071",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Carveol",
                       "SMILES" : "C=C(C)C1CC=C(C)C(O)C1",
                     "InChIKey" : "BAVONGHXFVOKBV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0006",
                  "PubChem CID" : "7438",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0004" : {
                                    "Substrate" : {
                     "Name" : "(-)-limonene",
                   "SMILES" : "[C@H]1(C(C)=C)CCC(=CC1)C",
                 "InChIKey" : "XMGQYMWWDOXHJM-SNVBAGLBSA-N",
                 "BTMDB_ID" : "BTM0005",
              "PubChem CID" : "439250",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Carveol",
                       "SMILES" : "C=C(C)C1CC=C(C)C(O)C1",
                     "InChIKey" : "BAVONGHXFVOKBV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0006",
                  "PubChem CID" : "7438",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0005" : {
                                    "Substrate" : {
                     "Name" : "(-)-thalidomide",
                   "SMILES" : "O=C1N([C@H]2CCC(=O)NC2=O)C(=O)C3=CC=CC=C13",
                 "InChIKey" : "UEJJHQNACJXSKW-VIFPVBQESA-N",
                 "BTMDB_ID" : "BTM0007",
              "PubChem CID" : "92142",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19",
                                "Reaction Type" : "Alpha hydroxylation of carbonyl group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1054",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "cis, trans-5'-OH-thalidomide",
                       "SMILES" : "N1C(=O)C(O)C[C@H](N2C(=O)C3=CC=CC=C3C2=O)C1=O",
                     "InChIKey" : "HHTOWVWIVBSOKC-IENPIDJESA-N",
                     "BTMDB_ID" : "BTM0008",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0006" : {
                                    "Substrate" : {
                     "Name" : "(-)-zileuton",
                   "SMILES" : "C[C@H](N(O)C(N)=O)C1=CC2=CC=CC=C2S1",
                 "InChIKey" : "MWLSOWXNZPKENC-ZETCQYMHSA-N",
                 "BTMDB_ID" : "BTM0009",
              "PubChem CID" : "10220327",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Thiohene S-oxidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0102",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Zileuton sulfoxide",
                       "SMILES" : "ON(C(=O)N)[C@H](C1=CC2=CC=CC=C2S1=O)C",
                     "InChIKey" : "KWEAXQJUQDQMNY-ISJKBYAMSA-N",
                     "BTMDB_ID" : "BTM0010",
                  "PubChem CID" : "95162932",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0007" : {
                                    "Substrate" : {
                     "Name" : "(?)-perhexiline",
                   "SMILES" : "C(C(C1CCCCC1)C2CCCCC2)[C@H]3CCCCN3",
                 "InChIKey" : "CYXKNKQEMFBLER-GOSISDBHSA-N",
                 "BTMDB_ID" : "BTM0011",
              "PubChem CID" : "38988177",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "trans-hydroxyperhexilline",
                       "SMILES" : "O[C@H]1CC[C@H](CC1)C(CC2CCCCN2)C3CCCCC3",
                     "InChIKey" : "DZFRYNPJLZCKSC-CRIGQSRLSA-N",
                     "BTMDB_ID" : "BTM0012",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
      },
      "BIOTID0008" : {
                                    "Substrate" : {
                     "Name" : "(+)-bisoprolol",
                   "SMILES" : "C1(=CC=C(C=C1)COCCOC(C)C)OC[C@@H](CNC(C)C)O",
                 "InChIKey" : "VHYCDWMUTMEGQY-QGZVFWFLSA-N",
                 "BTMDB_ID" : "BTM0013",
              "PubChem CID" : "6604464",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP3A4",
                                "Reaction Type" : "O-deisopropylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1130",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(+)-bisoprolol, O-deisopropyl",
                       "SMILES" : "O[C@@H](COC1=CC=C(C=C1)COCCO)CNC(C)C",
                     "InChIKey" : "AIGGWEPYIOOYLI-CQSZACIVSA-N",
                     "BTMDB_ID" : "BTM0014",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Horikiri, Y. (1998); Pharmacokinetics and Metabolism of Bisoprolol Enantiomers in Humans; Journal of Pharmaceutical Sciences; Vol. 87, No. 3"
      },
      "BIOTID0009" : {
                                    "Substrate" : {
                     "Name" : "(+)-bisoprolol",
                   "SMILES" : "C1(=CC=C(C=C1)COCCOC(C)C)OC[C@@H](CNC(C)C)O",
                 "InChIKey" : "VHYCDWMUTMEGQY-QGZVFWFLSA-N",
                 "BTMDB_ID" : "BTM0013",
              "PubChem CID" : "6604464",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP3A4",
                                "Reaction Type" : "O-dealkylation of dialkylether",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1129",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(+)-bisoprolol, O-deisopropyl",
                       "SMILES" : "O[C@@H](COC1=CC=C(C=C1)COCCO)CNC(C)C",
                     "InChIKey" : "AIGGWEPYIOOYLI-CQSZACIVSA-N",
                     "BTMDB_ID" : "BTM0014",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Horikiri, Y. (1998); Pharmacokinetics and Metabolism of Bisoprolol Enantiomers in Humans; Journal of Pharmaceutical Sciences; Vol. 87, No. 3"
      },
      "BIOTID0010" : {
                                    "Substrate" : {
                     "Name" : "(+)-halofantrine",
                   "SMILES" : "ClC=1C2=CC([C@H](O)CCN(CCCC)CCCC)=C3C(=C2C=C(Cl)C1)C=C(C=C3)C(F)(F)F",
                 "InChIKey" : "FOHHNHSLJDZUGQ-RUZDIDTESA-N",
                 "BTMDB_ID" : "BTM0015",
              "PubChem CID" : "36688213",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(+)-halofantrine, N-desbutyl",
                       "SMILES" : "O[C@@H](C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F)CCNCCCC",
                     "InChIKey" : "FYHCHSNOXWVJJT-OAQYLSRUSA-N",
                     "BTMDB_ID" : "BTM0016",
                  "PubChem CID" : "76971137",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Halliday, R.C. et al. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems. Br J Clin Phar- macol 1995; 40: 369-78."
      },
      "BIOTID0011" : {
                                    "Substrate" : {
                     "Name" : "(+)-isothujone",
                   "SMILES" : "[C@@H]1([C@H]2C[C@]2(CC1=O)C(C)C)C",
                 "InChIKey" : "USMNOWBWPHYOEA-XKSSXDPKSA-N",
                 "BTMDB_ID" : "BTM0017",
              "PubChem CID" : "91456",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6; CYP2B6; CYP2D6; CYP3A4",
                                "Reaction Type" : "Hydroxylation of penultimate aliphatic tertiary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1075",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7-hydroxy-isothujone",
                       "SMILES" : "OC(C)(C)[C@@]12C[C@@H]1[C@@H](C(=O)C2)C",
                     "InChIKey" : "BWIMEHVFTVSHCC-NYNCVSEMSA-N",
                     "BTMDB_ID" : "BTM0018",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Jäger, W. and Höferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253–279."
      },
      "BIOTID0012" : {
                                    "Substrate" : {
                     "Name" : "(+)-isothujone",
                   "SMILES" : "[C@@H]1([C@H]2C[C@]2(CC1=O)C(C)C)C",
                 "InChIKey" : "USMNOWBWPHYOEA-XKSSXDPKSA-N",
                 "BTMDB_ID" : "BTM0017",
              "PubChem CID" : "91456",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6; CYP2B6; CYP2D6; CYP3A4",
                                "Reaction Type" : "Hydroxylation of alkyl methine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0053",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7-hydroxy-isothujone",
                       "SMILES" : "OC(C)(C)[C@@]12C[C@@H]1[C@@H](C(=O)C2)C",
                     "InChIKey" : "BWIMEHVFTVSHCC-NYNCVSEMSA-N",
                     "BTMDB_ID" : "BTM0018",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Jäger, W. and Höferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253–279."
      },
      "BIOTID0013" : {
                                    "Substrate" : {
                     "Name" : "(2s,5s)-troglitazone",
                   "SMILES" : "C12=C(CC[C@](O1)(COC3=CC=C(C=C3)C[C@H]4C(NC(S4)=O)=O)C)C(=C(C(=C2C)C)O)C",
                 "InChIKey" : "GXPHKUHSUJUWKP-CYFREDJKSA-N",
                 "BTMDB_ID" : "BTM0019",
              "PubChem CID" : "6518172",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "2,4-thiazolidinedione ring opening",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1179",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(1S)-1-(formylcarbamoyl)-2-(4-{[(2S)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-yl]methoxy}phenyl)ethane-1-sulfinic acid",
                       "SMILES" : "OC1=C(C2=C(O[C@](C)(COC3=CC=C(C=C3)C[C@@H](C(=O)NC=O)S(O)=O)CC2)C(=C1C)C)C",
                     "InChIKey" : "XIINUBVMVMENJH-RDPSFJRHSA-N",
                     "BTMDB_ID" : "BTM0020",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) He, K. et al. (2001); Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction; Biochem Pharmacol.; 62(2):191-8 || (R2) Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103–141; PMID:23333322 || (R3) Sánchez, A. ET AL. (2006); Thiazolidinedione Bioactivation: A Comparison of the Bioactivation Potentials of Troglitazone, Rosiglitazone, and Pioglitazone Using Stable Isotope-Labeled Analogues and Liquid Chromatography Tandem Mass Spectrometry; Current Medicinal Chemistry, 2009 Vol. 16, No. 27"
      },
      "BIOTID0014" : {
                                    "Substrate" : {
                     "Name" : "Saquinavir",
                   "SMILES" : "O=C(NC(C)(C)C)[C@H]1N(C[C@@H]2[C@H](C1)CCCC2)C[C@@H](O)[C@@H](NC(=O)[C@@H](NC(=O)C3=NC=4C(C=C3)=CC=CC4)CC(=O)N)CC5=CC=CC=C5",
                 "InChIKey" : "QWAXKHKRTORLEM-UGJKXSETSA-N",
                 "BTMDB_ID" : "BTM0021",
              "PubChem CID" : "441243",
              "DrugBank ID" : "DB01232",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-7-hydroxy-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide",
                       "SMILES" : "CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCC(O)C[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=CC=C5C=CC=CC5=N4",
                     "InChIKey" : "YHJGQHOJUFVUIN-XFHLUWSMSA-N",
                     "BTMDB_ID" : "BTM0022",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Fitzsimmons, M.E. and Collins, J.M. (1997); Selective Biotransformation of the HIV Protease Inhibitor Saquinavir by Human Small Intestinal Cytochrome P450 3A4: Potential Contribution to High First-Pass Metabolism. Drug Metab. Dispos.; 25; pp. 256–266"
      },
      "BIOTID0015" : {
                                    "Substrate" : {
                     "Name" : "(R)-(-)-Mexiletine",
                   "SMILES" : "C[C@@H](N)COC1=C(C)C=CC=C1C",
                 "InChIKey" : "VLPIATFUUWWMKC-SNVBAGLBSA-N",
                 "BTMDB_ID" : "BTM0023",
              "PubChem CID" : "180621",
              "DrugBank ID" : "DB07129",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2D6",
                                "Reaction Type" : "Hydroxylation of benzene on carbon ortho to an electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1045",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(R)-(-)-Mexiletine, m-hydroxyl",
                       "SMILES" : "N[C@H](C)COC1=C(C(O)=CC=C1C)C",
                     "InChIKey" : "LBHCZYGJQAXJSW-MRVPVSSYSA-N",
                     "BTMDB_ID" : "BTM0024",
                  "PubChem CID" : "73211883",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987 || (R2) Zhou, S.F. and Wang, B. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218; PMID:19754423"
      },
      "BIOTID0016" : {
                                    "Substrate" : {
                     "Name" : "(r)-azelastine",
                   "SMILES" : "CN1CCC[C@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O",
                 "InChIKey" : "MBUVEWMHONZEQD-GOSISDBHSA-N",
                 "BTMDB_ID" : "BTM0025",
              "PubChem CID" : "12831280",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2D6; CYP1A2",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(r)-azelastine, N-desmethyl",
                       "SMILES" : "C1=CC=C2C(=C1)C(=O)N(N=C2CC3=CC=C(Cl)C=C3)[C@H]4CCNCCC4",
                     "InChIKey" : "WRYCMIFVXDQIKN-QGZVFWFLSA-N",
                     "BTMDB_ID" : "BTM0026",
                  "PubChem CID" : "40584683",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0017" : {
                                    "Substrate" : {
                     "Name" : "(r)-bupropion",
                   "SMILES" : "ClC=1C=C(C(=O)[C@H](NC(C)(C)C)C)C=CC1",
                 "InChIKey" : "SNPPWIUOZRMYNY-SECBINFHSA-N",
                 "BTMDB_ID" : "BTM0027",
              "PubChem CID" : "688387",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2B6;CYP2C19; CYP2E1",
                                "Reaction Type" : "Hydroxylation of aromatic carbon ortho to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1040",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(2R)-2-(tert-butylamino)-1-(3-chloro-4-hydroxyphenyl)propan-1-one",
                       "SMILES" : "N([C@@H](C(=O)C1=CC(Cl)=C(O)C=C1)C)C(C)(C)C",
                     "InChIKey" : "LSZBTGUSYVNVLH-MRVPVSSYSA-N",
                     "BTMDB_ID" : "BTM0028",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880 || (R2) Faucette, S.R. et al. (2000); Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity. Drug Metab. Dispos. 2000, 28, 1222 – 1230."
      },
      "BIOTID0018" : {
                                    "Substrate" : {
                     "Name" : "(r)-enflurane",
                   "SMILES" : "FC(F)OC(F)(F)[C@@H](Cl)F",
                 "InChIKey" : "JPGQOUSTVILISH-SFOWXEAESA-N",
                 "BTMDB_ID" : "BTM0029",
              "PubChem CID" : "11052326",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1",
                                "Reaction Type" : "Oxidation of halotrifluoroethane",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1161",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-(difluoromethoxy)-2,2-difluoroacetyl fluoride",
                       "SMILES" : "C(F)(F)OC(F)(F)C(F)=O",
                     "InChIKey" : "TVUMCYGRGFDDJV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0030",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kenna, J.G. et Al. (2013); Drug-induced Disease (3rd Edition) (2013), Chapter 23 - Mechanisim, Pathology, and Clinical Presentation of Hepatoxicity of Anesthetic Agents 2013, 403-422 http://dx.doi.org/10.1016/B978-0-12-387817-5.00023-6 || (R2) Chris, D.D. et al. (1988); Potential Metabolic basis for enflurane hepatitis and the appaarent cross-sensutuzation between enflurane and halothane; Drug Metab Dispos 1988, 16, 135-140"
      },
      "BIOTID0019" : {
                                    "Substrate" : {
                     "Name" : "(r)-metoprolol",
                   "SMILES" : "O(C[C@H](O)CNC(C)C)C1=CC=C(CCOC)C=C1",
                 "InChIKey" : "IUBSYMUCCVWXPE-CQSZACIVSA-N",
                 "BTMDB_ID" : "BTM0031",
              "PubChem CID" : "157717",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1077",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "alpha-Hydroxymetoprolol",
                       "SMILES" : "O[C@@H](COC1=CC=C(C=C1)C(O)COC)CNC(C)C",
                     "InChIKey" : "OFRYBPCSEMMZHR-AFYYWNPRSA-N",
                     "BTMDB_ID" : "BTM0032",
                  "PubChem CID" : "3082567",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985; PMID:18259985"
      },
      "BIOTID0020" : {
                                    "Substrate" : {
                     "Name" : "(s)-(-)-carvedilol",
                   "SMILES" : "C=12C3=C(NC1C=CC=C2OC[C@H](CNCCOC4=C(C=CC=C4)OC)O)C=CC=C3",
                 "InChIKey" : "OGHNVEJMJSYVRP-KRWDZBQOSA-N",
                 "BTMDB_ID" : "BTM0033",
              "PubChem CID" : "185395",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP2E1; CYP2C9; CYP3A4",
                                "Reaction Type" : "Hydroxylation of benzene on carbon para to a strongly electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1048",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5'-OH-carvedilol",
                       "SMILES" : "O[C@H](COC1=CC=CC2=C1C3=C(N2)C=CC=C3)CNCCOC4=C(OC)C=CC(O)=C4",
                     "InChIKey" : "PVUVZUBTCLBJMT-KRWDZBQOSA-N",
                     "BTMDB_ID" : "BTM0034",
                  "PubChem CID" : "40425353",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2)  Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0021" : {
                                    "Substrate" : {
                     "Name" : "(s)-(+)-ibuprofen",
                   "SMILES" : "[C@H](C(=O)O)(C)C1=CC=C(C=C1)CC(C)C",
                 "InChIKey" : "HEFNNWSXXWATRW-JTQLQIEISA-N",
                 "BTMDB_ID" : "BTM0035",
              "PubChem CID" : "39912",
              "DrugBank ID" : "DB09213",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C8",
                                "Reaction Type" : "Hydroxylation of terminal methyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1061",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-Hydroxyibuprofen",
                       "SMILES" : "OC(=O)[C@H](C1=CC=C(C=C1)CC(C)CO)C",
                     "InChIKey" : "HFAIHLSDLUYLQA-AXDSSHIGSA-N",
                     "BTMDB_ID" : "BTM0036",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0022" : {
                                    "Substrate" : {
                     "Name" : "(s)-fluoxetine",
                   "SMILES" : "[C@H](C1=CC=CC=C1)(OC2=CC=C(C=C2)C(F)(F)F)CCNC",
                 "InChIKey" : "RTHCYVBBDHJXIQ-INIZCTEOSA-N",
                 "BTMDB_ID" : "BTM0037",
              "PubChem CID" : "1548968",
              "DrugBank ID" : "DB08544",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19; CYP3A4",
                                "Reaction Type" : "O-dealkylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0052",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "p-Trifluoromethyl phenol",
                       "SMILES" : "C1=CC(=CC=C1O)C(F)(F)F",
                     "InChIKey" : "BAYGVMXZJBFEMB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0038",
                  "PubChem CID" : "67874",
                  "DrugBank ID" : "DB03610",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Ring, B.J. et al. (2001); Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine; J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50. || (R3) Margolis J.M.; (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes; Drug Metab Dispos. 2000 Oct;28(10):1187-91; PMID: 10997938; Drug Metab Dispos. 2000 Oct;28(10):1187-91."
      },
      "BIOTID0023" : {
                                    "Substrate" : {
                     "Name" : "(s)-hexobarbital",
                   "SMILES" : "C[C@@]1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2",
                 "InChIKey" : "UYXAWHWODHRRMR-LBPRGKRZSA-N",
                 "BTMDB_ID" : "BTM0039",
              "PubChem CID" : "7036944",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19",
                                "Reaction Type" : "Allylic hydroxylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0071",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3'-OH-(S)-hexobarbital",
                       "SMILES" : "N1C(=O)N(C(=O)[C@](C1=O)(C2=CC(O)CCC2)C)C",
                     "InChIKey" : "YHCGILGEMWNROZ-MYIOLCAUSA-N",
                     "BTMDB_ID" : "BTM0040",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0024" : {
                                    "Substrate" : {
                     "Name" : "(s)-hexobarbital",
                   "SMILES" : "C[C@@]1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2",
                 "InChIKey" : "UYXAWHWODHRRMR-LBPRGKRZSA-N",
                 "BTMDB_ID" : "BTM0039",
              "PubChem CID" : "7036944",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3'-OH-(S)-hexobarbital",
                       "SMILES" : "N1C(=O)N(C(=O)[C@](C1=O)(C2=CC(O)CCC2)C)C",
                     "InChIKey" : "YHCGILGEMWNROZ-MYIOLCAUSA-N",
                     "BTMDB_ID" : "BTM0040",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0025" : {
                                    "Substrate" : {
                     "Name" : "(s)-oxybutynin",
                   "SMILES" : "O[C@@](C1CCCCC1)(C2=CC=CC=C2)C(OCC#CCN(CC)CC)=O",
                 "InChIKey" : "XIQVNETUBQGFHX-JOCHJYFZSA-N",
                 "BTMDB_ID" : "BTM0041",
              "PubChem CID" : "206530",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-desethyloxybutynin",
                       "SMILES" : "O[C@](C(=O)OCC#CCNCC)(C1=CC=CC=C1)C2CCCCC2",
                     "InChIKey" : "SNIBJKHIKIIGPR-HXUWFJFHSA-N",
                     "BTMDB_ID" : "BTM0042",
                  "PubChem CID" : "9945371",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "\"(R1) Sato, Y. et al. (2012); Conclusive Identification of the Oxybutynin-Hydrolyzing Enzyme in Human Liver; DRUGMETABOLISM ANDDISPOSITION 2012; 40; 902–906 || (R2) MIZUSHIMA, H. et al. (2007); Stereoselective pharmacokinetics of oxybutynin and"
      },
      "BIOTID0026" : {
                                    "Substrate" : {
                     "Name" : "(s)-propafenone",
                   "SMILES" : "C=1(CCC(C=2C=CC=CC2OC[C@H](CNCCC)O)=O)C=CC=CC1",
                 "InChIKey" : "JWHAUXFOSRPERK-SFHVURJKSA-N",
                 "BTMDB_ID" : "BTM0043",
              "PubChem CID" : "184820",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP3A4",
                                "Reaction Type" : "N-dealkylation of acyclic secondary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1140",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(S)-N-Despropylpropafenone",
                       "SMILES" : "NC[C@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2",
                     "InChIKey" : "HIGKMVIPYOFHBP-HNNXBMFYSA-N",
                     "BTMDB_ID" : "BTM0044",
                  "PubChem CID" : "40582745",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0027" : {
                                    "Substrate" : {
                     "Name" : "(s)-tomoxetine",
                   "SMILES" : "C=1(C=CC=CC1)[C@@H](OC=2C=CC=CC2C)CCNC",
                 "InChIKey" : "VHGCDTVCOLNTBX-KRWDZBQOSA-N",
                 "BTMDB_ID" : "BTM0045",
              "PubChem CID" : "6093336",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP2B6; CYP2C19",
                                "Reaction Type" : "Aliphatic hydroxylation of carbon alpha to secondary or tertiary alkyl-N",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1081",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-Hydroxy-(s)-tomoxetine",
                       "SMILES" : "CC1=CC=CC=C1O[C@H](CCNCO)C2=CC=CC=C2",
                     "InChIKey" : "JQNRSAPXUBOGPP-QGZVFWFLSA-N",
                     "BTMDB_ID" : "BTM0046",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0028" : {
                                    "Substrate" : {
                     "Name" : "1-(3-chlorophenyl)piperazine",
                   "SMILES" : "C1(N2CCNCC2)=CC=CC(=C1)Cl",
                 "InChIKey" : "VHFVKMTVMIZMIK-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0047",
              "PubChem CID" : "1355",
              "DrugBank ID" : "DB12110",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Hydroxylation of aromatic carbon ortho to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1040",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2‐chloro‐4‐(piperazin‐1‐yl)phenol",
                       "SMILES" : "C1=CC(=CC(Cl)=C1O)N2CCNCC2",
                     "InChIKey" : "FXECOYYRPDGOQB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0048",
                  "PubChem CID" : "10420741",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) J. Bolleddula et al.; Drug Metab Rev, 2014; 46(3): 379–419"
      },
      "BIOTID0029" : {
                                    "Substrate" : {
                     "Name" : "1-(3-chlorophenyl)piperazine",
                   "SMILES" : "C1(N2CCNCC2)=CC=CC(=C1)Cl",
                 "InChIKey" : "VHFVKMTVMIZMIK-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0047",
              "PubChem CID" : "1355",
              "DrugBank ID" : "DB12110",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Hydroxylation of benzene on carbon para to a strongly electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1048",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2‐chloro‐4‐(piperazin‐1‐yl)phenol",
                       "SMILES" : "C1=CC(=CC(Cl)=C1O)N2CCNCC2",
                     "InChIKey" : "FXECOYYRPDGOQB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0048",
                  "PubChem CID" : "10420741",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) J. Bolleddula et al.; Drug Metab Rev, 2014; 46(3): 379–419"
      },
      "BIOTID0030" : {
                                    "Substrate" : {
                     "Name" : "1,2-dichlorobenzene",
                   "SMILES" : "C=1C=CC(=C(C1)Cl)Cl",
                 "InChIKey" : "RFFLAFLAYFXFSW-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0049",
              "PubChem CID" : "7239",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2E1; CYP3A4",
                                "Reaction Type" : "Hydroxylation of aromatic carbon para to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1041",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3,4-dichlorophenol",
                       "SMILES" : "OC1=CC(Cl)=C(Cl)C=C1",
                     "InChIKey" : "WDNBURPWRNALGP-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0050",
                  "PubChem CID" : "7258",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284 || (R2) Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53–70"
      },
      "BIOTID0031" : {
                                    "Substrate" : {
                     "Name" : "1,2,4-trichlorobenzene",
                   "SMILES" : "ClC=1C=CC(=C(C1)Cl)Cl",
                 "InChIKey" : "PBKONEOXTCPAFI-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0051",
              "PubChem CID" : "13",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1; CYP1A1",
                                "Reaction Type" : "Hydroxylation of aromatic carbon ortho to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1040",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2,4,5-trichlorophenol",
                       "SMILES" : "C1=C(O)C(Cl)=CC(Cl)=C1Cl",
                     "InChIKey" : "LHJGJYXLEPZJPM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0052",
                  "PubChem CID" : "7271",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284 || (R2) Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53–70"
      },
      "BIOTID0032" : {
                                    "Substrate" : {
                     "Name" : "2-acetamidofluorene",
                   "SMILES" : "N(C=1C=C2C(=CC1)C=3C(C2)=CC=CC3)C(C)=O",
                 "InChIKey" : "CZIHNRWJTSTCEX-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0053",
              "PubChem CID" : "5897",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "N-hydroxylatuon of secondary arylamide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1104",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Hydroxy-2-acetamidofluorene",
                       "SMILES" : "C1=CC=C2C(=C1)C3=CC=C(C=C3C2)N(O)C(=O)C",
                     "InChIKey" : "SOKUIEGXJHVFDV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0054",
                  "PubChem CID" : "5896",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) McManus, M. E. et al (1990), Metablism of 2-acetylaminofluorene and Benzo(a)pyrene activation of food-derived heterocyclic amine mutagens by human cytochromes P-450; Cancer research, 50 (11); 3367-3376, PMID: 2334931"
      },
      "BIOTID0033" : {
                                    "Substrate" : {
                     "Name" : "2-nitropyrene",
                   "SMILES" : "C=1C(=CC=2C=CC=3C=CC=C4C=CC1C2C34)[N+](=O)[O-]",
                 "InChIKey" : "MAZCGYFIOOIVHE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0055",
              "PubChem CID" : "13090",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1307",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6-OH-2-nitropyrene",
                       "SMILES" : "OC1=C2C=CC3=CC(=CC4=CC=C(C=C1)C2=C34)[N+]([O-])=O",
                     "InChIKey" : "IQFVRMOZMBFUFU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0056",
                  "PubChem CID" : "13807754",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423 || (R3) Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
      },
      "BIOTID0034" : {
                                    "Substrate" : {
                     "Name" : "2-phenylphenol",
                   "SMILES" : "OC1=C(C2=CC=CC=C2)C=CC=C1",
                 "InChIKey" : "LLEMOWNGBBNAJR-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0057",
              "PubChem CID" : "7017",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2B6; CYP2D6; CYP2E1; CYP3A4",
                                "Reaction Type" : "Hydroxylation of benzene on carbon para to a strongly electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1048",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2,5-dihydroxybiphenyl",
                       "SMILES" : "OC1=C(C=C(O)C=C1)C2=CC=CC=C2",
                     "InChIKey" : "XCZKKZXWDBOGPA-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0058",
                  "PubChem CID" : "14116",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0035" : {
                                    "Substrate" : {
                     "Name" : "2-phenylphenol",
                   "SMILES" : "OC1=C(C2=CC=CC=C2)C=CC=C1",
                 "InChIKey" : "LLEMOWNGBBNAJR-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0057",
              "PubChem CID" : "7017",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2B6; CYP2D6; CYP2E1; CYP3A4",
                                "Reaction Type" : "p-Hydroxylation of phenol",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1038",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2,5-dihydroxybiphenyl",
                       "SMILES" : "OC1=C(C=C(O)C=C1)C2=CC=CC=C2",
                     "InChIKey" : "XCZKKZXWDBOGPA-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0058",
                  "PubChem CID" : "14116",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0036" : {
                                    "Substrate" : {
                     "Name" : "4-aminobiphenyl",
                   "SMILES" : "C=1(C=CC(=CC1)N)C=2C=CC=CC2",
                 "InChIKey" : "DMVOXQPQNTYEKQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0059",
              "PubChem CID" : "7102",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "N-hydroxylation of primary arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0042",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-aminobiphenyl, N-oxide",
                       "SMILES" : "ONC1=CC=C(C=C1)C2=CC=CC=C2",
                     "InChIKey" : "MYVLYOJYVMLSFA-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0060",
                  "PubChem CID" : "81261",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Butler, M.A. et al. (1989); Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines; Proc Natl Acad Sci U S A. 1989 Oct;86(20):7696-700; PMID:2813353; PMCID:PMC298137"
      },
      "BIOTID0037" : {
                                    "Substrate" : {
                     "Name" : "4-aminobiphenyl",
                   "SMILES" : "C=1(C=CC(=CC1)N)C=2C=CC=CC2",
                 "InChIKey" : "DMVOXQPQNTYEKQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0059",
              "PubChem CID" : "7102",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "N-hydroxylation of aniline to hydroxylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1103",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-aminobiphenyl, N-oxide",
                       "SMILES" : "ONC1=CC=C(C=C1)C2=CC=CC=C2",
                     "InChIKey" : "MYVLYOJYVMLSFA-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0060",
                  "PubChem CID" : "81261",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Butler, M.A. et al. (1989); Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines; Proc Natl Acad Sci U S A. 1989 Oct;86(20):7696-700; PMID:2813353; PMCID:PMC298137"
      },
      "BIOTID0038" : {
                                    "Substrate" : {
                     "Name" : "7-ethoxyresorufin",
                   "SMILES" : "O1C2=C(N=C3C1=CC(=O)C=C3)C=CC(OCC)=C2",
                 "InChIKey" : "CRCWUBLTFGOMDD-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0061",
              "PubChem CID" : "3294",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP1A1",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Resorufin",
                       "SMILES" : "C1=CC2=C(OC3=CC(=O)C=CC3=N2)C=C1O",
                     "InChIKey" : "HSSLDCABUXLXKM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0062",
                  "PubChem CID" : "69462",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0039" : {
                                    "Substrate" : {
                     "Name" : "7-ethoxyresorufin",
                   "SMILES" : "O1C2=C(N=C3C1=CC(=O)C=C3)C=CC(OCC)=C2",
                 "InChIKey" : "CRCWUBLTFGOMDD-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0061",
              "PubChem CID" : "3294",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP1A1",
                                "Reaction Type" : "O-dealkylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0052",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Resorufin",
                       "SMILES" : "C1=CC2=C(OC3=CC(=O)C=CC3=N2)C=C1O",
                     "InChIKey" : "HSSLDCABUXLXKM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0062",
                  "PubChem CID" : "69462",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0040" : {
                                    "Substrate" : {
                     "Name" : "aceclofenac",
                   "SMILES" : "C1(=C(CC(OCC(O)=O)=O)C=CC=C1)NC2=C(C=CC=C2Cl)Cl",
                 "InChIKey" : "MNIPYSSQXLZQLJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0063",
              "PubChem CID" : "71771",
              "DrugBank ID" : "DB06736",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Hydroxylation of benzene on carbon para to an electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1047",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5-OH-aceclofenac",
                       "SMILES" : "OC(=O)COC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC(O)=C1",
                     "InChIKey" : "IUSFDHLZHGPYRJ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0064",
                  "PubChem CID" : "101998321",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0041" : {
                                    "Substrate" : {
                     "Name" : "acetaminophen",
                   "SMILES" : "CC(=O)NC1=CC=C(O)C=C1",
                 "InChIKey" : "RZVAJINKPMORJF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0065",
              "PubChem CID" : "1983",
              "DrugBank ID" : "DB00316",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2E1; CYP3A4; CYP2A6; CYP2C9; CYP2D6; CYP1A1",
                                "Reaction Type" : "Oxidation of p-substituted anilides",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1018",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Acetyl-p-benzoquinone",
                       "SMILES" : "C1=CC(=NC(=O)C)C=CC1=O",
                     "InChIKey" : "URNSECGXFRDEDC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0066",
                  "PubChem CID" : "39763",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0042" : {
                                    "Substrate" : {
                     "Name" : "acetanilide",
                   "SMILES" : "O=C(NC1=CC=CC=C1)C",
                 "InChIKey" : "FZERHIULMFGESH-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0067",
              "PubChem CID" : "904",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1",
                                "Reaction Type" : "N-hydroxylation of anilide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1105",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Hydroxy-N-phenylacetamide",
                       "SMILES" : "C1=CC=C(C=C1)N(O)C(=O)C",
                     "InChIKey" : "GMJUGPZVHVVVCG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0068",
                  "PubChem CID" : "115251",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0043" : {
                                    "Substrate" : {
                     "Name" : "aflatoxin b1",
                   "SMILES" : "C=12C3=C(C=C(C1C4=C(C(O2)=O)C(CC4)=O)OC)O[C@@H]5[C@H]3C=CO5",
                 "InChIKey" : "OQIQSTLJSLGHID-WNWIJWBNSA-N",
                 "BTMDB_ID" : "BTM0069",
              "PubChem CID" : "186907",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP3A4 ",
                                "Reaction Type" : "Allylic hydroxylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0071",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Aflatoxin Q1",
                       "SMILES" : "C1=C[C@H]2C3=C(O[C@H]2O1)C=C(OC)C4=C3OC(=O)C5=C4C(O)CC5=O",
                     "InChIKey" : "GYNOTJLCULOEIM-VYNLQGFGSA-N",
                     "BTMDB_ID" : "BTM0070",
                  "PubChem CID" : "101288447",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0044" : {
                                    "Substrate" : {
                     "Name" : "aflatoxin b1",
                   "SMILES" : "C=12C3=C(C=C(C1C4=C(C(O2)=O)C(CC4)=O)OC)O[C@@H]5[C@H]3C=CO5",
                 "InChIKey" : "OQIQSTLJSLGHID-WNWIJWBNSA-N",
                 "BTMDB_ID" : "BTM0069",
              "PubChem CID" : "186907",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP3A4 ",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1067",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Aflatoxin Q1",
                       "SMILES" : "C1=C[C@H]2C3=C(O[C@H]2O1)C=C(OC)C4=C3OC(=O)C5=C4C(O)CC5=O",
                     "InChIKey" : "GYNOTJLCULOEIM-VYNLQGFGSA-N",
                     "BTMDB_ID" : "BTM0070",
                  "PubChem CID" : "101288447",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0045" : {
                                    "Substrate" : {
                     "Name" : "alfentanil",
                   "SMILES" : "N1=NN(C(N1CCN2CCC(CC2)(COC)N(C(CC)=O)C=3C=CC=CC3)=O)CC",
                 "InChIKey" : "IDBPHNDTYPBSNI-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0071",
              "PubChem CID" : "51263",
              "DrugBank ID" : "DB00802",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2‐(4‐ethyl‐5‐oxo‐1,2,3,4‐tetrazol‐1‐yl)acetaldehyde",
                       "SMILES" : "C(=O)CN1N=NN(CC)C1=O",
                     "InChIKey" : "RWVLUTFSOYZBDA-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0073",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0046" : {
                                    "Substrate" : {
                     "Name" : "Ametryn",
                   "SMILES" : "N(C1=NC(=NC(SC)=N1)NC(C)C)CC",
                 "InChIKey" : "RQVYBGPQFYCBGX-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0074",
              "PubChem CID" : "13263",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2B6; CYP2C9; CYP3A4",
                                "Reaction Type" : "S-oxidation of alkylarylthioether to sulfoxide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-N-ethyl-6-methylsulfinyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine",
                       "SMILES" : "CCNC1=NC(NC(C)C)=NC(=N1)S(C)=O",
                     "InChIKey" : "LKFFHIOAQPRPCO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0075",
                  "PubChem CID" : "157663",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : " (R1) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015 || (R2) Lang, D.H.et al. (1997). Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem. Res. Toxicol., Vol. 10, No. 9, (1037-1044) || (R3) Lang DH et al. (1997); Identification of Enzymes Involved in the Metabolism of Atrazine, Terbuthylazine, Ametryne, and Terbutryne in Human Liver Microsomes; Chem. Res. Toxicol., 10, 1037-1044; PMID:9305587; DOI:10.1021/tx970081l"
      },
      "BIOTID0047" : {
                                    "Substrate" : {
                     "Name" : "amiodarone",
                   "SMILES" : "CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1",
                 "InChIKey" : "IYIKLHRQXLHMJQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0076",
              "PubChem CID" : "2157",
              "DrugBank ID" : "DB01118",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C8; CYP2C9; CYP1A2; CYP2D6",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Desethylamiodarone",
                       "SMILES" : "C1=CC=C2C(OC(=C2C(=O)C3=CC(I)=C(OCCNCC)C(I)=C3)CCCC)=C1",
                     "InChIKey" : "VXOKDLACQICQFA-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0077",
                  "PubChem CID" : "104774",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0048" : {
                                    "Substrate" : {
                     "Name" : "aniline",
                   "SMILES" : "C=1(N)C=CC=CC1",
                 "InChIKey" : "PAYRUJLWNCNPSJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0078",
              "PubChem CID" : "6115",
              "DrugBank ID" : "DB06728",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1",
                                "Reaction Type" : "N-hydroxylation of primary arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0042",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Hydroxyaniline",
                       "SMILES" : "N(O)C1=CC=CC=C1",
                     "InChIKey" : "CKRZKMFTZCFYGB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0079",
                  "PubChem CID" : "7518",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0049" : {
                                    "Substrate" : {
                     "Name" : "aniline",
                   "SMILES" : "C=1(N)C=CC=CC1",
                 "InChIKey" : "PAYRUJLWNCNPSJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0078",
              "PubChem CID" : "6115",
              "DrugBank ID" : "DB06728",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1",
                                "Reaction Type" : "N-hydroxylation of aniline to hydroxylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1103",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Hydroxyaniline",
                       "SMILES" : "N(O)C1=CC=CC=C1",
                     "InChIKey" : "CKRZKMFTZCFYGB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0079",
                  "PubChem CID" : "7518",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0050" : {
                                    "Substrate" : {
                     "Name" : "antipyrine",
                   "SMILES" : "CN1N(C(=O)C=C1C)C2=CC=CC=C2",
                 "InChIKey" : "VEQOALNAAJBPNY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0080",
              "PubChem CID" : "2206",
              "DrugBank ID" : "DB01435",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP1A2",
                                "Reaction Type" : "Hydroxylation of carbon alpha to conkjugated carbonyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1055",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-OH-antipyrine",
                       "SMILES" : "C1=CC=C(C=C1)N2N(C(=C(O)C2=O)C)C",
                     "InChIKey" : "SKVPTPMWXJSBTF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0081",
                  "PubChem CID" : "98889",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0051" : {
                                    "Substrate" : {
                     "Name" : "arachidonic acid",
                   "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCC",
                 "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                 "BTMDB_ID" : "BTM0082",
              "PubChem CID" : "444899",
              "DrugBank ID" : "DB04557",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2C8; CYP2C9",
                                "Reaction Type" : "Aliphatic hydroxylation of acyclic 1,2-disubstituted alkene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1053",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5-HETE",
                       "SMILES" : "OC(=O)CCCC(O)/C=C/C=C\\C/C=C\\C/C=C\\CCCCC",
                     "InChIKey" : "KGIJOOYOSFUGPC-XTDASVJISA-N",
                     "BTMDB_ID" : "BTM0083",
                  "PubChem CID" : "9862886",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423 || (R2) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R3) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0052" : {
                                    "Substrate" : {
                     "Name" : "arachidonic acid",
                   "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCC",
                 "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                 "BTMDB_ID" : "BTM0082",
              "PubChem CID" : "444899",
              "DrugBank ID" : "DB04557",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2C8; CYP2C9; CYP3A4",
                                "Reaction Type" : "Bisallylic hydroxylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0072",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "13-HETE",
                       "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\C(O)/C=C\\CCCCC",
                     "InChIKey" : "SAKQICHVWOJSNI-BWWNDVLWSA-N",
                     "BTMDB_ID" : "BTM0084",
                  "PubChem CID" : "53481471",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423 || (R2) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R3) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0053" : {
                                    "Substrate" : {
                     "Name" : "arachidonic acid",
                   "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCC",
                 "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                 "BTMDB_ID" : "BTM0082",
              "PubChem CID" : "444899",
              "DrugBank ID" : "DB04557",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2E1",
                                "Reaction Type" : "Hydroxylation of acyclic aliphatic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1063",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "18-HETE",
                       "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(O)CC",
                     "InChIKey" : "PPCHNRUZQWLEMF-XBOCNYGYSA-N",
                     "BTMDB_ID" : "BTM0085",
                  "PubChem CID" : "6442778",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423 || (R2) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R3) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0054" : {
                                    "Substrate" : {
                     "Name" : "arachidonic acid",
                   "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCC",
                 "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                 "BTMDB_ID" : "BTM0082",
              "PubChem CID" : "444899",
              "DrugBank ID" : "DB04557",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2B6; CYP2D6",
                                "Reaction Type" : "Epxodation of alkene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0109",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "14,15-EET",
                       "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\CC1OC1CCCCC",
                     "InChIKey" : "JBSCUHKPLGKXKH-ILYOTBPNSA-N",
                     "BTMDB_ID" : "BTM0086",
                  "PubChem CID" : "5283205",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423 || (R2) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R3) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0055" : {
                                    "Substrate" : {
                     "Name" : "arachidonic acid",
                   "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCC",
                 "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                 "BTMDB_ID" : "BTM0082",
              "PubChem CID" : "444899",
              "DrugBank ID" : "DB04557",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2B6; CYP2D6",
                                "Reaction Type" : "Epxodation of alkene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0109",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5,6-EET",
                       "SMILES" : "OC(=O)CCCC1OC1C/C=C\\C/C=C\\C/C=C\\CCCCC",
                     "InChIKey" : "VBQNSZQZRAGRIX-QNEBEIHSSA-N",
                     "BTMDB_ID" : "BTM0087",
                  "PubChem CID" : "5283202",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423 || (R2) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R3) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0056" : {
                                    "Substrate" : {
                     "Name" : "arachidonic acid",
                   "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCC",
                 "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                 "BTMDB_ID" : "BTM0082",
              "PubChem CID" : "444899",
              "DrugBank ID" : "DB04557",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2C8",
                                "Reaction Type" : "Aliphatic hydroxylation of acyclic 1,2-disubstituted alkene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1053",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "11-HETE",
                       "SMILES" : "OC(=O)CCC/C=C\\C/C=C\\CC(O)C=C/C=C\\CCCCC",
                     "InChIKey" : "GCZRCCHPLVMMJE-RLZWZWKOSA-N",
                     "BTMDB_ID" : "BTM0088",
                  "PubChem CID" : "14123410",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423 || (R2) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R3) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0057" : {
                                    "Substrate" : {
                     "Name" : "aripiprazole",
                   "SMILES" : "ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl",
                 "InChIKey" : "CEUORZQYGODEFX-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0089",
              "PubChem CID" : "60795",
              "DrugBank ID" : "DB01238",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Dehydrogenation of alpha,beta-unsaturated amide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1193",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "dehydro-aripiprazole",
                       "SMILES" : "ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(C=CC(=O)N4)C=C3)CC2)=C1Cl",
                     "InChIKey" : "CDONPRYEWWPREK-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0090",
                  "PubChem CID" : "10114519",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Bauman, N. et al (2008), Comparison of the Bioactivation Potential of the Antidepressant and Hepatotaxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug, DMD 36:1016-1029, 2008"
      },
      "BIOTID0058" : {
                                    "Substrate" : {
                     "Name" : "arverapamil",
                   "SMILES" : "C=1C(=C(C=C(CCNCCC[C@@](C(C)C)(C2=CC=C(OC)C(OC)=C2)C#N)C1)OC)OC",
                 "InChIKey" : "UPKQNCPKPOLASS-AREMUKBSSA-N",
                 "BTMDB_ID" : "BTM0091",
              "PubChem CID" : "15593907",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8; CYP3A4; CYP2D6",
                                "Reaction Type" : "O-aryl dealkylation adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1131",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(2R)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile",
                       "SMILES" : "N(CCC1=CC(OC)=C(OC)C=C1)CCC[C@](C#N)(C2=CC=CC(OC)=C2)C(C)C",
                     "InChIKey" : "IQVLXQZAOGCLEE-RUZDIDTESA-N",
                     "BTMDB_ID" : "BTM0092",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545–552; doi: 10.1046/j.1365-2125.1999.00923.x || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0059" : {
                                    "Substrate" : {
                     "Name" : "astemizole",
                   "SMILES" : "COC1=CC=C(CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1",
                 "InChIKey" : "GXDALQBWZGODGZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0093",
              "PubChem CID" : "2247",
              "DrugBank ID" : "DB00637",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP3A4",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6-Hydroxyastemizole",
                       "SMILES" : "N(C1=NC2=CC=C(O)C=C2N1CC3=CC=C(F)C=C3)C4CCN(CCC5=CC=C(OC)C=C5)CC4",
                     "InChIKey" : "GJJYAIIDIMCSIM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0094",
                  "PubChem CID" : "10027871",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Matsumoto, S.and Yamazoe, Y. (2001); Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine; Br J Clin Pharmacol.; 51(2):133-42; PMID:11259984; PMCID:PMC2014443"
      },
      "BIOTID0060" : {
                                    "Substrate" : {
                     "Name" : "bosentan",
                   "SMILES" : "C=1(C(=C(N=C(N1)C=2N=CC=CN2)OCCO)OC=3C(=CC=CC3)OC)NS(=O)(=O)C=4C=CC(=CC4)C(C)(C)C",
                 "InChIKey" : "GJPICJJJRGTNOD-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0095",
              "PubChem CID" : "104865",
              "DrugBank ID" : "DB00559",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C9",
                                "Reaction Type" : "O-aryl demethylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1133",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2’]bipyrimidinyl-4-yl]-benzenesulfonamide",
                       "SMILES" : "OCCOC1=C(OC2=CC=CC=C2O)C(=NC(=N1)C3=NC=CC=N3)NS(=O)(=O)C4=CC=C(C=C4)C(C)(C)C",
                     "InChIKey" : "STTLKJGYAWXIPP-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0096",
                  "PubChem CID" : "6426756",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0061" : {
                                    "Substrate" : {
                     "Name" : "bropirimine",
                   "SMILES" : "C=1(NC(C(=C(N1)C=2C=CC=CC2)Br)=O)N",
                 "InChIKey" : "CIUUIPMOFZIWIZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0097",
              "PubChem CID" : "65457",
              "DrugBank ID" : "DB04168",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "p-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1035",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "p-hydroxybropirimine",
                       "SMILES" : "OC1=CC=C(C=C1)C2=C(Br)C(O)=NC(=N)N2",
                     "InChIKey" : "BPQDHWHENINUML-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0098",
                  "PubChem CID" : "6320168",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wynalda, M.A. et al. (1998); Human biotransformation of bropirimine. Characterization of the major bropirimine oxidative metabolites formed in vitro; Drug Metab Dispos; 26(10):1048-51; PMID:9763414"
      },
      "BIOTID0062" : {
                                    "Substrate" : {
                     "Name" : "carbamazepine",
                   "SMILES" : "NC(=O)N1C2=CC=CC=C2C=CC3=CC=CC=C13",
                 "InChIKey" : "FFGPTBGBLSHEPO-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0099",
              "PubChem CID" : "2554",
              "DrugBank ID" : "DB00564",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP3A4; CYP2C8 ",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-Hydroxycarbamazepine",
                       "SMILES" : "NC(=O)N1C2=CC=CC=C2C=CC3=CC=C(O)C=C13",
                     "InChIKey" : "QQCFBZCATDIWTH-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0100",
                  "PubChem CID" : "135290",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Panesar, S. K., Bandiera, S. M., Abbott, F. S. (1996). Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Drug Metab. Dispos. 24:619–628"
      },
      "BIOTID0063" : {
                                    "Substrate" : {
                     "Name" : "Carbofuran",
                   "SMILES" : "CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2",
                 "InChIKey" : "DUEPRVBVGDRKAG-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0101",
              "PubChem CID" : "2566",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2C19; CYP3A4",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1067",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "e-hydroxy-carbofuran",
                       "SMILES" : "CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2O",
                     "InChIKey" : "RHSUJRQZTQNSLL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0102",
                  "PubChem CID" : "27975",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Abass, K. et al. (2010). Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem. Biol. Interact., Vol. 185, No. 3, (163-173)."
      },
      "BIOTID0064" : {
                                    "Substrate" : {
                     "Name" : "Seratrodast",
                   "SMILES" : "[C@H](C=1C=CC=CC1)(C2=C(C(=O)C(=C(C2=O)C)C)C)CCCCCC(O)=O",
                 "InChIKey" : "ZBVKEHDGYSLCCC-SFHVURJKSA-N",
                 "BTMDB_ID" : "BTM0103",
              "PubChem CID" : "73346713",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19; CYP2C9; CYP2C8; CYP3A4; CYP2B6",
                                "Reaction Type" : "Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5-OH-seratrodast",
                       "SMILES" : "OC(=O)CCCCC[C@@H](C1=CC=CC=C1)C2=C(C(=O)C(=C(C2=O)C)CO)C",
                     "InChIKey" : "AQWOADAKGYZHIB-KRWDZBQOSA-N",
                     "BTMDB_ID" : "BTM0104",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0065" : {
                                    "Substrate" : {
                     "Name" : "chlorpromazine",
                   "SMILES" : "CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(Cl)C=C3",
                 "InChIKey" : "ZPEIMTDSQAKGNT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0105",
              "PubChem CID" : "2726",
              "DrugBank ID" : "DB00477",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "S-oxidation of diarylthioether to sulfoxide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0059",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Chlorpromazine S-oxide",
                       "SMILES" : "C1=CC=C2C(=C1)N(C3=C(C=CC(Cl)=C3)S2=O)CCCN(C)C",
                     "InChIKey" : "QEPPAOXKZOTMPM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0106",
                  "PubChem CID" : "70413",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
      },
      "BIOTID0066" : {
                                    "Substrate" : {
                     "Name" : "chlorpropamide",
                   "SMILES" : "C1(S(NC(NCCC)=O)(=O)=O)=CC=C(C=C1)Cl",
                 "InChIKey" : "RKWGIWYCVPQPMF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0107",
              "PubChem CID" : "2727",
              "DrugBank ID" : "DB00672",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Hydroxylation of aromatic carbon ortho to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1040",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-OH-chlorpropamide",
                       "SMILES" : "CCCNC(=O)NS(=O)(=O)C1=CC(O)=C(Cl)C=C1",
                     "InChIKey" : "RXFPYNAVFFDUJE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0108",
                  "PubChem CID" : "131750724",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675 || (R2) Shon, J. (2004), Chlorpropamide 2 hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism, British Journal of Clinical Pharmacology; DOI:10.1111/j.1365-2125.2005.02364.x"
      },
      "BIOTID0067" : {
                                    "Substrate" : {
                     "Name" : "Chlorpyrifos",
                   "SMILES" : "C1=C(Cl)C(OP(=S)(OCC)OCC)=NC(Cl)=C1Cl",
                 "InChIKey" : "SBPBAQFWLVIOKP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0109",
              "PubChem CID" : "2730",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19; CYP2B6; CYP3A4",
                                "Reaction Type" : "Dearylation of organphosphosulfur compound",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1170",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Diethyl phosphorothioate",
                       "SMILES" : "CCOP(O)(=O)OCC",
                     "InChIKey" : "UCQFCFPECQILOL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0110",
                  "PubChem CID" : "654",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0068" : {
                                    "Substrate" : {
                     "Name" : "cinnarizine",
                   "SMILES" : "C=1(/C=C/CN2CCN(C(C=3C=CC=CC3)C=4C=CC=CC4)CC2)C=CC=CC1",
                 "InChIKey" : "DERZBLKQOCDDDZ-JLHYYAGUSA-N",
                 "BTMDB_ID" : "BTM0111",
              "PubChem CID" : "1547484",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP1A2; CYP2A6",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Cinnamaldehyde",
                       "SMILES" : "O=C/C=C/C1=CC=CC=C1",
                     "InChIKey" : "KJPRLNWUNMBNBZ-QPJJXVBHSA-N",
                     "BTMDB_ID" : "BTM0113",
                  "PubChem CID" : "637511",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0069" : {
                                    "Substrate" : {
                     "Name" : "cisapride",
                   "SMILES" : "C=1(C=CC(=CC1)F)OCCCN2CC[C@@H]([C@@H](C2)OC)NC(=O)C=3C(=CC(=C(C3)Cl)N)OC",
                 "InChIKey" : "DCSUBABJRXZOMT-RBBKRZOGSA-N",
                 "BTMDB_ID" : "BTM0114",
              "PubChem CID" : "5311047",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C8; CYP2B6",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Norcisapride",
                       "SMILES" : "NC1=C(Cl)C=C(C(=O)N[C@H]2CCNC[C@H]2OC)C(OC)=C1",
                     "InChIKey" : "OMLDMGPCWMBPAN-WCQYABFASA-N",
                     "BTMDB_ID" : "BTM0115",
                  "PubChem CID" : "9861621",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0070" : {
                                    "Substrate" : {
                     "Name" : "cisapride",
                   "SMILES" : "C=1(C=CC(=CC1)F)OCCCN2CC[C@@H]([C@@H](C2)OC)NC(=O)C=3C(=CC(=C(C3)Cl)N)OC",
                 "InChIKey" : "DCSUBABJRXZOMT-RBBKRZOGSA-N",
                 "BTMDB_ID" : "BTM0114",
              "PubChem CID" : "5311047",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of benzene on carbon ortho to an electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1045",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Fluoro-2- hydroxycisapride",
                       "SMILES" : "NC1=C(Cl)C=C(C(=O)N[C@H]2CCN(CCCOC3=C(O)C=C(F)C=C3)C[C@H]2OC)C(OC)=C1",
                     "InChIKey" : "FNNZAZYOQRBQAC-PGRDOPGGSA-N",
                     "BTMDB_ID" : "BTM0116",
                  "PubChem CID" : "101124818",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0071" : {
                                    "Substrate" : {
                     "Name" : "(+-)-Cisapride",
                   "SMILES" : "NC1=C(Cl)C=C(C(=O)NC2CCN(CCCOC3=CC=C(F)C=C3)CC2OC)C(OC)=C1",
                 "InChIKey" : "DCSUBABJRXZOMT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0117",
              "PubChem CID" : "2769",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "2-Hydroxylation of 1,4-disubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0039",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Fluoro-2-hydroxycisapride",
                       "SMILES" : "COC1CN(CCCOC2=C(O)C=C(F)C=C2)CCC1NC(=O)C3=CC(Cl)=C(N)C=C3OC",
                     "InChIKey" : "FNNZAZYOQRBQAC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0118",
                  "PubChem CID" : "101146906",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0072" : {
                                    "Substrate" : {
                     "Name" : "(+-)-Cisapride",
                   "SMILES" : "NC1=C(Cl)C=C(C(=O)NC2CCN(CCCOC3=CC=C(F)C=C3)CC2OC)C(OC)=C1",
                 "InChIKey" : "DCSUBABJRXZOMT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0117",
              "PubChem CID" : "2769",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of benzene on carbon ortho to an electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1045",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Fluoro-2-hydroxycisapride",
                       "SMILES" : "COC1CN(CCCOC2=C(O)C=C(F)C=C2)CCC1NC(=O)C3=CC(Cl)=C(N)C=C3OC",
                     "InChIKey" : "FNNZAZYOQRBQAC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0118",
                  "PubChem CID" : "101146906",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0073" : {
                                    "Substrate" : {
                     "Name" : "(+-)-Cisapride",
                   "SMILES" : "NC1=C(Cl)C=C(C(=O)NC2CCN(CCCOC3=CC=C(F)C=C3)CC2OC)C(OC)=C1",
                 "InChIKey" : "DCSUBABJRXZOMT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0117",
              "PubChem CID" : "2769",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of aromatic carbon meta to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1039",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Fluoro-2-hydroxycisapride",
                       "SMILES" : "COC1CN(CCCOC2=C(O)C=C(F)C=C2)CCC1NC(=O)C3=CC(Cl)=C(N)C=C3OC",
                     "InChIKey" : "FNNZAZYOQRBQAC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0118",
                  "PubChem CID" : "101146906",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0074" : {
                                    "Substrate" : {
                     "Name" : "clomipramine",
                   "SMILES" : "CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(Cl)C=C3",
                 "InChIKey" : "GDLIGKIOYRNHDA-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0119",
              "PubChem CID" : "2801",
              "DrugBank ID" : "DB01242",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-OH-clomipramine",
                       "SMILES" : "C1=CC=C2C(=C1)N(C3=C(C=C(O)C(Cl)=C3)CC2)CCCN(C)C",
                     "InChIKey" : "QXZNSJJZRXNDJQ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0120",
                  "PubChem CID" : "10246110",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0075" : {
                                    "Substrate" : {
                     "Name" : "clomipramine",
                   "SMILES" : "CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(Cl)C=C3",
                 "InChIKey" : "GDLIGKIOYRNHDA-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0119",
              "PubChem CID" : "2801",
              "DrugBank ID" : "DB01242",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Hydroxylation of heteroalicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1070",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "10-OH-clomipramine",
                       "SMILES" : "C1=CC=C2C(=C1)N(C3=C(C=CC(Cl)=C3)CC2O)CCCN(C)C",
                     "InChIKey" : "OVNBDHJPQNLBSY-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0121",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754424"
      },
      "BIOTID0076" : {
                                    "Substrate" : {
                     "Name" : "clozapine",
                   "SMILES" : "CN1CCN(CC1)C2=NC3=CC(Cl)=CC=C3NC4=CC=CC=C24",
                 "InChIKey" : "QZUDBNBUXVUHMW-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0122",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP1A2; CYP2C8; CYP2C19; CYP3A5",
                                "Reaction Type" : "N-oxidation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1099",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Clozapine-N-oxide",
                       "SMILES" : "N1C2=CC=C(Cl)C=C2N=C(N3CC[N+]([O-])(C)CC3)C4=CC=CC=C14",
                     "InChIKey" : "OGUCZBIQSYYWEF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0123",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0077" : {
                                    "Substrate" : {
                     "Name" : "cotinine",
                   "SMILES" : "C=1N=CC([C@H]2N(C)C(=O)CC2)=CC1",
                 "InChIKey" : "UIKROCXWUNQSPJ-VIFPVBQESA-N",
                 "BTMDB_ID" : "BTM0124",
              "PubChem CID" : "854019",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6",
                                "Reaction Type" : "Hydroxylation of  carbon next to amide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1090",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5'-hydroxycotinine",
                       "SMILES" : "C1=CC=C(C=N1)[C@@]2(O)N(C)C(=O)CC2",
                     "InChIKey" : "BBNHNZGTKSWIHD-SNVBAGLBSA-N",
                     "BTMDB_ID" : "BTM0125",
                  "PubChem CID" : "9815515",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Oscarson, M; (2001); Genetic Polymorphisms in the Cytochrome P450 2A6 (CYP2A6) Gene: Implications for Interindividual Differences in Nicotine Metabolism; Drug Metabolism and Disposition;  February 2001, 29 (2) 91-95; DMD 29:91–95, 200"
      },
      "BIOTID0078" : {
                                    "Substrate" : {
                     "Name" : "cotinine",
                   "SMILES" : "C=1N=CC([C@H]2N(C)C(=O)CC2)=CC1",
                 "InChIKey" : "UIKROCXWUNQSPJ-VIFPVBQESA-N",
                 "BTMDB_ID" : "BTM0124",
              "PubChem CID" : "854019",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6",
                                "Reaction Type" : "Alpha hydroxylation of carbonyl group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1054",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5'-hydroxycotinine",
                       "SMILES" : "C1=CC=C(C=N1)[C@@]2(O)N(C)C(=O)CC2",
                     "InChIKey" : "BBNHNZGTKSWIHD-SNVBAGLBSA-N",
                     "BTMDB_ID" : "BTM0125",
                  "PubChem CID" : "9815515",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Oscarson, M; (2001); Genetic Polymorphisms in the Cytochrome P450 2A6 (CYP2A6) Gene: Implications for Interindividual Differences in Nicotine Metabolism; Drug Metabolism and Disposition;  February 2001, 29 (2) 91-95; DMD 29:91–95, 200"
      },
      "BIOTID0079" : {
                                    "Substrate" : {
                     "Name" : "coumarin",
                   "SMILES" : "C=12C=CC=CC1C=CC(=O)O2",
                 "InChIKey" : "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0126",
              "PubChem CID" : "323",
              "DrugBank ID" : "DB04665",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2E1",
                                "Reaction Type" : "Epoxidation of arene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1027",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Coumarin 3,4-epoxide",
                       "SMILES" : "C1=CC2=C(C3OC3C(=O)O2)C=C1",
                     "InChIKey" : "YGDJSRSAEUNWRE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0127",
                  "PubChem CID" : "126771",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Born, S.L. et al. (2002); Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation; Drug Metab Dispos; 30(5):483-7; PMID:11950775; DOI:https://doi.org/10.1124/dmd.30.5.483"
      },
      "BIOTID0080" : {
                                    "Substrate" : {
                     "Name" : "desmethylcitalopram",
                   "SMILES" : "CNCCCC1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3",
                 "InChIKey" : "PTJADDMMFYXMMG-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0128",
              "PubChem CID" : "162180",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "N-dealkylation of acyclic secondary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1140",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N,N-Didesmethylcitalopram",
                       "SMILES" : "NCCCC1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3",
                     "InChIKey" : "RKUKMUWCRLRPEJ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0129",
                  "PubChem CID" : "162976",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0081" : {
                                    "Substrate" : {
                     "Name" : "dexamethasone",
                   "SMILES" : "[C@@H]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@H]2CCC4=CC(=O)C=C[C@]34C",
                 "InChIKey" : "UREBDLICKHMUKA-CXSFZGCWSA-N",
                 "BTMDB_ID" : "BTM0130",
              "PubChem CID" : "5743",
              "DrugBank ID" : "DB01234",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of carbon gamma to conkjugated carbonyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1057",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6-alpha-OH DEXAMETHASONE",
                       "SMILES" : "OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](O)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C",
                     "InChIKey" : "RVBSTEHLLHXILB-GQKYHHCASA-N",
                     "BTMDB_ID" : "BTM0131",
                  "PubChem CID" : "10386732",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Daniela, M. (1995); DexamethasoneMetabolismby Human Liverin Vitro.Metabolite Identificationand Inhibitionof 6-Hydroxylation; Department of Pharmacology & Therapeutics, University of Liverpool; 0022-3565/96/2771-0105$"
      },
      "BIOTID0082" : {
                                    "Substrate" : {
                     "Name" : "dextromethorphan",
                   "SMILES" : "O(C1=CC=2[C@]34[C@@H]([C@@H](N(CC3)C)CC2C=C1)CCCC4)C",
                 "InChIKey" : "MKXZASYAUGDDCJ-NJAFHUGGSA-N",
                 "BTMDB_ID" : "BTM0132",
              "PubChem CID" : "5360696",
              "DrugBank ID" : "DB00514",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2D6; CYP2C9; CYP2B6; CYP2C19",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-methoxymorphinan",
                       "SMILES" : "COC1=CC2=C(C[C@@H]3NCC[C@]24CCCC[C@H]34)C=C1",
                     "InChIKey" : "ILNSWVUXAPSPEH-PVAVHDDUSA-N",
                     "BTMDB_ID" : "BTM0133",
                  "PubChem CID" : "6603912",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675 || (R2) Yu, A. et al; (2001); COMPARATIVE CONTRIBUTION TO DEXTROMETHORPHAN METABOLISM BY CYTOCHROME P450 ISOFORMS IN VITRO: CAN DEXTROMETHORPHAN BE USED AS A DUAL PROBE FOR BOTH CYP2D6 AND CYP3A ACTIVITIES?; Drug metabolism and Disposition, 2001 Vol. 29, No. 11"
      },
      "BIOTID0083" : {
                                    "Substrate" : {
                     "Name" : "dexverapamil",
                   "SMILES" : "O(C=1C=C([C@](C(C)C)(CCCN(CCC2=CC(OC)=C(OC)C=C2)C)C#N)C=CC1OC)C",
                 "InChIKey" : "SGTNSNPWRIOYBX-HHHXNRCGSA-N",
                 "BTMDB_ID" : "BTM0134",
              "PubChem CID" : "65808",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8",
                                "Reaction Type" : "O-aryl dealkylation adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1131",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(2R)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(4-hydroxy-3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile",
                       "SMILES" : "C1=CC(=CC(OC)=C1O)[C@@](C#N)(CCCN(C)CCC2=CC(OC)=C(OC)C=C2)C(C)C",
                     "InChIKey" : "WLKVZSXOMGNZLB-AREMUKBSSA-N",
                     "BTMDB_ID" : "BTM0135",
                  "PubChem CID" : "91810609",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545–552; doi: 10.1046/j.1365-2125.1999.00923.x || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0084" : {
                                    "Substrate" : {
                     "Name" : "diazepam",
                   "SMILES" : "CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C3=CC=CC=C3",
                 "InChIKey" : "AAOVKJBEBIDNHE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0136",
              "PubChem CID" : "3016",
              "DrugBank ID" : "DB00829",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP3A5; CYP2C19",
                                "Reaction Type" : "3-Hydroxylation of 5-aryl-1,4-benzodiazepine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1082",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Temazepam",
                       "SMILES" : "C1=CC=C(C=C1)C2=NC(O)C(=O)N(C3=C2C=C(Cl)C=C3)C",
                     "InChIKey" : "SEQDDYPDSLOBDC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0137",
                  "PubChem CID" : "5391",
                  "DrugBank ID" : "DB00231",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0085" : {
                                    "Substrate" : {
                     "Name" : "Diazinon",
                   "SMILES" : "CCOP(=S)(OCC)OC1=CC(C)=NC(=N1)C(C)C",
                 "InChIKey" : "FHIVAFMUCKRCQO-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0138",
              "PubChem CID" : "3017",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP2D6; CYP3A4",
                                "Reaction Type" : "Desulfuration of organophosphothioates",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0070",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Diazoxon",
                       "SMILES" : "CCOP(=O)(OCC)OC1=CC(C)=NC(=N1)C(C)C",
                     "InChIKey" : "VBLJFQYCTRKKKF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0139",
                  "PubChem CID" : "13754",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kappers, W.A. et al.; (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicol. Appl. Pharmacol., Vol. 177, No. 1, (68-76) || (R2) Buratti, F.M. et al.; Toxicology and Applied Pharmacology 186 (2003) 143–154."
      },
      "BIOTID0086" : {
                                    "Substrate" : {
                     "Name" : "diltiazem",
                   "SMILES" : "COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O",
                 "InChIKey" : "HSUGRBWQSSZJOP-RTWAWAEBSA-N",
                 "BTMDB_ID" : "BTM0140",
              "PubChem CID" : "39186",
              "DrugBank ID" : "DB00343",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "O-Demethyldiltiazem",
                       "SMILES" : "C1=CC=C2N(C(=O)[C@H](OC(=O)C)[C@@H](SC2=C1)C3=CC=C(O)C=C3)CCN(C)C",
                     "InChIKey" : "ALISTFINEQANJP-UXHICEINSA-N",
                     "BTMDB_ID" : "BTM0141",
                  "PubChem CID" : "25834477",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kurokawa, T. et al. (2015); Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase; The American Society for Pharmacology and Experimental Therapeutics; 43:1218–1225, August 2015; "
      },
      "BIOTID0087" : {
                                    "Substrate" : {
                     "Name" : "doxepin",
                   "SMILES" : "C(\\CCN(C)C)=C\\1/C2=CC=CC=C2COC3=CC=CC=C13",
                 "InChIKey" : "ODQWQRRAPPTVAG-BOPFTXTBSA-N",
                 "BTMDB_ID" : "BTM0142",
              "PubChem CID" : "667468",
              "DrugBank ID" : "DB01142",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-OH-doxepin",
                       "SMILES" : "C(=C/1\\C2=CC=CC=C2OCC3=CC=C(O)C=C13)\\CCN(C)C",
                     "InChIKey" : "JCZHLWUPQBSZCM-FRKPEAEDSA-N",
                     "BTMDB_ID" : "BTM0143",
                  "PubChem CID" : "58600463",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Musshoff F. et al. (2010); Pharmacogenetics and forensic toxicology; Forensic Sci Int.; 203, 53-62. doi: doi:10.1016/j.forsciint.2010.07.011"
      },
      "BIOTID0088" : {
                                    "Substrate" : {
                     "Name" : "ecabapide",
                   "SMILES" : "C1(=C(C=C(C=C1)CCNC(CNC2=CC(=CC=C2)C(NC)=O)=O)OC)OC",
                 "InChIKey" : "JTAGHJPZEDNHHA-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0144",
              "PubChem CID" : "65885",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-dealkylation of secondary arylalkylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1141",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-[2-(3,4-dimethoxyphenyl)ethyl]-2-oxoacetamide",
                       "SMILES" : "COC1=C(OC)C=C(CCNC(=O)C=O)C=C1",
                     "InChIKey" : "JKKUHHGGROMBJG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0146",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Fujimaki, N. et al. (1999); Identi®cation of cytochromes P450 involved in human liver microsomal metabolism of ecabapide, a prokinetic agent; xenobiotica; 29:12, 1273-1282; DOI:10.1080/004982599237930"
      },
      "BIOTID0089" : {
                                    "Substrate" : {
                     "Name" : "eletriptan",
                   "SMILES" : "C=12[C@H](C[C@@H]3N(CCC3)C)CNC1C=CC(=C2)CCS(C4=CC=CC=C4)(=O)=O",
                 "InChIKey" : "BBMOMQCRLMEOQE-RTBURBONSA-N",
                 "BTMDB_ID" : "BTM0147",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP3A4; CYP2C9; CYP2C19; CYP1A2; CYP2C8",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Desmethyleletriptan",
                       "SMILES" : "N1C2=C(C=C(C=C2)CCS(=O)(=O)C3=CC=CC=C3)[C@H](C[C@@H]4NCCC4)C1",
                     "InChIKey" : "DZPWTXAGCISGJW-QZTJIDSGSA-N",
                     "BTMDB_ID" : "BTM0148",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0090" : {
                                    "Substrate" : {
                     "Name" : "eletriptan",
                   "SMILES" : "C=12[C@H](C[C@@H]3N(CCC3)C)CNC1C=CC(=C2)CCS(C4=CC=CC=C4)(=O)=O",
                 "InChIKey" : "BBMOMQCRLMEOQE-RTBURBONSA-N",
                 "BTMDB_ID" : "BTM0147",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP3A4; CYP2C9; CYP2C19; CYP1A2; CYP2C8",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Desmethyleletriptan",
                       "SMILES" : "N1C2=C(C=C(C=C2)CCS(=O)(=O)C3=CC=CC=C3)[C@H](C[C@@H]4NCCC4)C1",
                     "InChIKey" : "DZPWTXAGCISGJW-QZTJIDSGSA-N",
                     "BTMDB_ID" : "BTM0148",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0091" : {
                                    "Substrate" : {
                     "Name" : "eplerenone",
                   "SMILES" : "[C@]123[C@H](O1)C[C@]4([C@H]([C@@H]2[C@@H](CC=5[C@@]3(CCC(C5)=O)C)C(OC)=O)CC[C@@]46CCC(O6)=O)C",
                 "InChIKey" : "JUKPWJGBANNWMW-VWBFHTRKSA-N",
                 "BTMDB_ID" : "BTM0149",
              "PubChem CID" : "443872",
              "DrugBank ID" : "DB00700",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of carbon gamma to conkjugated carbonyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1057",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6beta-hydroxyeplerenone",
                       "SMILES" : "COC(=O)[C@@H]1C(O)C2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14",
                     "InChIKey" : "DDHQRXOAZNEFKY-YEIJCWOFSA-N",
                     "BTMDB_ID" : "BTM0150",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) cook, C, S. et al. (2002); INVOLVEMENT OF CYP3A IN THE METABOLISM OF EPLERENONE IN HUMANS AND DOGS: DIFFERENTIAL METABOLISM BY CYP3A4 AND CYP3A5; The American Society for Pharmacology and Experimental Therapeutics; 30:1344–1351, 2002; DOI: 0090-9556/02/3011"
      },
      "BIOTID0092" : {
                                    "Substrate" : {
                     "Name" : "esomeprazole",
                   "SMILES" : "[S@](=O)(CC1=NC=C(C(OC)=C1C)C)C=2NC3=C(N2)C=CC(OC)=C3",
                 "InChIKey" : "SUBDBMMJDZJVOS-DEOSSOPVSA-N",
                 "BTMDB_ID" : "BTM0151",
              "PubChem CID" : "9568614",
              "DrugBank ID" : "DB00736",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP3A4 ",
                                "Reaction Type" : "S-oxidation of sulfoxide to sulfone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0060",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Omeprazole sulfone",
                       "SMILES" : "N1C2=C(N=C1S(=O)(=O)CC3=NC=C(C(OC)=C3C)C)C=CC(OC)=C2",
                     "InChIKey" : "IXEQEYRTSRFZEO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0152",
                  "PubChem CID" : "145900",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
      },
      "BIOTID0093" : {
                                    "Substrate" : {
                     "Name" : "estradiol",
                   "SMILES" : "O[C@@H]1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                 "InChIKey" : "VOXZDWNPVJITMN-ZBRFXRBCSA-N",
                 "BTMDB_ID" : "BTM0153",
              "PubChem CID" : "5757",
              "DrugBank ID" : "DB00783",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP1A2; CYP3A4; CYP1A1",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-Hydroxyestradiol",
                       "SMILES" : "C[C@]12CC[C@H]3[C@@H](CCC4=C3C=C(O)C(O)=C4)[C@@H]1CC[C@@H]2O",
                     "InChIKey" : "DILDHNKDVHLEQB-XSSYPUMDSA-N",
                     "BTMDB_ID" : "BTM0154",
                  "PubChem CID" : "247304",
                  "DrugBank ID" : "DB07706",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0094" : {
                                    "Substrate" : {
                     "Name" : "estrone",
                   "SMILES" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                 "InChIKey" : "DNXHEGUUPJUMQT-CBZIJGRNSA-N",
                 "BTMDB_ID" : "BTM0155",
              "PubChem CID" : "5870",
              "DrugBank ID" : "DB00655",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2C9; CYP3A4; CYP3A5; CYP3A7",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-OH-estrone",
                       "SMILES" : "C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4O)[C@@H]1CCC2=O",
                     "InChIKey" : "XQZVQQZZOVBNLU-QDTBLXIISA-N",
                     "BTMDB_ID" : "BTM0156",
                  "PubChem CID" : "9971251",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754424"
      },
      "BIOTID0095" : {
                                    "Substrate" : {
                     "Name" : "estrone",
                   "SMILES" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                 "InChIKey" : "DNXHEGUUPJUMQT-CBZIJGRNSA-N",
                 "BTMDB_ID" : "BTM0155",
              "PubChem CID" : "5870",
              "DrugBank ID" : "DB00655",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7alpha-OH-estrone",
                       "SMILES" : "C[C@]12CC[C@H]3C([C@@H]1CCC2=O)[C@H](O)CC4=C3C=CC(O)=C4",
                     "InChIKey" : "MXXBVPDRVYYYJY-JIHIFKDMSA-N",
                     "BTMDB_ID" : "BTM0157",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754427"
      },
      "BIOTID0096" : {
                                    "Substrate" : {
                     "Name" : "estrone",
                   "SMILES" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                 "InChIKey" : "DNXHEGUUPJUMQT-CBZIJGRNSA-N",
                 "BTMDB_ID" : "BTM0155",
              "PubChem CID" : "5870",
              "DrugBank ID" : "DB00655",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8; CYP3A4; CYP3A5",
                                "Reaction Type" : "Alpha hydroxylation of carbonyl group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1054",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "16beta-OH-estrone",
                       "SMILES" : "C[C@]12CC[C@H]3C(CCC4=C3C=CC(O)=C4)[C@@H]1C[C@H](O)C2=O",
                     "InChIKey" : "WPOCIZJTELRQMF-CCIOVHFFSA-N",
                     "BTMDB_ID" : "BTM0158",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754430"
      },
      "BIOTID0097" : {
                                    "Substrate" : {
                     "Name" : "ethiprole",
                   "SMILES" : "N1(C2=C(C=C(C=C2Cl)C(F)(F)F)Cl)C(=C(C(=N1)C#N)S(CC)=O)N",
                 "InChIKey" : "FNELVJVBIYMIMC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0159",
              "PubChem CID" : "9930667",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "S-oxidation of sulfoxide to sulfone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0060",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Ethiprole Sulfone",
                       "SMILES" : "CCS(=O)(=O)C1=C(N)N(N=C1C#N)C2=C(Cl)C=C(C=C2Cl)C(F)(F)F",
                     "InChIKey" : "SGTQRPFDKIRFIQ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0160",
                  "PubChem CID" : "22618433",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Caboni, P. et al. (2003); Phenylpyrazole Insecticide Photochemistry, Metabolism, and GABAergic Action: Ethiprole Compared with Fipronil; J. Agric. Food Chem. 2003, 51, 7055−7061; DOI: 10.1021/jf030439"
      },
      "BIOTID0098" : {
                                    "Substrate" : {
                     "Name" : "etoricoxib",
                   "SMILES" : "CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O",
                 "InChIKey" : "MNJVRJDLRVPLFE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0161",
              "PubChem CID" : "123619",
              "DrugBank ID" : "DB01628",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C9; CYP2D6; CYP1A2",
                                "Reaction Type" : "Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6-Hydroxymethyletoricoxib",
                       "SMILES" : "C1=NC(C2=CN=C(C=C2)CO)=C(C=C1Cl)C3=CC=C(C=C3)S(=O)(=O)C",
                     "InChIKey" : "SCVWZQQMIZJGJY-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0162",
                  "PubChem CID" : "44266438",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675 || (R3) Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023 || (R4) Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
      },
      "BIOTID0099" : {
                                    "Substrate" : {
                     "Name" : "fentanyl",
                   "SMILES" : "CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3",
                 "InChIKey" : "PJMPHNIQZUBGLI-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0163",
              "PubChem CID" : "3345",
              "DrugBank ID" : "DB00813",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Phenylacetaldehyde",
                       "SMILES" : "C1=CC=C(CC=O)C=C1",
                     "InChIKey" : "DTUQWGWMVIHBKE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0165",
                  "PubChem CID" : "998",
                  "DrugBank ID" : "DB02178",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Feierman, D. et al. (1996); Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes; Drug metabolism and disposition; 0090-9556/96/2409-0932-939$02.OO/O"
      },
      "BIOTID0100" : {
                                    "Substrate" : {
                     "Name" : "fk_506",
                   "SMILES" : "O1[C@H]2[C@@H](OC)C[C@H]([C@]1(O)C(=O)C(=O)N3[C@@H](CCCC3)C(O[C@@H]([C@@H]([C@@H](O)CC(=O)[C@@H](C=C(C[C@@H](C[C@@H]2OC)C)C)CC=C)C)/C(=C/[C@H]4C[C@@H](OC)[C@H](O)CC4)/C)=O)C",
                 "InChIKey" : "QJJXYPPXXYFBGM-AZRUOWBRSA-N",
                 "BTMDB_ID" : "BTM0166",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "O-dealkylation of dialkylether",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1129",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "15-O-Desmethyltacrolimus",
                       "SMILES" : "CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(\\C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](O)C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C",
                     "InChIKey" : "ZQRSWRVAAABQEF-XFIJPYNGSA-N",
                     "BTMDB_ID" : "BTM0167",
                  "PubChem CID" : "101656646",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0101" : {
                                    "Substrate" : {
                     "Name" : "flunarizine",
                   "SMILES" : "C=1(/C=C/CN2CCN(C(C=3C=CC(F)=CC3)C=4C=CC(F)=CC4)CC2)C=CC=CC1",
                 "InChIKey" : "SMANXXCATUTDDT-QPJJXVBHSA-N",
                 "BTMDB_ID" : "BTM0168",
              "PubChem CID" : "941361",
              "DrugBank ID" : "DB04841",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP1A1",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "bis(4‐fluorophenyl)methanone",
                       "SMILES" : "C1=CC(=CC=C1F)C(=O)C2=CC=C(F)C=C2",
                     "InChIKey" : "LSQARZALBDFYQZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0169",
                  "PubChem CID" : "9582",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || "
      },
      "BIOTID0102" : {
                                    "Substrate" : {
                     "Name" : "flutamide",
                   "SMILES" : "CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F",
                 "InChIKey" : "MKXKFYHWDHIYRV-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0170",
              "PubChem CID" : "3397",
              "DrugBank ID" : "DB00499",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP1B1",
                                "Reaction Type" : "Alpha hydroxylation of carbonyl group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1054",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-OH-flutamide",
                       "SMILES" : "CC(C)(O)C(=O)NC1=CC=C(C(=C1)C(F)(F)F)[N+]([O-])=O",
                     "InChIKey" : "YPQLFJODEKMJEF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0171",
                  "PubChem CID" : "91649",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0103" : {
                                    "Substrate" : {
                     "Name" : "fluvastatin",
                   "SMILES" : "C=1(C2=C(N(C1/C=C/[C@@H](C[C@@H](CC(O)=O)O)O)C(C)C)C=CC=C2)C3=CC=C(C=C3)F",
                 "InChIKey" : "FJLGEFLZQAZZCD-JUFISIKESA-N",
                 "BTMDB_ID" : "BTM0172",
              "PubChem CID" : "1548972",
              "DrugBank ID" : "DB01095",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "N-deisopropylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0051",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Deisopropyl-fluvastatin",
                       "SMILES" : "O[C@@H](C[C@@H](O)/C=C/C1=C(C2=C(N1)C=CC=C2)C3=CC=C(F)C=C3)CC(O)=O",
                     "InChIKey" : "POFAWBXODXSMNI-IGXNXKSNSA-N",
                     "BTMDB_ID" : "BTM0173",
                  "PubChem CID" : "131750727",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675 || (R3) Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023 || (R4) Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
      },
      "BIOTID0104" : {
                                    "Substrate" : {
                     "Name" : "formononetin",
                   "SMILES" : "C12=C(C(C(=CO1)C=3C=CC(=CC3)OC)=O)C=CC(=C2)O",
                 "InChIKey" : "HKQYGTCOTHHOMP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0174",
              "PubChem CID" : "5280378",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Daidzein",
                       "SMILES" : "OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=C(O)C=C3",
                     "InChIKey" : "ZQSIJRDFPHDXIC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0175",
                  "PubChem CID" : "5281708",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0105" : {
                                    "Substrate" : {
                     "Name" : "haloperidol",
                   "SMILES" : "OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3",
                 "InChIKey" : "LNEPOXFFQSENCJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0176",
              "PubChem CID" : "3559",
              "DrugBank ID" : "DB00502",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2D6",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "p-Fluorobenzoylpropionic acid and 4-(4-chlorophenyl)-4-hydroxypiperidine",
                       "SMILES" : "C1=CC(=CC=C1F)C(=O)CCC(O)=O",
                     "InChIKey" : "WUYWHIAAQYQKPP-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0177",
                  "PubChem CID" : "101359",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : ""
      },
      "BIOTID0106" : {
                                    "Substrate" : {
                     "Name" : "harmine",
                   "SMILES" : "C=12C3=C(NC1C(=NC=C2)C)C=C(C=C3)OC",
                 "InChIKey" : "BXNJHAXVSOCGBA-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0178",
              "PubChem CID" : "5280953",
              "DrugBank ID" : "DB07919",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP2C9; CYP2C19; CYP1A2",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Harmol",
                       "SMILES" : "N1C2=C(C=C(O)C(OC)=C2)C3=C1C(=NC=C3)C",
                     "InChIKey" : "AVGHDEIZJIEIFK-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0179",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "North American ZSSX Meeting, San Diego, CA, October 20-25,"
      },
      "BIOTID0107" : {
                                    "Substrate" : {
                     "Name" : "hexane",
                   "SMILES" : "CCCCCC",
                 "InChIKey" : "VLKZOEOYAKHREP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0180",
              "PubChem CID" : "8058",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2B6; CYP2E1",
                                "Reaction Type" : "Hydroxylation of penultimate aliphatic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1074",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Hexanol",
                       "SMILES" : "CCCCC(O)C",
                     "InChIKey" : "QNVRIHYSUZMSGM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0181",
                  "PubChem CID" : "12297",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : ""
      },
      "BIOTID0108" : {
                                    "Substrate" : {
                     "Name" : "imatinib",
                   "SMILES" : "O=C(NC1=CC(NC=2N=C(C=3C=CC=NC3)C=CN2)=C(C=C1)C)C4=CC=C(CN5CCN(CC5)C)C=C4",
                 "InChIKey" : "KTUFNOKKBVMGRW-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0182",
              "PubChem CID" : "5291",
              "DrugBank ID" : "DB00619",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C8",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-desmethylimatinib",
                       "SMILES" : "N(C(=O)C1=CC=C(C=C1)CN2CCNCC2)C3=CC(NC4=NC=CC(=N4)C5=CN=CC=C5)=C(C=C3)C",
                     "InChIKey" : "BQQYXPHRXIZMDM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0183",
                  "PubChem CID" : "9869737",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Vol. 10, p. 230.."
      },
      "BIOTID0109" : {
                                    "Substrate" : {
                     "Name" : "imipramine",
                   "SMILES" : "CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C13",
                 "InChIKey" : "BCGWQEUPMDMJNV-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0184",
              "PubChem CID" : "3696",
              "DrugBank ID" : "DB00458",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP2C19; CYP2C18; CYP2D6; CYP1A2 ",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Desimipramine",
                       "SMILES" : "C1=CC=C2C(=C1)N(C3=CC=CC=C3CC2)CCCNC",
                     "InChIKey" : "HCYAFALTSJYZDH-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0185",
                  "PubChem CID" : "2995",
                  "DrugBank ID" : "DB01151",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0110" : {
                                    "Substrate" : {
                     "Name" : "irbesartan",
                   "SMILES" : "CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5",
                 "InChIKey" : "YOSHYTLCDANDAN-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0186",
              "PubChem CID" : "3749",
              "DrugBank ID" : "DB01029",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1067",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "M5",
                       "SMILES" : "N1N=NC(=N1)C2=CC=CC=C2C3=CC=C(C=C3)CN4C(=O)C5(N=C4CCCC)CCC(O)C5",
                     "InChIKey" : "SGLAKMDXJPVHBY-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0187",
                  "PubChem CID" : "101944494",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0111" : {
                                    "Substrate" : {
                     "Name" : "kaempferide",
                   "SMILES" : "O=C1C2=C(OC(=C1O)C3=CC=C(C=C3)OC)C=C(C=C2O)O",
                 "InChIKey" : "SQFSKOYWJBQGKQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0188",
              "PubChem CID" : "5281666",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2 ; CYP2C9",
                                "Reaction Type" : "O-aryl demethylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1133",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4'-OH-galangin",
                       "SMILES" : "OC1=CC2=C(C(=O)C(O)=C(O2)C3=CC=C(O)C=C3)C(O)=C1",
                     "InChIKey" : "IYRMWMYZSQPJKC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0189",
                  "PubChem CID" : "5280863",
                  "DrugBank ID" : "DB01852",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0112" : {
                                    "Substrate" : {
                     "Name" : "kaempferide",
                   "SMILES" : "O=C1C2=C(OC(=C1O)C3=CC=C(C=C3)OC)C=C(C=C2O)O",
                 "InChIKey" : "SQFSKOYWJBQGKQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0188",
              "PubChem CID" : "5281666",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2 ; CYP2C9",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4'-OH-galangin",
                       "SMILES" : "OC1=CC2=C(C(=O)C(O)=C(O2)C3=CC=C(O)C=C3)C(O)=C1",
                     "InChIKey" : "IYRMWMYZSQPJKC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0189",
                  "PubChem CID" : "5280863",
                  "DrugBank ID" : "DB01852",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0113" : {
                                    "Substrate" : {
                     "Name" : "l-ifosfamide",
                   "SMILES" : "ClCCN[P@@]1(=O)OCCCN1CCCl",
                 "InChIKey" : "HOMGKSMUEGBAAB-CQSZACIVSA-N",
                 "BTMDB_ID" : "BTM0190",
              "PubChem CID" : "9588020",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2B6; CYP3A4; CYP3A5",
                                "Reaction Type" : "N-dechloroethylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1155",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "chloroacetaldehyde",
                       "SMILES" : "C(=O)CCl",
                     "InChIKey" : "QSKPIOLLBIHNAC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0192",
                  "PubChem CID" : "33",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675 || (R3) Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023 || (R4) Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
      },
      "BIOTID0114" : {
                                    "Substrate" : {
                     "Name" : "l-trofosfamide",
                   "SMILES" : "N(CCCl)(CCCl)[P@@]1(=O)N(CCCl)CCCO1",
                 "InChIKey" : "UMKFEPPTGMDVMI-QGZVFWFLSA-N",
                 "BTMDB_ID" : "BTM0193",
              "PubChem CID" : "9576167",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2B6; CYP2A6; CYP2C9",
                                "Reaction Type" : "4-alkyl hydroxylation of oxoazaphosphorine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1052",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "l-ifosfamide",
                       "SMILES" : "C(Cl)CN(CCCl)[P@]1(=O)OCCC(O)N1CCCl",
                     "InChIKey" : "RAXABQCFPAWRSY-AHMWTOSDSA-N",
                     "BTMDB_ID" : "BTM0194",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023"
      },
      "BIOTID0115" : {
                                    "Substrate" : {
                     "Name" : "laquinimod",
                   "SMILES" : "C12=C(N(C(C(=C1O)C(N(C3=CC=CC=C3)CC)=O)=O)C)C=CC=C2Cl",
                 "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0195",
              "PubChem CID" : "54677946",
              "DrugBank ID" : "DB06685",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "p-Hydroxylation of anilide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1036",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5-chloro-N-ethyl-4-hydroxy-N-(4-hydroxyphenyl)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide",
                       "SMILES" : "OC1=C(C(=O)N(C2=CC=C(O)C=C2)CC)C(=O)N(C3=C1C(Cl)=CC=C3)C",
                     "InChIKey" : "HBMNTNTZJMZXKP-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0196",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
      },
      "BIOTID0116" : {
                                    "Substrate" : {
                     "Name" : "laquinimod",
                   "SMILES" : "C12=C(N(C(C(=C1O)C(N(C3=CC=CC=C3)CC)=O)=O)C)C=CC=C2Cl",
                 "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0195",
              "PubChem CID" : "54677946",
              "DrugBank ID" : "DB06685",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of benzene on carbon para to an electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1047",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5-chloro-N-ethyl-4-hydroxy-N-(4-hydroxyphenyl)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide",
                       "SMILES" : "OC1=C(C(=O)N(C2=CC=C(O)C=C2)CC)C(=O)N(C3=C1C(Cl)=CC=C3)C",
                     "InChIKey" : "HBMNTNTZJMZXKP-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0196",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
      },
      "BIOTID0117" : {
                                    "Substrate" : {
                     "Name" : "laquinimod",
                   "SMILES" : "C12=C(N(C(C(=C1O)C(N(C3=CC=CC=C3)CC)=O)=O)C)C=CC=C2Cl",
                 "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0195",
              "PubChem CID" : "54677946",
              "DrugBank ID" : "DB06685",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5-chloro-N-ethyl-4,8-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                       "SMILES" : "OC1=C(C(=O)N(C2=CC=CC=C2)CC)C(=O)N(C3=C1C(Cl)=CC=C3O)C",
                     "InChIKey" : "KBIYOPLLPLGYEU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0197",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
      },
      "BIOTID0118" : {
                                    "Substrate" : {
                     "Name" : "laquinimod",
                   "SMILES" : "C12=C(N(C(C(=C1O)C(N(C3=CC=CC=C3)CC)=O)=O)C)C=CC=C2Cl",
                 "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0195",
              "PubChem CID" : "54677946",
              "DrugBank ID" : "DB06685",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of aromatic carbon ortho to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1040",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5-chloro-N-ethyl-4,8-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                       "SMILES" : "OC1=C(C(=O)N(C2=CC=CC=C2)CC)C(=O)N(C3=C1C(Cl)=CC=C3O)C",
                     "InChIKey" : "KBIYOPLLPLGYEU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0197",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
      },
      "BIOTID0119" : {
                                    "Substrate" : {
                     "Name" : "lauric acid",
                   "SMILES" : "CCCCCCCCCCCC(=O)O",
                 "InChIKey" : "POULHZVOKOAJMA-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0198",
              "PubChem CID" : "3893",
              "DrugBank ID" : "DB03017",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1; CYP2C8; CYP2B6",
                                "Reaction Type" : "Hydroxylation of terminal methyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1061",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "12-Hydroxylauric acid",
                       "SMILES" : "OC(=O)CCCCCCCCCCCO",
                     "InChIKey" : "ZDHCZVWCTKTBRY-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0199",
                  "PubChem CID" : "79034",
                  "DrugBank ID" : "DB03704",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : ""
      },
      "BIOTID0120" : {
                                    "Substrate" : {
                     "Name" : "licofelone",
                   "SMILES" : "CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C3=CC=CC=C3)C4=CC=C(Cl)C=C4",
                 "InChIKey" : "UAWXGRJVZSAUSZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0200",
              "PubChem CID" : "133021",
              "DrugBank ID" : "DB04725",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8; CYP2C9",
                                "Reaction Type" : "Hydroxylation of aromatic carbon ortho to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1040",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "licofelone M2",
                       "SMILES" : "CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C3=CC=CC=C3)C4=CC=C(Cl)C(O)=C4",
                     "InChIKey" : "QUCLYFKWRYCDCG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0201",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0121" : {
                                    "Substrate" : {
                     "Name" : "lidocaine",
                   "SMILES" : "CCN(CC)CC(=O)NC1=C(C)C=CC=C1C",
                 "InChIKey" : "NNJVILVZKWQKPM-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0202",
              "PubChem CID" : "3676",
              "DrugBank ID" : "DB00281",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2D6; CYP3A4",
                                "Reaction Type" : "Hydroxylation of benzene on carbon ortho to an electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1045",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-Hydroxylidocaine",
                       "SMILES" : "N(C(=O)CN(CC)CC)C1=C(C=CC(O)=C1C)C",
                     "InChIKey" : "PMGUCIDDSCRAMY-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0203",
                  "PubChem CID" : "161824",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Ekins, S. and Wrighton, S.A. (1999); The role of CYP2B6 in Human Xenobiotic Metabolism; Drug Metabolism Reviews, 31:3, 719-754, DOI:10.1081/ DMR-100101942; PMID:10461547 || (R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693 || (R4) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015 || (R5) Thomas, J., Meffin, P. (1972). Aromatic hydroxylation of lidocaine and mepivacaine in rats and humans. J. Med. Chem. 15:1046–1049."
      },
      "BIOTID0122" : {
                                    "Substrate" : {
                     "Name" : "linomide",
                   "SMILES" : "C12=C(N(C(C(=C1O)C(N(C3=CC=CC=C3)C)=O)=O)C)C=CC=C2",
                 "InChIKey" : "SGOOQMRIPALTEL-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0204",
              "PubChem CID" : "54676478",
              "DrugBank ID" : "DB11366",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4,7-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                       "SMILES" : "OC1=C(C(=O)N(C2=CC=CC=C2)C)C(=O)N(C3=C1C=CC(O)=C3)C",
                     "InChIKey" : "NPWHYPYXYXHWLK-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0205",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Tuvesson,H. et al.(2000) Identification of cytochrome P4503A as the major subfamily responsible for the metabolismof roquinimex in man, Xenobiotica, 30:9, 905-914, DOI: 10.1080/004982500433327"
      },
      "BIOTID0123" : {
                                    "Substrate" : {
                     "Name" : "linomide",
                   "SMILES" : "C12=C(N(C(C(=C1O)C(N(C3=CC=CC=C3)C)=O)=O)C)C=CC=C2",
                 "InChIKey" : "SGOOQMRIPALTEL-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0204",
              "PubChem CID" : "54676478",
              "DrugBank ID" : "DB11366",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-dealkylation of tertiary carboxamide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1139",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                       "SMILES" : "OC1=C(C(=O)NC2=CC=CC=C2)C(=O)N(C)C3=C1C=CC=C3",
                     "InChIKey" : "SCIYKTDXFNBCIV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0206",
                  "PubChem CID" : "54676449",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Tuvesson,H. et al.(2000) Identification of cytochrome P4503A as the major subfamily responsible for the metabolismof roquinimex in man, Xenobiotica, 30:9, 905-914, DOI: 10.1080/004982500433327"
      },
      "BIOTID0124" : {
                                    "Substrate" : {
                     "Name" : "lisofylline",
                   "SMILES" : "C12=C(N(C(N(C1=O)CCCC[C@@H](C)O)=O)C)N=CN2C",
                 "InChIKey" : "NSMXQKNUPPXBRG-SECBINFHSA-N",
                 "BTMDB_ID" : "BTM0207",
              "PubChem CID" : "501254",
              "DrugBank ID" : "DB12406",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "Oxidation of secondary alcohol to ketone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0079",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "pentoxifylline",
                       "SMILES" : "C1=NC2=C(N1C)C(=O)N(C(=O)N2C)CCCCC(=O)C",
                     "InChIKey" : "BYPFEZZEUUWMEJ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0208",
                  "PubChem CID" : "4740",
                  "DrugBank ID" : "DB00806",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Lee, S.H. et al. (1997); Cytochrome P450 Isozymes Involved in Lisofylline Metabolism to Pentoxifylline in Human Liver Microsomes, Drug Metabolism and Disposition, 1997, 25, 1354-1358 || (R2)  Lillibridge. et al. (1996); Metabolism of Lisofylline and Pentoxifylline in Human Liver Microsomes and Cytosol, Drug Metabolism and Disposition, 1996, 24, 1174-1179 || (R3) Shin, H.S. et al. (1998); CYP3A4-mediated Oxidation of Lisofylline to Lisofylline 4,5-diol in Human Liver Microsomes, Journal of Pharmaceutical Sciences, 1998, 87, 390-393"
      },
      "BIOTID0125" : {
                                    "Substrate" : {
                     "Name" : "maprotiline",
                   "SMILES" : "N(CCCC12CCC(C=3C1=CC=CC3)C=4C2=CC=CC4)C",
                 "InChIKey" : "QSLMDECMDJKHMQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0209",
              "PubChem CID" : "4011",
              "DrugBank ID" : "DB00934",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP1A2",
                                "Reaction Type" : "N-dealkylation of acyclic secondary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1140",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "desmethylmaprotiline",
                       "SMILES" : "NCCCC12C3=CC=CC=C3C(C4=CC=CC=C14)CC2",
                     "InChIKey" : "IFHUOEQJTQWFGJ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0210",
                  "PubChem CID" : "119409",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Regioselective Metabolism of Toluene and o-, m- and p-Xylene1"
      },
      "BIOTID0126" : {
                                    "Substrate" : {
                     "Name" : "mefenamic acid",
                   "SMILES" : "CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1",
                 "InChIKey" : "HYYBABOKPJLUIN-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0211",
              "PubChem CID" : "4044",
              "DrugBank ID" : "DB00784",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9 ",
                                "Reaction Type" : "Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-hydroxymethyl mefenamic aci",
                       "SMILES" : "OC(=O)C1=CC=CC=C1NC2=CC=CC(=C2C)CO",
                     "InChIKey" : "QBONJEHEDCBRMZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0212",
                  "PubChem CID" : "610738",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Hug, F. (2007); Molecular Modelling Analysis of the Metabolism of Mefenamic Acid. Journal of Pharmacology and Toxicology, 2: 72-79; DOI: 10.3923/jpt.2007.72.79 "
      },
      "BIOTID0127" : {
                                    "Substrate" : {
                     "Name" : "melatonin",
                   "SMILES" : "COC1=CC2=C(NC=C2CCNC(C)=O)C=C1",
                 "InChIKey" : "DRLFMBDRBRZALE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0213",
              "PubChem CID" : "896",
              "DrugBank ID" : "DB01065",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2C19; CYP2E1",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6-Hydroxymelatonin",
                       "SMILES" : "N(C(=O)C)CCC1=CNC2=C1C=C(OC)C(O)=C2",
                     "InChIKey" : "OMYMRCXOJJZYKE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0214",
                  "PubChem CID" : "1864",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Kazumi, Y.Y. et al. (2011); Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order; Drug Metabolism Reviews; 43:4; 409-439; DOI:10.3109/03602532.2011.624103; PMID:22017508"
      },
      "BIOTID0128" : {
                                    "Substrate" : {
                     "Name" : "midazolam",
                   "SMILES" : "CC1=NC=C2CN=C(C3=CC=CC=C3F)C4=C(C=CC(Cl)=C4)N12",
                 "InChIKey" : "DDLIGBOFAVUZHB-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0215",
              "PubChem CID" : "4192",
              "DrugBank ID" : "DB00683",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP3A5; CYP3A7",
                                "Reaction Type" : "3-Hydroxylation of 5-aryl-1,4-benzodiazepine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1082",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxymidazolam",
                       "SMILES" : "C1=C2N(C(=N1)C)C3=C(C=C(Cl)C=C3)C(=NC2O)C4=CC=CC=C4F",
                     "InChIKey" : "ZYISITHKPKHPKG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0216",
                  "PubChem CID" : "124449",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Khan, K. K. et al. (2002); Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: An evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation; Mol. Pharmacol. 61:495–506 || (R3) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0129" : {
                                    "Substrate" : {
                     "Name" : "minaprine",
                   "SMILES" : "C1(C2=CC=CC=C2)=CC(=C(N=N1)NCCN3CCOCC3)C",
                 "InChIKey" : "LDMWSLGGVTVJPG-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0217",
              "PubChem CID" : "4199",
              "DrugBank ID" : "DB00805",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "p-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1035",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxyminaprine",
                       "SMILES" : "N(C1=C(C=C(N=N1)C2=CC=C(O)C=C2)C)CCN3CCOCC3",
                     "InChIKey" : "ADRHYFBXMFKHDO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0218",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0130" : {
                                    "Substrate" : {
                     "Name" : "montelukast",
                   "SMILES" : "OC(=O)CC1(CC1)CS[C@H](CCC2=CC=CC=C2C(O)(C)C)C3=CC=CC(/C=C/C4=NC5=C(C=CC(Cl)=C5)C=C4)=C3",
                 "InChIKey" : "UCHDWCPVSPXUMX-TZIWLTJVSA-N",
                 "BTMDB_ID" : "BTM0219",
              "PubChem CID" : "5281040",
              "DrugBank ID" : "DB00471",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of acyclic aliphatic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1063",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "21-Hydroxymontelukast",
                       "SMILES" : "OC(=O)CC1(CS[C@@H](C2=CC=CC(/C=C/C3=NC4=C(C=CC(Cl)=C4)C=C3)=C2)C[C@@H](O)C5=CC=CC=C5C(O)(C)C)CC1",
                     "InChIKey" : "CHRNGXJVKOMERP-FPUIOERCSA-N",
                     "BTMDB_ID" : "BTM0220",
                  "PubChem CID" : "11801753",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
      },
      "BIOTID0131" : {
                                    "Substrate" : {
                     "Name" : "naproxen",
                   "SMILES" : "C12=C(C=C(C=C1)OC)C=CC(=C2)[C@@H](C(O)=O)C",
                 "InChIKey" : "CMWTZPSULFXXJA-VIFPVBQESA-N",
                 "BTMDB_ID" : "BTM0221",
              "PubChem CID" : "156391",
              "DrugBank ID" : "DB00788",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP2C9; CYP1A2 ",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Desmethylnaproxen",
                       "SMILES" : "OC(=O)[C@H](C1=CC2=C(C=C1)C=C(O)C=C2)C",
                     "InChIKey" : "XWJUDDGELKXYNO-QMMMGPOBSA-N",
                     "BTMDB_ID" : "BTM0222",
                  "PubChem CID" : "13393711",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0132" : {
                                    "Substrate" : {
                     "Name" : "nicotine",
                   "SMILES" : "CN1CCC[C@H]1C2=CN=CC=C2",
                 "InChIKey" : "SNICXCGAKADSCV-JTQLQIEISA-N",
                 "BTMDB_ID" : "BTM0223",
              "PubChem CID" : "89594",
              "DrugBank ID" : "DB00184",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6; CYP2B6; CYP2A13",
                                "Reaction Type" : "Formation of iminium from pyrrolidine ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1189",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(S)-Nicotine Δ1',5'-iminium ion",
                       "SMILES" : "C1=[N+](C)[C@H](C2=CN=CC=C2)CC1",
                     "InChIKey" : "GTQXYYYOJZZJHL-JTQLQIEISA-N",
                     "BTMDB_ID" : "BTM0224",
                  "PubChem CID" : "181139",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : ""
      },
      "BIOTID0133" : {
                                    "Substrate" : {
                     "Name" : "nifedipine",
                   "SMILES" : "COC(=O)C1=C(C)NC(C)=C(C1C2=CC=CC=C2[N+]([O-])=O)C(=O)OC",
                 "InChIKey" : "HYIMSNHJOBLJNT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0225",
              "PubChem CID" : "4485",
              "DrugBank ID" : "DB01115",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Dehydrogenation of 4-aryl substituted 1,4-dihydropyridine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1196",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Oxidized nifedipine",
                       "SMILES" : "C1=CC=C(C(=C1)C2=C(C(=O)OC)C(=NC(=C2C(=O)OC)C)C)[N+]([O-])=O",
                     "InChIKey" : "UMQHJQGNGLQJPF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0226",
                  "PubChem CID" : "128753",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0134" : {
                                    "Substrate" : {
                     "Name" : "perphenazine",
                   "SMILES" : "OCCN1CCN(CCCN2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1",
                 "InChIKey" : "RGCVKNLCSQQDEP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0227",
              "PubChem CID" : "4748",
              "DrugBank ID" : "DB00850",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP1A2; CYP3A4; CYP2C9; CYP2C19; CYP2D6 ",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Dealkylated perphenazine",
                       "SMILES" : "C1=CC=C2N(C3=C(SC2=C1)C=CC(Cl)=C3)CCCN4CCNCC4",
                     "InChIKey" : "ZWIQAXTYRCAVFE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0228",
                  "PubChem CID" : "10451115",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0135" : {
                                    "Substrate" : {
                     "Name" : "phenacetin",
                   "SMILES" : "O(C1=CC=C(NC(=O)C)C=C1)CC",
                 "InChIKey" : "CPJSUEIXXCENMM-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0229",
              "PubChem CID" : "4754",
              "DrugBank ID" : "DB03783",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2",
                                "Reaction Type" : "N-hydroxylatuon of secondary arylamide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1104",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-OH-phenacetin",
                       "SMILES" : "C1=CC(=CC=C1OCC)N(O)C(=O)C",
                     "InChIKey" : "GPMYDZBSYQUDJZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0230",
                  "PubChem CID" : "29539",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015 || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423 || (R3) Venkatakrishnan, K. et al. (1998); Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity; J Pharm Sci. 1998 Dec;87(12):1502-7; PMID:10189256"
      },
      "BIOTID0136" : {
                                    "Substrate" : {
                     "Name" : "phenytoin",
                   "SMILES" : "O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3",
                 "InChIKey" : "CXOFVDLJLONNDW-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0231",
              "PubChem CID" : "1775",
              "DrugBank ID" : "DB00252",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19",
                                "Reaction Type" : "m-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1033",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3'-HPPH",
                       "SMILES" : "N1C(=O)NC(C1=O)(C2=CC=CC=C2)C3=CC=CC(O)=C3",
                     "InChIKey" : "FSPRLRPJSPWQNC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0232",
                  "PubChem CID" : "91597",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3679"
      },
      "BIOTID0137" : {
                                    "Substrate" : {
                     "Name" : "progesterone",
                   "SMILES" : "[C@@H]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C",
                 "InChIKey" : "RJKFOVLPORLFTN-LEKSSAKUSA-N",
                 "BTMDB_ID" : "BTM0233",
              "PubChem CID" : "5994",
              "DrugBank ID" : "DB00396",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D4; CYP2D6; CYP2C19 ",
                                "Reaction Type" : "Alpha hydroxylation of carbonyl group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1054",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "17beta-OH-progesterone",
                       "SMILES" : "C1=C2CC[C@H]3[C@@H]4CC[C@](O)(C(=O)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CCC1=O",
                     "InChIKey" : "DBPWSSGDRRHUNT-CEGNMAFCSA-N",
                     "BTMDB_ID" : "BTM0234",
                  "PubChem CID" : "6238",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3680"
      },
      "BIOTID0138" : {
                                    "Substrate" : {
                     "Name" : "promazine",
                   "SMILES" : "N1(C2=C(SC3=C1C=CC=C3)C=CC=C2)CCCN(C)C",
                 "InChIKey" : "ZGUGWUXLJSTTMA-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0235",
              "PubChem CID" : "4926",
              "DrugBank ID" : "DB00420",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2C9; CYP2C19; CYP2A6; CYP2B6; CYP2D6; CYP2E1",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Desmethyl promazine",
                       "SMILES" : "C1=CC2=C(C=C1)N(C3=C(S2)C=CC=C3)CCCNC",
                     "InChIKey" : "WOCOVPRTRIBGFZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0236",
                  "PubChem CID" : "28315",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0139" : {
                                    "Substrate" : {
                     "Name" : "quinidine",
                   "SMILES" : "[C@@H]12CCN(C[C@@H]1C=C)[C@H](C2)[C@@H](O)C3=C4C=C(OC)C=CC4=NC=C3",
                 "InChIKey" : "LOUPRKONTZGTKE-LHHVKLHASA-N",
                 "BTMDB_ID" : "BTM0237",
              "PubChem CID" : "441074",
              "DrugBank ID" : "DB00908",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Allylic hydroxylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0071",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-Hydroxyquinidine",
                       "SMILES" : "O[C@@H](C1=C2C=C(OC)C=CC2=NC=C1)[C@@H]3N4CC[C@@H](C3)[C@@](O)(C=C)C4",
                     "InChIKey" : "BSRUJCFCZKMFMB-LGWHJFRWSA-N",
                     "BTMDB_ID" : "BTM0238",
                  "PubChem CID" : "13217486",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0140" : {
                                    "Substrate" : {
                     "Name" : "(R)-mianserin",
                   "SMILES" : "C1=CC=CC2=C1CC3=C(C=CC=C3)[C@H]4N2CCN(C4)C",
                 "InChIKey" : "UEQUQVLFIPOEMF-SFHVURJKSA-N",
                 "BTMDB_ID" : "BTM0239",
              "PubChem CID" : "154412",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP3A4",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(R)-mianserin, 8-hydroxy",
                       "SMILES" : "C1=CC2=C(C=C1)[C@H]3N(C4=C(C=CC(O)=C4)C2)CCN(C)C3",
                     "InChIKey" : "IXAPYQICIDTITB-SFHVURJKSA-N",
                     "BTMDB_ID" : "BTM0240",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423 || (R2) Rendic, S., Di Carlo, F. (1997) Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors; Drug Metabolism Reviews, 29:1-2, 413-580; DOI:10.3109/03602539709037591; PMID:9187528"
      },
      "BIOTID0141" : {
                                    "Substrate" : {
                     "Name" : "reduced_dolasetron",
                   "SMILES" : "C=1C=C2C(=CC1)NC=C2C(OC3C[C@@H]4N5[C@H](C3)CC([C@@H](C5)O)C4)=O",
                 "InChIKey" : "MLWGAEVSWJXOQJ-DMDLWJMZSA-N",
                 "BTMDB_ID" : "BTM0241",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Oxidation of nitrogen in a strained ring system",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1116",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dolasetron N-oxide",
                       "SMILES" : "O[C@@H]1C[N+]2([O-])[C@H]3CC(OC(=O)C4=CNC5=CC=CC=C45)C[C@@H]2CC1C3",
                     "InChIKey" : "HISIYQCTEKKZGZ-KXFXSALQSA-N",
                     "BTMDB_ID" : "BTM0242",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0142" : {
                                    "Substrate" : {
                     "Name" : "reduced_dolasetron",
                   "SMILES" : "C=1C=C2C(=CC1)NC=C2C(OC3C[C@@H]4N5[C@H](C3)CC([C@@H](C5)O)C4)=O",
                 "InChIKey" : "MLWGAEVSWJXOQJ-DMDLWJMZSA-N",
                 "BTMDB_ID" : "BTM0241",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-oxidation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1099",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dolasetron N-oxide",
                       "SMILES" : "O[C@@H]1C[N+]2([O-])[C@H]3CC(OC(=O)C4=CNC5=CC=CC=C45)C[C@@H]2CC1C3",
                     "InChIKey" : "HISIYQCTEKKZGZ-KXFXSALQSA-N",
                     "BTMDB_ID" : "BTM0242",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0143" : {
                                    "Substrate" : {
                     "Name" : "reduced_dolasetron",
                   "SMILES" : "C=1C=C2C(=CC1)NC=C2C(OC3C[C@@H]4N5[C@H](C3)CC([C@@H](C5)O)C4)=O",
                 "InChIKey" : "MLWGAEVSWJXOQJ-DMDLWJMZSA-N",
                 "BTMDB_ID" : "BTM0241",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-oxdation of aliphatic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1100",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dolasetron N-oxide",
                       "SMILES" : "O[C@@H]1C[N+]2([O-])[C@H]3CC(OC(=O)C4=CNC5=CC=CC=C45)C[C@@H]2CC1C3",
                     "InChIKey" : "HISIYQCTEKKZGZ-KXFXSALQSA-N",
                     "BTMDB_ID" : "BTM0242",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0144" : {
                                    "Substrate" : {
                     "Name" : "reduced_dolasetron",
                   "SMILES" : "C=1C=C2C(=CC1)NC=C2C(OC3C[C@@H]4N5[C@H](C3)CC([C@@H](C5)O)C4)=O",
                 "InChIKey" : "MLWGAEVSWJXOQJ-DMDLWJMZSA-N",
                 "BTMDB_ID" : "BTM0241",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP2C9",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7-Hydroxydolasetron",
                       "SMILES" : "O[C@@H]1CN2[C@H]3CC(OC(=O)C4=CNC5=C(O)C=CC=C45)C[C@@H]2CC1C3",
                     "InChIKey" : "OBVOORYFKGUOIG-MJRCBCLYSA-N",
                     "BTMDB_ID" : "BTM0243",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0145" : {
                                    "Substrate" : {
                     "Name" : "riluzole",
                   "SMILES" : "S1C2=C(N=C1N)C=CC(OC(F)(F)F)=C2",
                 "InChIKey" : "FTALBRSUTCGOEG-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0244",
              "PubChem CID" : "5070",
              "DrugBank ID" : "DB00740",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-OH-riluzole",
                       "SMILES" : "NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2O",
                     "InChIKey" : "GXFFABIWILZVMT-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0245",
                  "PubChem CID" : "85752610",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0146" : {
                                    "Substrate" : {
                     "Name" : "riluzole",
                   "SMILES" : "S1C2=C(N=C1N)C=CC(OC(F)(F)F)=C2",
                 "InChIKey" : "FTALBRSUTCGOEG-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0244",
              "PubChem CID" : "5070",
              "DrugBank ID" : "DB00740",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1",
                                "Reaction Type" : "N-hydroxylation of primary arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0042",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-OH-riluzole",
                       "SMILES" : "N(O)C1=NC2=C(S1)C=C(OC(F)(F)F)C=C2",
                     "InChIKey" : "MFGRTKLVQQZZIE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0246",
                  "PubChem CID" : "9859774",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754426"
      },
      "BIOTID0147" : {
                                    "Substrate" : {
                     "Name" : "s-methyl diethylthiocarbamate",
                   "SMILES" : "N(CC)(CC)C(=O)SC",
                 "InChIKey" : "AQTFQQHFHGBCPG-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0247",
              "PubChem CID" : "119467",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2A6; CYP2C9; CYP1A2; CYP2B6; CYP2E1; CYP2D6",
                                "Reaction Type" : "S-oxidation of thiocarbamate",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1126",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "MeDTC sulfoxide",
                       "SMILES" : "CS(=O)C(=O)N(CC)CC",
                     "InChIKey" : "FQSRGOGWCPXJIN-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0248",
                  "PubChem CID" : "3035711",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754426"
      },
      "BIOTID0148" : {
                                    "Substrate" : {
                     "Name" : "selegiline",
                   "SMILES" : "C=1C=CC(=CC1)C[C@H](N(C)CC#C)C",
                 "InChIKey" : "MEZLKOACVSPNER-GFCCVEGCSA-N",
                 "BTMDB_ID" : "BTM0249",
              "PubChem CID" : "26757",
              "DrugBank ID" : "DB01037",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2B6; CYP2C19; CYP2D6; CYP1A2; CYP2C9; CYP3A4",
                                "Reaction Type" : "N-depropargylation of secondary or tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1153",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Methamphetamine",
                       "SMILES" : "C1=CC=C(C=C1)C[C@H](NC)C",
                     "InChIKey" : "MYWUZJCMWCOHBA-SECBINFHSA-N",
                     "BTMDB_ID" : "BTM0250",
                  "PubChem CID" : "36604",
                  "DrugBank ID" : "DB09571",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0149" : {
                                    "Substrate" : {
                     "Name" : "simvastatin",
                   "SMILES" : "[C@H]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]3C[C@@H](O)CC(=O)O3)OC(=O)C(C)(C)CC",
                 "InChIKey" : "RYMZZMVNJRMUDD-HGQWONQESA-N",
                 "BTMDB_ID" : "BTM0251",
              "PubChem CID" : "54454",
              "DrugBank ID" : "DB00641",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP3A5",
                                "Reaction Type" : "Allylic hydroxylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0071",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6'-β-Hydroxysimvastatin",
                       "SMILES" : "O[C@H]1CC(=O)O[C@H](CC[C@H]2[C@H](C=CC3=C[C@](O)(C)C[C@H](OC(=O)C(C)(C)CC)[C@H]23)C)C1",
                     "InChIKey" : "WJKSTNFUSXHVRJ-ZEUMIXTGSA-N",
                     "BTMDB_ID" : "BTM0252",
                  "PubChem CID" : "25221209",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0150" : {
                                    "Substrate" : {
                     "Name" : "sirolimus",
                   "SMILES" : "N12C(C([C@@]3(O[C@H](C[C@@H](C(=CC=CC=C[C@H](C[C@H](C([C@@H]([C@@H](C(=C[C@H](C(C[C@H](OC([C@@H]1CCCC2)=O)[C@@H](C[C@H]4C[C@H]([C@@H](CC4)O)OC)C)=O)C)C)O)OC)=O)C)C)C)OC)CC[C@H]3C)O)=O)=O",
                 "InChIKey" : "QFJCIRLUMZQUOT-QDDUNPAYSA-N",
                 "BTMDB_ID" : "BTM0253",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "O-dealkylation of dialkylether",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1129",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "39-O-Desmethylsirolimus",
                       "SMILES" : "O[C@@H]1CC[C@@H](C[C@@H](C)[C@H]2OC(=O)[C@H]3N(C(=O)C(=O)[C@]4(O)O[C@@H](CC[C@H]4C)C[C@H](OC)C(=CC=CC=C[C@@H](C)C[C@H](C(=O)[C@H](OC)[C@H](O)C(=C[C@H](C(=O)C2)C)C)C)C)CCCC3)C[C@H]1O",
                     "InChIKey" : "RGRYVHKBWYXMGM-KPMJGVQNSA-N",
                     "BTMDB_ID" : "BTM0254",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0151" : {
                                    "Substrate" : {
                     "Name" : "sirolimus",
                   "SMILES" : "N12C(C([C@@]3(O[C@H](C[C@@H](C(=CC=CC=C[C@H](C[C@H](C([C@@H]([C@@H](C(=C[C@H](C(C[C@H](OC([C@@H]1CCCC2)=O)[C@@H](C[C@H]4C[C@H]([C@@H](CC4)O)OC)C)=O)C)C)O)OC)=O)C)C)C)OC)CC[C@H]3C)O)=O)=O",
                 "InChIKey" : "QFJCIRLUMZQUOT-QDDUNPAYSA-N",
                 "BTMDB_ID" : "BTM0253",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of alkyl methine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0053",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "11-OH-sirolimus",
                       "SMILES" : "O[C@@H]1CC[C@@H](C[C@@H](C)[C@H]2OC(=O)[C@H]3N(C(=O)C(=O)[C@]4(O)O[C@@H](CC[C@@]4(O)C)C[C@H](OC)C(=CC=CC=C[C@@H](C)C[C@H](C(=O)[C@H](OC)[C@H](O)C(=C[C@H](C(=O)C2)C)C)C)C)CCCC3)C[C@H]1OC",
                     "InChIKey" : "VNPBYTOPCULMPL-DAYGUYCOSA-N",
                     "BTMDB_ID" : "BTM0255",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259988"
      },
      "BIOTID0152" : {
                                    "Substrate" : {
                     "Name" : "sirolimus",
                   "SMILES" : "N12C(C([C@@]3(O[C@H](C[C@@H](C(=CC=CC=C[C@H](C[C@H](C([C@@H]([C@@H](C(=C[C@H](C(C[C@H](OC([C@@H]1CCCC2)=O)[C@@H](C[C@H]4C[C@H]([C@@H](CC4)O)OC)C)=O)C)C)O)OC)=O)C)C)C)OC)CC[C@H]3C)O)=O)=O",
                 "InChIKey" : "QFJCIRLUMZQUOT-QDDUNPAYSA-N",
                 "BTMDB_ID" : "BTM0253",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of terminal methyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1061",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "46-OH-sirolimus",
                       "SMILES" : "O[C@@H]1CC[C@@H](C[C@@H](C)[C@H]2OC(=O)[C@H]3N(C(=O)C(=O)[C@]4(O)O[C@@H](CC[C@H]4C)C[C@H](OC)C(=CC=CC=C[C@@H](C)C[C@H](C(=O)[C@H](OC)[C@H](O)C(=C[C@H](C(=O)C2)C)C)CO)C)CCCC3)C[C@H]1OC",
                     "InChIKey" : "OEGQYPSSHFUXKW-JYIPRCQDSA-N",
                     "BTMDB_ID" : "BTM0256",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259991"
      },
      "BIOTID0153" : {
                                    "Substrate" : {
                     "Name" : "tacrine",
                   "SMILES" : "N1=C2C(CCCC2)=C(N)C3=C1C=CC=C3",
                 "InChIKey" : "YLJREFDVOIBQDA-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0257",
              "PubChem CID" : "1935",
              "DrugBank ID" : "DB00382",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4- Hydroxytacrine",
                       "SMILES" : "NC1=C2C(=NC3=C1C=CC=C3)C(O)CCC2",
                     "InChIKey" : "BISIFJGUTDFVFR-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0258",
                  "PubChem CID" : "179850",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259993"
      },
      "BIOTID0154" : {
                                    "Substrate" : {
                     "Name" : "tamoxifen",
                   "SMILES" : "CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(OCCN(C)C)C=C2)/C3=CC=CC=C3",
                 "InChIKey" : "NKANXQFJJICGDU-QPLCGJKRSA-N",
                 "BTMDB_ID" : "BTM0259",
              "PubChem CID" : "2733526",
              "DrugBank ID" : "DB00675",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP2B6",
                                "Reaction Type" : "p-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1035",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4'-Hydroxytamoxifen",
                       "SMILES" : "C1=CC=C(C=C1)\\C(=C(\\C2=CC=C(O)C=C2)/CC)\\C3=CC=C(OCCN(C)C)C=C3",
                     "InChIKey" : "DODQJNMQWMSYGS-QPLCGJKRSA-N",
                     "BTMDB_ID" : "BTM0260",
                  "PubChem CID" : "5284643",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423 || (R3) Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987 || (R4) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0155" : {
                                    "Substrate" : {
                     "Name" : "taxol",
                   "SMILES" : "[C@H]12[C@]3([C@H](OC3)C[C@@H]([C@]1(C([C@@H](C=4C([C@]([C@H]2OC(C5=CC=CC=C5)=O)(C[C@@H](C4C)OC(=O)[C@@H]([C@H](C6=CC=CC=C6)NC(C7=CC=CC=C7)=O)O)O)(C)C)OC(C)=O)=O)C)O)OC(C)=O",
                 "InChIKey" : "RCINICONZNJXQF-YUKVPPSFSA-N",
                 "BTMDB_ID" : "BTM0261",
              "PubChem CID" : "14060306",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP2C8",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6α-Hydroxypaclitaxel",
                       "SMILES" : "O[C@@H](C(=O)O[C@@H]1C(=C2[C@@H](OC(=O)C)C(=O)[C@]3(C)[C@@H](O)[C@H](O)[C@H]4OC[C@@]4(OC(=O)C)[C@@H]3[C@H](OC(=O)C5=CC=CC=C5)[C@](O)(C1)C2(C)C)C)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7",
                     "InChIKey" : "NDCWHEDPSFRTDA-ZYWDROJESA-N",
                     "BTMDB_ID" : "BTM0262",
                  "PubChem CID" : "125121557",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423 || (R3) Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987 || (R4) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0156" : {
                                    "Substrate" : {
                     "Name" : "terbinafine",
                   "SMILES" : "CN(C/C=C/C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12",
                 "InChIKey" : "DOMXUEMWDBAQBQ-WEVVVXLNSA-N",
                 "BTMDB_ID" : "BTM0263",
              "PubChem CID" : "1549008",
              "DrugBank ID" : "DB00857",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "1-Naphtaldehyde",
                       "SMILES" : "C(=O)C1=CC=CC2=CC=CC=C12",
                     "InChIKey" : "SQAINHDHICKHLX-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0264",
                  "PubChem CID" : "6195",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
      },
      "BIOTID0157" : {
                                    "Substrate" : {
                     "Name" : "testosterone",
                   "SMILES" : "[C@@H]12CC[C@H](O)[C@@]1(C)CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C",
                 "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                 "BTMDB_ID" : "BTM0265",
              "PubChem CID" : "6013",
              "DrugBank ID" : "DB00624",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP3A4 ",
                                "Reaction Type" : "Alpha hydroxylation of carbonyl group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1054",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2α-Hydroxytestosterone",
                       "SMILES" : "O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C",
                     "InChIKey" : "ZOIPFFUVGMVQGE-DTQPDNRZSA-N",
                     "BTMDB_ID" : "BTM0266",
                  "PubChem CID" : "14311666",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0158" : {
                                    "Substrate" : {
                     "Name" : "testosterone",
                   "SMILES" : "[C@@H]12CC[C@H](O)[C@@]1(C)CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C",
                 "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                 "BTMDB_ID" : "BTM0265",
              "PubChem CID" : "6013",
              "DrugBank ID" : "DB00624",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1067",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "15β-Hydroxytestosterone",
                       "SMILES" : "O[C@H]1C[C@@H](O)[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C",
                     "InChIKey" : "KYGUQDTWUBBBSD-XJBBOAPUSA-N",
                     "BTMDB_ID" : "BTM0267",
                  "PubChem CID" : "53255472",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
      },
      "BIOTID0159" : {
                                    "Substrate" : {
                     "Name" : "testosterone",
                   "SMILES" : "[C@@H]12CC[C@H](O)[C@@]1(C)CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C",
                 "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                 "BTMDB_ID" : "BTM0265",
              "PubChem CID" : "6013",
              "DrugBank ID" : "DB00624",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19; CYP2C9 ",
                                "Reaction Type" : "Oxidation of secondary alcohol to ketone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0079",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Androstenedione",
                       "SMILES" : "C1=C2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CCC1=O",
                     "InChIKey" : "AEMFNILZOJDQLW-QAGGRKNESA-N",
                     "BTMDB_ID" : "BTM0268",
                  "PubChem CID" : "6128",
                  "DrugBank ID" : "DB01536",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259989"
      },
      "BIOTID0160" : {
                                    "Substrate" : {
                     "Name" : "theophylline",
                   "SMILES" : "O=C1N(C(=O)N(C=2N=CNC21)C)C",
                 "InChIKey" : "ZFXYFBGIUFBOJW-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0269",
              "PubChem CID" : "2153",
              "DrugBank ID" : "DB00277",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : " CYP1A2",
                                "Reaction Type" : "N-dealkylation of N-acylurea",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1149",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-Methylxanthine",
                       "SMILES" : "N1C=NC2=C1C(=O)NC(=O)N2C",
                     "InChIKey" : "GMSNIKWWOQHZGF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0270",
                  "PubChem CID" : "70639",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
      },
      "BIOTID0161" : {
                                    "Substrate" : {
                     "Name" : "ticlopidine",
                   "SMILES" : "ClC1=CC=CC=C1CN2CCC3=C(C2)C=CS3",
                 "InChIKey" : "PHWBOXQYWZNQIN-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0271",
              "PubChem CID" : "5472",
              "DrugBank ID" : "DB00208",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C19",
                                "Reaction Type" : "Formation of imminium ion from N-substituted piperidine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1187",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Thienodihydropyridinium",
                       "SMILES" : "C1=CC2=C(S1)CC[N+](=C2)CC3=CC=CC=C3Cl",
                     "InChIKey" : "RLTCLQFOWWSHJX-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0272",
                  "PubChem CID" : "71314787",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0162" : {
                                    "Substrate" : {
                     "Name" : "ticrynafen",
                   "SMILES" : "C1(=C(C(=C(OCC(=O)O)C=C1)Cl)Cl)C(C=2SC=CC2)=O",
                 "InChIKey" : "AGHANLSBXUWXTB-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0273",
              "PubChem CID" : "38409",
              "DrugBank ID" : "DB04831",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8; CYP2C9; CYP2C18; CYP2C19",
                                "Reaction Type" : "Epoxidation of thiophene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0131",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Thiophene-4,5-epoxide",
                       "SMILES" : "OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C2=CC3OC3S2",
                     "InChIKey" : "RJEINYXLECHKSU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0274",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0163" : {
                                    "Substrate" : {
                     "Name" : "tolbutamide",
                   "SMILES" : "CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1",
                 "InChIKey" : "JLRGJRBPOGGCBT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0275",
              "PubChem CID" : "5505",
              "DrugBank ID" : "DB01124",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19",
                                "Reaction Type" : "Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxytolbutamide",
                       "SMILES" : "N(C(=O)NS(=O)(=O)C1=CC=C(C=C1)CO)CCCC",
                     "InChIKey" : "SJRHYONYKZIRPM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0276",
                  "PubChem CID" : "3656",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423 || (R3) Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987 || (R4) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0164" : {
                                    "Substrate" : {
                     "Name" : "toluene",
                   "SMILES" : "C=1C(C)=CC=CC1",
                 "InChIKey" : "YXFVVABEGXRONW-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0277",
              "PubChem CID" : "1140",
              "DrugBank ID" : "DB11558",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1 (at low concentrations); CYP2B6 (at hight concentrations); CYP2C8; CYP1A2; CYP1A1",
                                "Reaction Type" : "Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Benzyl alcohol",
                       "SMILES" : "OCC1=CC=CC=C1",
                     "InChIKey" : "WVDDGKGOMKODPV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0278",
                  "PubChem CID" : "244",
                  "DrugBank ID" : "DB06770",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0165" : {
                                    "Substrate" : {
                     "Name" : "torasemide",
                   "SMILES" : "CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1",
                 "InChIKey" : "NGBFQHCMQULJNZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0279",
              "PubChem CID" : "41781",
              "DrugBank ID" : "DB00214",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-[(4-{[3-(hydroxymethyl)phenyl]imino}-1,4-dihydropyridin-3-yl)sulfonyl]propane-2-carbamimidic acid",
                       "SMILES" : "N(C1=CC=CC(CO)=C1)C2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C",
                     "InChIKey" : "WCYVLAMJCQZUCR-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0280",
                  "PubChem CID" : "14475217",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0166" : {
                                    "Substrate" : {
                     "Name" : "trazodone",
                   "SMILES" : "C=1C=CN2C(C1)=NN(C2=O)CCCN3CCN(CC3)C=4C=C(C=CC4)Cl",
                 "InChIKey" : "PHLBKPHSAVXXEF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0281",
              "PubChem CID" : "5533",
              "DrugBank ID" : "DB00656",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "1-(3-chlorophenyl)piperazine",
                       "SMILES" : "C1(N2CCNCC2)=CC=CC(=C1)Cl",
                     "InChIKey" : "VHFVKMTVMIZMIK-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0047",
                  "PubChem CID" : "1355",
                  "DrugBank ID" : "DB12110",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754425"
      },
      "BIOTID0167" : {
                                    "Substrate" : {
                     "Name" : "triamterene",
                   "SMILES" : "NC1=NC(N)=C2N=C(C(N)=NC2=N1)C3=CC=CC=C3",
                 "InChIKey" : "FNYLWPVRPXGIIP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0282",
              "PubChem CID" : "5546",
              "DrugBank ID" : "DB00384",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "p-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1035",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4'-OH-triamterene",
                       "SMILES" : "NC1=NC(N)=C2N=C(C(=NC2=N1)N)C3=CC=C(O)C=C3",
                     "InChIKey" : "QNJVMSASTUDLGC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0283",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754425"
      },
      "BIOTID0168" : {
                                    "Substrate" : {
                     "Name" : "triamterene",
                   "SMILES" : "NC1=NC(N)=C2N=C(C(N)=NC2=N1)C3=CC=CC=C3",
                 "InChIKey" : "FNYLWPVRPXGIIP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0282",
              "PubChem CID" : "5546",
              "DrugBank ID" : "DB00384",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "Hydroxylation of benzene on carbon para to an electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1047",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4'-OH-triamterene",
                       "SMILES" : "NC1=NC(N)=C2N=C(C(=NC2=N1)N)C3=CC=C(O)C=C3",
                     "InChIKey" : "QNJVMSASTUDLGC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0283",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754425"
      },
      "BIOTID0169" : {
                                    "Substrate" : {
                     "Name" : "valproic acid",
                   "SMILES" : "CCCC(CCC)C(O)=O",
                 "InChIKey" : "NIJJYAXOARWZEE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0284",
              "PubChem CID" : "3121",
              "DrugBank ID" : "DB00313",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2B6; CYP2A6",
                                "Reaction Type" : "Hydroxylation of penultimate aliphatic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1074",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxyvalproate",
                       "SMILES" : "OC(=O)C(CCC)CC(O)C",
                     "InChIKey" : "OASKNPCLIHUTTL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0285",
                  "PubChem CID" : "134467",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0170" : {
                                    "Substrate" : {
                     "Name" : "valproic acid",
                   "SMILES" : "CCCC(CCC)C(O)=O",
                 "InChIKey" : "NIJJYAXOARWZEE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0284",
              "PubChem CID" : "3121",
              "DrugBank ID" : "DB00313",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2B6; CYP2A6",
                                "Reaction Type" : "Hydroxylation of acyclic aliphatic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1063",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxyvalproate",
                       "SMILES" : "OC(=O)C(CCC)CC(O)C",
                     "InChIKey" : "OASKNPCLIHUTTL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0285",
                  "PubChem CID" : "134467",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0171" : {
                                    "Substrate" : {
                     "Name" : "valproic acid",
                   "SMILES" : "CCCC(CCC)C(O)=O",
                 "InChIKey" : "NIJJYAXOARWZEE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0284",
              "PubChem CID" : "3121",
              "DrugBank ID" : "DB00313",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Terminal desaturation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1190",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-ene-valproate",
                       "SMILES" : "OC(=O)C(CC=C)CCC",
                     "InChIKey" : "UMYDNZXEHYSVFY-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0286",
                  "PubChem CID" : "104896",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0172" : {
                                    "Substrate" : {
                     "Name" : "vicriviroc",
                   "SMILES" : "COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F",
                 "InChIKey" : "CNPVJJQCETWNEU-CYFREDJKSA-N",
                 "BTMDB_ID" : "BTM0287",
              "PubChem CID" : "3009355",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP3A5",
                                "Reaction Type" : "N-oxidation of pyrimidine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1115",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Vicriviroc N-oxide",
                       "SMILES" : "COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)[N+]([O-])=CN=C3C)C4=CC=C(C=C4)C(F)(F)F",
                     "InChIKey" : "FJGWJMSLTFKZKY-CYFREDJKSA-N",
                     "BTMDB_ID" : "BTM0288",
                  "PubChem CID" : "11577561",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3680"
      },
      "BIOTID0173" : {
                                    "Substrate" : {
                     "Name" : "voriconazole",
                   "SMILES" : "C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3",
                 "InChIKey" : "BCEHBSKCWLPMDN-MGPLVRAMSA-N",
                 "BTMDB_ID" : "BTM0289",
              "PubChem CID" : "71616",
              "DrugBank ID" : "DB00582",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19; CYP3A4",
                                "Reaction Type" : "N-oxidation of pyrimidine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1115",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Voriconazole N-Oxide",
                       "SMILES" : "O[C@](C1=C(F)C=C(F)C=C1)(CN2N=CN=C2)[C@H](C3=NC=[N+]([O-])C=C3F)C",
                     "InChIKey" : "KPLFPLUCFPRUHU-MGPLVRAMSA-N",
                     "BTMDB_ID" : "BTM0290",
                  "PubChem CID" : "10044355",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0174" : {
                                    "Substrate" : {
                     "Name" : "warfarin-r",
                   "SMILES" : "O1C(O)=C([C@H](CC(=O)C)C2=CC=CC=C2)C(=O)C3=C1C=CC=C3",
                 "InChIKey" : "QTXVAVXCBMYBJW-OAHLLOKOSA-N",
                 "BTMDB_ID" : "BTM0291",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP1A1; CYP2C19",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "8-Hydroxywarfarin",
                       "SMILES" : "OC1=C(C(=O)C2=C(O1)C(O)=CC=C2)[C@@H](C3=CC=CC=C3)CC(=O)C",
                     "InChIKey" : "RCTGERXIFCOAHF-CQSZACIVSA-N",
                     "BTMDB_ID" : "BTM0292",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : ""
      },
      "BIOTID0175" : {
                                    "Substrate" : {
                     "Name" : "warfarin-s",
                   "SMILES" : "O1C(O)=C([C@@H](CC(=O)C)C2=CC=CC=C2)C(=O)C3=C1C=CC=C3",
                 "InChIKey" : "QTXVAVXCBMYBJW-HNNXBMFYSA-N",
                 "BTMDB_ID" : "BTM0293",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7-Hydroxywarfarin",
                       "SMILES" : "OC1=C(C(=O)C2=C(O1)C=C(O)C=C2)[C@H](C3=CC=CC=C3)CC(=O)C",
                     "InChIKey" : "BQSUFDMOXLLKQK-HNNXBMFYSA-N",
                     "BTMDB_ID" : "BTM0294",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0176" : {
                                    "Substrate" : {
                     "Name" : "warfarin-s",
                   "SMILES" : "O1C(O)=C([C@@H](CC(=O)C)C2=CC=CC=C2)C(=O)C3=C1C=CC=C3",
                 "InChIKey" : "QTXVAVXCBMYBJW-HNNXBMFYSA-N",
                 "BTMDB_ID" : "BTM0293",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Alpha hydroxylation of carbonyl group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1054",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "10-Hydroxylation",
                       "SMILES" : "OC1=C(C(=O)C2=C(O1)C=CC=C2)[C@H](C3=CC=CC=C3)C(O)C(=O)C",
                     "InChIKey" : "KLDFTXZRAPVGLB-MYJWUSKBSA-N",
                     "BTMDB_ID" : "BTM0295",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0177" : {
                                    "Substrate" : {
                     "Name" : "warfarin-s",
                   "SMILES" : "O1C(O)=C([C@@H](CC(=O)C)C2=CC=CC=C2)C(=O)C3=C1C=CC=C3",
                 "InChIKey" : "QTXVAVXCBMYBJW-HNNXBMFYSA-N",
                 "BTMDB_ID" : "BTM0293",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of acyclic aliphatic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1063",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "10-Hydroxylation",
                       "SMILES" : "OC1=C(C(=O)C2=C(O1)C=CC=C2)[C@H](C3=CC=CC=C3)C(O)C(=O)C",
                     "InChIKey" : "KLDFTXZRAPVGLB-MYJWUSKBSA-N",
                     "BTMDB_ID" : "BTM0295",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0178" : {
                                    "Substrate" : {
                     "Name" : "7-Benzyloxyresorufin",
                   "SMILES" : "C1=CC=C(C=C1)COC2=CC=C3C(=C2)OC4=CC(=O)C=CC4=N3",
                 "InChIKey" : "XNZRYTITWLGTJS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0296",
              "PubChem CID" : "114982",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP1B1",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Resorufin",
                       "SMILES" : "C1=CC2=C(OC3=CC(=O)C=CC3=N2)C=C1O",
                     "InChIKey" : "HSSLDCABUXLXKM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0062",
                  "PubChem CID" : "69462",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0179" : {
                                    "Substrate" : {
                     "Name" : "Nitrosodiethylamine",
                   "SMILES" : "CCN(CC)N=O",
                 "InChIKey" : "WBNQDOYYEUMPFS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0297",
              "PubChem CID" : "5921",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6; CYP2B6; CYP2E1",
                                "Reaction Type" : "N-dealkylation of nitrosodialkylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0084",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Nitrosomonoethylamine",
                       "SMILES" : "N(CC)N=O",
                     "InChIKey" : "SCSKXSBERKMMJG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0298",
                  "PubChem CID" : "149201",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015 || (R2) Ekins, S. and Wrighton, S.A. (1999); The role of CYP2B6 in Human Xenobiotic Metabolism; Drug Metabolism Reviews, 31:3, 719-754, DOI:10.1081/ DMR-100101942; PMID:10461547"
      },
      "BIOTID0180" : {
                                    "Substrate" : {
                     "Name" : "dibenzo(a,h)anthracene",
                   "SMILES" : "C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32",
                 "InChIKey" : "LHRCREOYAASXPZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0299",
              "PubChem CID" : "5889",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2",
                                "Reaction Type" : "Epoxidation of arene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1027",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "dibenzo(a,h)anthracene 1,2-epoxide",
                       "SMILES" : "O1C2C=CC3=C(C12)C4=C(C=C3)C=C5C(C=CC6=C5C=CC=C6)=C4",
                     "InChIKey" : "KRMRQHCFOIRUMJ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0300",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675 || (R2) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0181" : {
                                    "Substrate" : {
                     "Name" : "Proguanil",
                   "SMILES" : "CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1",
                 "InChIKey" : "SSOLNOMRVKKSON-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0301",
              "PubChem CID" : "6178111",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19",
                                "Reaction Type" : "N-deisopropylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0051",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Chlorophenylbiguanide",
                       "SMILES" : "NC(=N)NC(=N)NC1=CC=C(Cl)C=C1",
                     "InChIKey" : "HTYFFCPFVMJTKM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0302",
                  "PubChem CID" : "19933",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Diaz, D.S. et al. (2008); Role of Specific Cytochrome P450 Isoforms in the Conversion of Phenoxypropoxybiguanide Analogs in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines; Drug Metabolism and Disposition February 2008, 36 (2) 380-385; DOI: https://doi.org/10.1124/dmd.106.013920 || (R3) Birkett, D.J. et al. (1994); In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase; Br J Clin Pharmacol.; 37(5):413-20."
      },
      "BIOTID0182" : {
                                    "Substrate" : {
                     "Name" : "Verapamil",
                   "SMILES" : "COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)C=C1OC",
                 "InChIKey" : "SGTNSNPWRIOYBX-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0303",
              "PubChem CID" : "2520",
              "DrugBank ID" : "DB00661",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8; CYP2C18",
                                "Reaction Type" : "O-aryl dealkylation adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1131",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "D-702",
                       "SMILES" : "COC1=CC(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)=CC=C1O",
                     "InChIKey" : "CAAKRPRWCVWYAO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0304",
                  "PubChem CID" : "157039",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545–552; doi: 10.1046/j.1365-2125.1999.00923.x || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0183" : {
                                    "Substrate" : {
                     "Name" : "Bufuralol",
                   "SMILES" : "CCC1=C2OC(=CC2=CC=C1)C(O)CNC(C)(C)C",
                 "InChIKey" : "SSEBTPPFLLCUMN-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0305",
              "PubChem CID" : "71733",
              "DrugBank ID" : "DB06726",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2D6",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxybufuralol",
                       "SMILES" : "CCC1=C2OC(=CC2=C(O)C=C1)C(O)CNC(C)(C)C",
                     "InChIKey" : "VWEQAYFMBKZBLK-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0306",
                  "PubChem CID" : "173807",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Yamazaki, H. et al. (1994); Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes; Molecular Pharmacology September 1994, 46 (3) 568-577"
      },
      "BIOTID0184" : {
                                    "Substrate" : {
                     "Name" : "Halothane",
                   "SMILES" : "FC(F)(F)C(Cl)Br",
                 "InChIKey" : "BCQZXOMGPXTTIC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0307",
              "PubChem CID" : "3562",
              "DrugBank ID" : "DB01159",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6; CYP3A4",
                                "Reaction Type" : "Reduction of halotrifluoroethane",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1164",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "chlorodifluoroethene",
                       "SMILES" : "C(Cl)=C(F)F",
                     "InChIKey" : "HTHNTJCVPNKCPZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0308",
                  "PubChem CID" : "9664",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0185" : {
                                    "Substrate" : {
                     "Name" : "delta-9-Tetrahydrocannabinol",
                   "SMILES" : "CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O",
                 "InChIKey" : "CYQFCXCEBYINGO-IAGOWNOFSA-N",
                 "BTMDB_ID" : "BTM0309",
              "PubChem CID" : "16078",
              "DrugBank ID" : "DB00470",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7-OH-delta-9-Tetrahydrocannabinol",
                       "SMILES" : "CCCCCC1=CC(O)=C2[C@@H]3C=C(C)C[C@H](O)C3C(C)(C)OC2=C1",
                     "InChIKey" : "DJCKLUPKZRLTPE-RQFJBDDASA-N",
                     "BTMDB_ID" : "BTM0310",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0186" : {
                                    "Substrate" : {
                     "Name" : "delta-9-Tetrahydrocannabinol",
                   "SMILES" : "CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O",
                 "InChIKey" : "CYQFCXCEBYINGO-IAGOWNOFSA-N",
                 "BTMDB_ID" : "BTM0309",
              "PubChem CID" : "16078",
              "DrugBank ID" : "DB00470",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "8alpha-OH-delta-9-Tetrahydrocannabinol",
                       "SMILES" : "CCCCCC1=CC(O)=C2[C@@H]3C=C(C)[C@H](O)CC3C(C)(C)OC2=C1",
                     "InChIKey" : "INKUWBOHCFHXTJ-PWZMFNOBSA-N",
                     "BTMDB_ID" : "BTM0311",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0187" : {
                                    "Substrate" : {
                     "Name" : "zafirlukast",
                   "SMILES" : "COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C",
                 "InChIKey" : "YEEZWCHGZNKEEK-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0312",
              "PubChem CID" : "5717",
              "DrugBank ID" : "DB00549",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP3A4",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1067",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3‐hydroxycyclopentyl N‐[3‐({2‐methoxy‐4‐[(2‐methylbenzenesulfonyl)carbamoyl]phenyl}methyl)‐1‐methylindol‐5‐yl]carbamate",
                       "SMILES" : "N(C(=O)OC1CCC(O)C1)C2=CC3=C(C=C2)N(C=C3CC4=C(OC)C=C(C=C4)C(=O)NS(=O)(=O)C5=CC=CC=C5C)C",
                     "InChIKey" : "OPQKYGDYABHOST-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0313",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
      },
      "BIOTID0188" : {
                                    "Substrate" : {
                     "Name" : "zolmitriptan",
                   "SMILES" : "O1C[C@@H](NC1=O)CC=2C=C3C(CCN(C)C)=CNC3=CC2",
                 "InChIKey" : "ULSDMUVEXKOYBU-ZDUSSCGKSA-N",
                 "BTMDB_ID" : "BTM0314",
              "PubChem CID" : "60857",
              "DrugBank ID" : "DB00315",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "N-oxdation of aliphatic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1100",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Zolmitriptan N-oxide",
                       "SMILES" : "N1C=C(C2=CC(=CC=C12)C[C@@H]3NC(=O)OC3)CC[N+]([O-])(C)C",
                     "InChIKey" : "GZYCQRZFJIZOKU-ZDUSSCGKSA-N",
                     "BTMDB_ID" : "BTM0315",
                  "PubChem CID" : "25241756",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0189" : {
                                    "Substrate" : {
                     "Name" : "zotepine",
                   "SMILES" : "C12=C(SC3=C(C=C1OCCN(C)C)C=CC=C3)C=CC(=C2)Cl",
                 "InChIKey" : "HDOZVRUNCMBHFH-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0316",
              "PubChem CID" : "5736",
              "DrugBank ID" : "DB09225",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-OH-zotepine",
                       "SMILES" : "C1=CC2=C(C=C1O)C=C(OCCN(C)C)C3=C(S2)C=CC(Cl)=C3",
                     "InChIKey" : "MCQGRTOFLHWZAG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0317",
                  "PubChem CID" : "12882318",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0190" : {
                                    "Substrate" : {
                     "Name" : "Benzo[a]pyrene",
                   "SMILES" : "C1=CC=C2C(=C1)C=C3C=CC4=CC=CC5=CC=C2C3=C45",
                 "InChIKey" : "FMMWHPNWAFZXNH-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0318",
              "PubChem CID" : "2336",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP1B1",
                                "Reaction Type" : "Epoxidation of arene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1027",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Benzo[a]pyrene-7,8-epoxide",
                       "SMILES" : "C1=CC2=CC=C3C4=C(C=C5C=CC(=C1)C2=C35)C6OC6C=C4",
                     "InChIKey" : "OLLMQFHYRYHKTD-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0319",
                  "PubChem CID" : "37455",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0191" : {
                                    "Substrate" : {
                     "Name" : "Benzo[a]pyrene",
                   "SMILES" : "C1=CC=C2C(=C1)C=C3C=CC4=CC=CC5=CC=C2C3=C45",
                 "InChIKey" : "FMMWHPNWAFZXNH-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0318",
              "PubChem CID" : "2336",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1",
                                "Reaction Type" : "Epoxidation of arene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1027",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "1-Hydroxybenzo[a]pyrene",
                       "SMILES" : "C1=CC2=C(C=C1)C3=C4C(C=CC5=CC6OC6C(C=C3)=C45)=C2",
                     "InChIKey" : "SFZMXWGXHHIMNU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0320",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0192" : {
                                    "Substrate" : {
                     "Name" : "Retinoic acid, all-trans",
                   "SMILES" : "C1(=C(CCCC1(C)C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C",
                 "InChIKey" : "SHGAZHPCJJPHSC-YCNIQYBTSA-N",
                 "BTMDB_ID" : "BTM0321",
              "PubChem CID" : "444795",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8; CYP2C9; CYP1A1; CYP2D6",
                                "Reaction Type" : "Epxodation of alkene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0110",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5,6-Epoxy-retinoic acid",
                       "SMILES" : "C/C(/C=C/C12OC1(C)CCCC2(C)C)=C\\C=C\\C(\\C)=C\\C(O)=O",
                     "InChIKey" : "KEEHJLBAOLGBJZ-WEDZBJJJSA-N",
                     "BTMDB_ID" : "BTM0322",
                  "PubChem CID" : "5363137",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0193" : {
                                    "Substrate" : {
                     "Name" : "Metamphetamine",
                   "SMILES" : "CN[C@@H](C)CC1=CC=CC=C1",
                 "InChIKey" : "MYWUZJCMWCOHBA-VIFPVBQESA-N",
                 "BTMDB_ID" : "BTM0323",
              "PubChem CID" : "10836",
              "DrugBank ID" : "DB01577",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "p-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1035",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxymethamphetamine",
                       "SMILES" : "CN[C@@H](C)CC1=CC=C(O)C=C1",
                     "InChIKey" : "SBUQZKJEOOQSBV-QMMMGPOBSA-N",
                     "BTMDB_ID" : "BTM0324",
                  "PubChem CID" : "158815",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0194" : {
                                    "Substrate" : {
                     "Name" : "Methylene chloride",
                   "SMILES" : "ClCCl",
                 "InChIKey" : "YMWUJEATGCHHMB-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0325",
              "PubChem CID" : "6344",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1",
                                "Reaction Type" : "Hydroxylation of carbon adjacent to halogen",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1079",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dichloromethanol",
                       "SMILES" : "OC(Cl)Cl",
                     "InChIKey" : "GJYVZUKSNFSLCL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0326",
                  "PubChem CID" : "169730",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0195" : {
                                    "Substrate" : {
                     "Name" : "Phenobarbital",
                   "SMILES" : "CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2",
                 "InChIKey" : "DDBREPKUVSBGFI-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0327",
              "PubChem CID" : "4763",
              "DrugBank ID" : "DB01174",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19; CYP2E1",
                                "Reaction Type" : "p-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1035",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "p-Hydroxyphenobarbital",
                       "SMILES" : "CCC1(C(=O)NC(=O)NC1=O)C2=CC=C(O)C=C2",
                     "InChIKey" : "IEPXMKJNWPXDBP-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0328",
                  "PubChem CID" : "9785",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Lee, A.M. et al. (2006); Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism; Eur J Pharmacol. 2006 Dec 15;552(1-3):151-8; PMID:17049344; DOI:10.1016/j.ejphar.2006.09.006"
      },
      "BIOTID0196" : {
                                    "Substrate" : {
                     "Name" : "Glyburide",
                   "SMILES" : "N(C(=O)C1=C(OC)C=CC(Cl)=C1)CCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3",
                 "InChIKey" : "ZNNLBTZKUZBEKO-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0329",
              "PubChem CID" : "3488",
              "DrugBank ID" : "DB01016",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C9; CYP2C19",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-trans-hydroxycyclohexyl glyburide",
                       "SMILES" : "N(C(=O)C1=C(OC)C=CC(Cl)=C1)CCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](O)CC3",
                     "InChIKey" : "IUWSGCQEWOOQDN-IYARVYRRSA-N",
                     "BTMDB_ID" : "BTM0330",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
      },
      "BIOTID0197" : {
                                    "Substrate" : {
                     "Name" : "(-)-bisoprolol",
                   "SMILES" : "CC(C)NC[C@@H](COC1=CC=C(C=C1)COCCOC(C)C)O",
                 "InChIKey" : "VHYCDWMUTMEGQY-KRWDZBQOSA-N",
                 "BTMDB_ID" : "BTM0331",
              "PubChem CID" : "10892731",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP3A4",
                                "Reaction Type" : "O-deisopropylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1130",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(-)-bisoprolol, O-deisopropyl",
                       "SMILES" : "CC(C)NC[C@H](O)COC1=CC=C(COCCO)C=C1",
                     "InChIKey" : "AIGGWEPYIOOYLI-AWEZNQCLSA-N",
                     "BTMDB_ID" : "BTM0332",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Horikiri, Y. (1998); Pharmacokinetics and Metabolism of Bisoprolol Enantiomers in Humans; Journal of Pharmaceutical Sciences; Vol. 87, No. 3"
      },
      "BIOTID0198" : {
                                    "Substrate" : {
                     "Name" : "(r)-fluoxetine",
                   "SMILES" : "N(C)CC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2",
                 "InChIKey" : "RTHCYVBBDHJXIQ-MRXNPFEDSA-N",
                 "BTMDB_ID" : "BTM0333",
              "PubChem CID" : "1548970",
              "DrugBank ID" : "DB08472",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "O-dealkylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0052",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-(methylamino)-1-phenylpropan-1-one",
                       "SMILES" : "N(C)CCC(=O)C1=CC=CC=C1",
                     "InChIKey" : "CAIKBWLFBLRPJU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0334",
                  "PubChem CID" : "407877",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Ring, B.J. et al. (2001); Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine; J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50. || (R3) Margolis J.M.; (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes; Drug Metab Dispos. 2000 Oct;28(10):1187-91; PMID: 10997938; Drug Metab Dispos. 2000 Oct;28(10):1187-91."
      },
      "BIOTID0199" : {
                                    "Substrate" : {
                     "Name" : "(S)-(-)-Mexiletine",
                   "SMILES" : "CC1=C(C(=CC=C1)C)OC[C@H](C)N",
                 "InChIKey" : "VLPIATFUUWWMKC-JTQLQIEISA-N",
                 "BTMDB_ID" : "BTM0335",
              "PubChem CID" : "185376",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2B6; CYP2E1",
                                "Reaction Type" : "N-hydroxylation of primary or secondary aliphatic amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1096",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(S)-(-)-Mexiletine, N-hydroxy",
                       "SMILES" : "C[C@@H](COC1=C(C)C=CC=C1C)NO",
                     "InChIKey" : "ABMUWCMGKRQAIK-JTQLQIEISA-N",
                     "BTMDB_ID" : "BTM0336",
                  "PubChem CID" : "92288930",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Abolfathi, Z. et al. (1995); CYP1A2 is the Major Enzyme Involved in the N-Oxidation of Mexiletine (MEX) in Man. Clin. Pharmacol. Ther.; 57; 221 (OIII- A33) || (R2) Labbe, L. et al.; (2003). Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine. Xenobi- otica 33:13–25."
      },
      "BIOTID0200" : {
                                    "Substrate" : {
                     "Name" : "(S)-mianserin",
                   "SMILES" : "C1=CC=C2C(=C1)N3CCN(C)C[C@@H]3C4=CC=CC=C4C2",
                 "InChIKey" : "UEQUQVLFIPOEMF-GOSISDBHSA-N",
                 "BTMDB_ID" : "BTM0337",
              "PubChem CID" : "154315",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "N-oxidation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1099",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(S)-mianserin, N-oxide",
                       "SMILES" : "C1=CC=C2C(=C1)N3CC[N+]([O-])(C)C[C@@H]3C4=CC=CC=C4C2",
                     "InChIKey" : "VVDXWJOYXVNLLQ-QSVWIEALSA-N",
                     "BTMDB_ID" : "BTM0338",
                  "PubChem CID" : "29984842",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Rendic, S., Di Carlo, F. (1997) Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors; Drug Metabolism Reviews, 29:1-2, 413-580; DOI:10.3109/03602539709037591; PMID:9187528"
      },
      "BIOTID0201" : {
                                    "Substrate" : {
                     "Name" : "(s)-bupropion",
                   "SMILES" : "N([C@H](C(=O)C1=CC(Cl)=CC=C1)C)C(C)(C)C",
                 "InChIKey" : "SNPPWIUOZRMYNY-VIFPVBQESA-N",
                 "BTMDB_ID" : "BTM0339",
              "PubChem CID" : "667684",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19",
                                "Reaction Type" : "Hydroxylation of terminal methyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1061",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(2S)-2-(tert-butylamino)-1-(3-chlorophenyl)-3-hydroxypropan-1-one",
                       "SMILES" : "N([C@H](C(=O)C1=CC(Cl)=CC=C1)CO)C(C)(C)C",
                     "InChIKey" : "MYCARDPPKMGEQK-NSHDSACASA-N",
                     "BTMDB_ID" : "BTM0340",
                  "PubChem CID" : "22943245",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880"
      },
      "BIOTID0202" : {
                                    "Substrate" : {
                     "Name" : "1,4-dichlorobenzene",
                   "SMILES" : "C1=CC(Cl)=CC=C1Cl",
                 "InChIKey" : "OCJBOOLMMGQPQU-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0341",
              "PubChem CID" : "4685",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2E1",
                                "Reaction Type" : "Hydroxylation of aromatic carbon ortho to halide group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1040",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2,5-dichlorophenol",
                       "SMILES" : "OC1=C(Cl)C=CC(Cl)=C1",
                     "InChIKey" : "RANCECPPZPIPNO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0342",
                  "PubChem CID" : "66",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284 || (R2) Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53–70"
      },
      "BIOTID0203" : {
                                    "Substrate" : {
                     "Name" : "1‐{3‐[4‐(3‐chloro‐4‐hydroxyphenyl)piperazin‐1‐yl]propyl}‐3‐ethyl‐4‐(2‐phenoxyethyl)‐4,5‐dihydro‐1H‐1,2,4‐triazol‐5‐one",
                   "SMILES" : "OC1=CC=C(C=C1Cl)N2CCN(CCCN3N=C(N(C3=O)CCOC4=CC=CC=C4)CC)CC2",
                 "InChIKey" : "XGIODORTBODPTQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0343",
              "PubChem CID" : "10435492",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Oxidation of 4-substituted phenol",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0113",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "1‐{3‐[4‐(3‐chloro‐1‐hydroxy‐4‐oxocyclohexa‐2,5‐dien‐1‐yl)piperazin‐1‐yl]propyl}‐3‐ethyl‐4‐(2‐phenoxyethyl)‐4,5‐dihydro‐1H‐1,2,4‐triazol‐5‐one",
                       "SMILES" : "O[C@]1(C=CC(=O)C(Cl)=C1)N2CCN(CCCN3N=C(N(C3=O)CCOC4=CC=CC=C4)CC)CC2",
                     "InChIKey" : "XAUKQBXYNIMIMU-VWLOTQADSA-N",
                     "BTMDB_ID" : "BTM0344",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Bolleddula, J. et al. (2014); Biotransformation and bioactivation reactions of alicyclic amines in drug molecules, Drug Metabolism Reviews, 46:3, 379-419, DOI: 10.3109/03602532.2014.924962."
      },
      "BIOTID0204" : {
                                    "Substrate" : {
                     "Name" : "17alpha-Ethinylestradiol",
                   "SMILES" : "[C@@H]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@H]3C4=CC=C(O)C=C4CC[C@@]23C",
                 "InChIKey" : "DQHWEKFXUGLNRV-TXVWBRJLSA-N",
                 "BTMDB_ID" : "BTM0345",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP3A4; CYP2C19; CYP1A2",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2beta-OH-17beta-Ethinylestradiol",
                       "SMILES" : "[C@@H]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@H]3C4=CC(O)=C(O)C=C4CC[C@@]23C",
                     "InChIKey" : "SYRDZWUTDZQTTL-PQLHGUBISA-N",
                     "BTMDB_ID" : "BTM0346",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0205" : {
                                    "Substrate" : {
                     "Name" : "17alpha-Ethinylestradiol",
                   "SMILES" : "[C@@H]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@H]3C4=CC=C(O)C=C4CC[C@@]23C",
                 "InChIKey" : "DQHWEKFXUGLNRV-TXVWBRJLSA-N",
                 "BTMDB_ID" : "BTM0345",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP3A4",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4alpha-OH-17beta-Ethinylestradiol",
                       "SMILES" : "[C@@H]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@H]3C4=CC=C(O)C(O)=C4CC[C@@]23C",
                     "InChIKey" : "OFVWXERYXWCPBX-FVJLHALJSA-N",
                     "BTMDB_ID" : "BTM0347",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0206" : {
                                    "Substrate" : {
                     "Name" : "2,6-Xylidine",
                   "SMILES" : "NC1=C(C=CC=C1C)C",
                 "InChIKey" : "UFFBMTHBGFGIHF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0348",
              "PubChem CID" : "6896",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2A6; CYP2E1",
                                "Reaction Type" : "Hydroxylation of benzene on carbon para to a strongly electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1048",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-hydroxy-2,6-dimethylaniline",
                       "SMILES" : "NC1=C(C=C(O)C=C1C)C",
                     "InChIKey" : "GCWYXRHXGLFVFE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0349",
                  "PubChem CID" : "76543",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
      },
      "BIOTID0207" : {
                                    "Substrate" : {
                     "Name" : "3-Hydroxylidocaine",
                   "SMILES" : "N(C(=O)CN(CC)CC)C1=C(C=CC(O)=C1C)C",
                 "InChIKey" : "PMGUCIDDSCRAMY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0203",
              "PubChem CID" : "161824",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2D6; CYP3A4",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-Hydroxymonoethyl glycinexylidide",
                       "SMILES" : "N(C(=O)CNCC)C1=C(C=CC(O)=C1C)C",
                     "InChIKey" : "YITCMQBVWIHTTA-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0350",
                  "PubChem CID" : "3015693",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
      },
      "BIOTID0208" : {
                                    "Substrate" : {
                     "Name" : "(R)-acenocoumarol",
                   "SMILES" : "OC1=C(C(=O)OC2=CC=CC=C12)C(CC(C)=O)C3=CC=C(C=C3)[N+]([O-])=O",
                 "InChIKey" : "VABCILAOYCMVPS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0351",
              "PubChem CID" : "54676537",
              "DrugBank ID" : "DB01418",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7-OH-R-acenocoumarol",
                       "SMILES" : "OC1=C(C(=O)OC2=CC(O)=CC=C12)C(CC(C)=O)C3=CC=C(C=C3)[N+]([O-])=O",
                     "InChIKey" : "JTCREUDLEYTCAB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0352",
                  "PubChem CID" : "57369793",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
      },
      "BIOTID0209" : {
                                    "Substrate" : {
                     "Name" : "Aminoflavone",
                   "SMILES" : "NC1=C(F)C=C(C=C1)C2=CC(=O)C3=C(N)C(F)=C(C(F)=C3O2)C",
                 "InChIKey" : "RTUZVPPGTJRELI-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0353",
              "PubChem CID" : "389710",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP1A1; CYP2C9; CYP2C19",
                                "Reaction Type" : "N-hydroxylation of primary arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0042",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Aminoflavone, N4'-Hydroxy",
                       "SMILES" : "NC1=C2C(=O)C=C(OC2=C(F)C(=C1F)C)C3=CC(F)=C(NO)C=C3",
                     "InChIKey" : "BUGQDNPBVYMEFE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0354",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0210" : {
                                    "Substrate" : {
                     "Name" : "Aminoflavone, N4'-Hydroxy",
                   "SMILES" : "NC1=C2C(=O)C=C(OC2=C(F)C(=C1F)C)C3=CC(F)=C(NO)C=C3",
                 "InChIKey" : "BUGQDNPBVYMEFE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0354",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2C9; CYP2C19",
                                "Reaction Type" : "N-hydroxylation of primary arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0042",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Aminoflavone, N4', N5-dihydroxy",
                       "SMILES" : "ONC1=C(F)C=C(C=C1)C2=CC(=O)C3=C(NO)C(F)=C(C(F)=C3O2)C",
                     "InChIKey" : "GEASYZROZMRJJL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0355",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0211" : {
                                    "Substrate" : {
                     "Name" : "Amphetamine",
                   "SMILES" : "N[C@H](C)CC1=CC=CC=C1",
                 "InChIKey" : "KWTSXDURSIMDCE-MRVPVSSYSA-N",
                 "BTMDB_ID" : "BTM0356",
              "PubChem CID" : "32893",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "p-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1035",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxyamphetamine",
                       "SMILES" : "CC(N)CC1=CC=C(O)C=C1",
                     "InChIKey" : "GIKNHHRFLCDOEU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0357",
                  "PubChem CID" : "3651",
                  "DrugBank ID" : "DB09352",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0212" : {
                                    "Substrate" : {
                     "Name" : "Aprindine",
                   "SMILES" : "C1=CC=C(C=C1)N(CCCN(CC)CC)C2CC3=CC=CC=C3C2",
                 "InChIKey" : "NZLBHDRPUJLHCE-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0358",
              "PubChem CID" : "2218",
              "DrugBank ID" : "DB01429",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Desethylaprindine",
                       "SMILES" : "N(CC)CCCN(C1=CC=CC=C1)C2CC3=CC=CC=C3C2",
                     "InChIKey" : "JVKNBCGVGGFZLV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0359",
                  "PubChem CID" : "162697",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259988"
      },
      "BIOTID0213" : {
                                    "Substrate" : {
                     "Name" : "(+)-Camphor",
                   "SMILES" : "C[C@@]12C(=O)C[C@@H](CC1)C2(C)C",
                 "InChIKey" : "DSSYKIVIOFKYAU-XCBNKYQSSA-N",
                 "BTMDB_ID" : "BTM0360",
              "PubChem CID" : "159055",
              "DrugBank ID" : "DB01744",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "8-hydroxycamphor",
                       "SMILES" : "CC1(C)[C@H]2CC(=O)[C@]1(C)CC2O",
                     "InChIKey" : "DJQYBVLXBVJHMU-ZRJGNOHYSA-N",
                     "BTMDB_ID" : "BTM0361",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Jäger, W. and Höferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253–279."
      },
      "BIOTID0214" : {
                                    "Substrate" : {
                     "Name" : "Carbosulfan",
                   "SMILES" : "C1=CC2=C(OC(C)(C)C2)C(OC(=O)N(SN(CCCC)CCCC)C)=C1",
                 "InChIKey" : "JLQUFIHWVLZVTJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0362",
              "PubChem CID" : "41384",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C19; CYP3A4",
                                "Reaction Type" : "NS-cleavage",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0107",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "dibutyl(sulfanyl)amine",
                       "SMILES" : "CCCCN(S)CCCC",
                     "InChIKey" : "WVGQYNKWWPBXTB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0363",
                  "PubChem CID" : "21163218",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Abass, K. et al. (2010). Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem. Biol. Interact., Vol. 185, No. 3, (163-173)."
      },
      "BIOTID0215" : {
                                    "Substrate" : {
                     "Name" : "Chlorpyrifos-oxon",
                   "SMILES" : "C1=C(Cl)C(OP(=O)(OCC)OCC)=NC(Cl)=C1Cl",
                 "InChIKey" : "OTMOUPHCTWPNSL-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0364",
              "PubChem CID" : "21804",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19; CYP2B6; CYP3A4",
                                "Reaction Type" : "Dearylation of organphosphosulfur compound",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1170",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Diethyl phosphorothioate",
                       "SMILES" : "CCOP(O)(=O)OCC",
                     "InChIKey" : "UCQFCFPECQILOL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0110",
                  "PubChem CID" : "654",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0216" : {
                                    "Substrate" : {
                     "Name" : "Citalopram",
                   "SMILES" : "C1=CC(C#N)=CC2=C1C(OC2)(C3=CC=C(F)C=C3)CCCN(C)C",
                 "InChIKey" : "WSEQXVZVJXJVFP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0366",
              "PubChem CID" : "2771",
              "DrugBank ID" : "DB00215",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP2C19; CYP3A4",
                                "Reaction Type" : "N-dealkylation of acyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1142",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "desmethylcitalopram",
                       "SMILES" : "CNCCCC1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3",
                     "InChIKey" : "PTJADDMMFYXMMG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0128",
                  "PubChem CID" : "162180",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0217" : {
                                    "Substrate" : {
                     "Name" : "DEET",
                   "SMILES" : "C1=CC(=CC(=C1)C)C(=O)N(CC)CC",
                 "InChIKey" : "MMOXZBCLCQITDF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0367",
              "PubChem CID" : "4284",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP2B6; CYP2D6; CYP2E1",
                                "Reaction Type" : "Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "DEET",
                       "SMILES" : "C1=CC(=CC(=C1)C)C(=O)N(CC)CC",
                     "InChIKey" : "MMOXZBCLCQITDF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0367",
                  "PubChem CID" : "4284",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Usmani, K.A.; (2002). In vitro human metabolism and interactions of repellent N,N-diethyl-m- toluamide. Drug Metab. Dispos., Vol. 30, No. 3, (289-294)."
      },
      "BIOTID0218" : {
                                    "Substrate" : {
                     "Name" : "Diazoxon",
                   "SMILES" : "CCOP(=O)(OCC)OC1=CC(C)=NC(=N1)C(C)C",
                 "InChIKey" : "VBLJFQYCTRKKKF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0139",
              "PubChem CID" : "13754",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19",
                                "Reaction Type" : "Dearylation of organphosphosulfur compound",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1170",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Diethyl phosphorothioate",
                       "SMILES" : "CCOP(O)(=O)OCC",
                     "InChIKey" : "UCQFCFPECQILOL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0110",
                  "PubChem CID" : "654",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kappers, W.A. et al.; (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicol. Appl. Pharmacol., Vol. 177, No. 1, (68-76) || (R2) Buratti, F.M. et al.; Toxicology and Applied Pharmacology 186 (2003) 143–154."
      },
      "BIOTID0219" : {
                                    "Substrate" : {
                     "Name" : "Disulfoton",
                   "SMILES" : "CCOP(=S)(OCC)SCCSCC",
                 "InChIKey" : "DOFZAZXDOSGAJZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0368",
              "PubChem CID" : "3118",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2B6; CYP2C9; CYP2C18; CYP2C19; CYP2D6; CYP3A4",
                                "Reaction Type" : "S-oxidation of dialkylthioether to sulfoxide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0057",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Disulfoton sulfoxide",
                       "SMILES" : "CCOP(=S)(OCC)SCCS(=O)CC",
                     "InChIKey" : "UPUGLJYNCXXUQV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0369",
                  "PubChem CID" : "17242",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Usmani, K.A.; (2004b). In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab. Dispos., Vol. 32, No. 3, (333-339)."
      },
      "BIOTID0220" : {
                                    "Substrate" : {
                     "Name" : "donepezil",
                   "SMILES" : "C1=CC=C(C=C1)CN2CCC(CC3C(=O)C4=CC(OC)=C(OC)C=C4C3)CC2",
                 "InChIKey" : "ADEBPBSSDYVVLD-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0370",
              "PubChem CID" : "3152",
              "DrugBank ID" : "DB00843",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C9",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5,6‐dimethoxy‐2‐(piperidin‐4‐ylmethyl)‐2,3‐dihydroinden‐1‐one",
                       "SMILES" : "C1=C2C(=O)C(CC3CCNCC3)CC2=CC(OC)=C1OC",
                     "InChIKey" : "PGBZORAISITZTF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0371",
                  "PubChem CID" : "10446897",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
      },
      "BIOTID0221" : {
                                    "Substrate" : {
                     "Name" : "Encainide",
                   "SMILES" : "COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C",
                 "InChIKey" : "PJWPNDMDCLXCOM-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0372",
              "PubChem CID" : "48041",
              "DrugBank ID" : "DB01228",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "O-aryl demethylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1133",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "O-demethylencainide",
                       "SMILES" : "CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(O)C=C3",
                     "InChIKey" : "QMHJFCPHRGVEAF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0373",
                  "PubChem CID" : "54736",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
      },
      "BIOTID0222" : {
                                    "Substrate" : {
                     "Name" : "Encainide",
                   "SMILES" : "COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3C",
                 "InChIKey" : "PJWPNDMDCLXCOM-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0372",
              "PubChem CID" : "48041",
              "DrugBank ID" : "DB01228",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "O-demethylencainide",
                       "SMILES" : "CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(O)C=C3",
                     "InChIKey" : "QMHJFCPHRGVEAF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0373",
                  "PubChem CID" : "54736",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
      },
      "BIOTID0223" : {
                                    "Substrate" : {
                     "Name" : "N-Desmethylclomipramine",
                   "SMILES" : "C1=CC=C2C(=C1)N(C3=C(C=CC(Cl)=C3)CC2)CCCNC",
                 "InChIKey" : "VPIXQGUBUKFLRF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0374",
              "PubChem CID" : "622606",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19; CYP3A4; CYP1A2",
                                "Reaction Type" : "N-dealkylation of acyclic secondary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1140",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Didesmethylclomipramine",
                       "SMILES" : "C1=CC=C2C(=C1)N(C3=C(C=CC(Cl)=C3)CC2)CCCN",
                     "InChIKey" : "LHDZEFLZJRLKPT-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0375",
                  "PubChem CID" : "3085253",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0224" : {
                                    "Substrate" : {
                     "Name" : "O-demethylencainide",
                   "SMILES" : "CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(O)C=C3",
                 "InChIKey" : "QMHJFCPHRGVEAF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0373",
              "PubChem CID" : "54736",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N,O-didemethylencainide",
                       "SMILES" : "OC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2CCC3CCCCN3",
                     "InChIKey" : "PAXWCICVMPVYNO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0376",
                  "PubChem CID" : "159040",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R3) Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
      },
      "BIOTID0225" : {
                                    "Substrate" : {
                     "Name" : "Fluoxetine",
                   "SMILES" : "CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2",
                 "InChIKey" : "RTHCYVBBDHJXIQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0377",
              "PubChem CID" : "3386",
              "DrugBank ID" : "DB00472",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19; CYP3A4",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "p-Trifluoromethyl phenol",
                       "SMILES" : "C1=CC(=CC=C1O)C(F)(F)F",
                     "InChIKey" : "BAYGVMXZJBFEMB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0038",
                  "PubChem CID" : "67874",
                  "DrugBank ID" : "DB03610",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0226" : {
                                    "Substrate" : {
                     "Name" : "Gliclazide",
                   "SMILES" : "N(N1CC2CCCC2C1)C(=O)NS(=O)(=O)C3=CC=C(C=C3)C",
                 "InChIKey" : "BOVGTQGAOIONJV-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0378",
              "PubChem CID" : "3475",
              "DrugBank ID" : "DB01120",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1067",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7-OH-gliclazide",
                       "SMILES" : "N(N1CC2CC(O)CC2C1)C(=O)NS(=O)(=O)C3=CC=C(C=C3)C",
                     "InChIKey" : "JMHDCYDSYHLATB-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0379",
                  "PubChem CID" : "131750725",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0227" : {
                                    "Substrate" : {
                     "Name" : "Glimepiride",
                   "SMILES" : "CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(C)CC3)C1=O",
                 "InChIKey" : "WIGIZIANZCJQQY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0380",
              "PubChem CID" : "3476",
              "DrugBank ID" : "DB00222",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Hydroxylation of terminal methyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1061",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Cyclohexylhydroymethylglimepiride",
                       "SMILES" : "C1CC(CO)CCC1NC(=O)NS(=O)(=O)C2=CC=C(CCNC(=O)N3CC(C)=C(CC)C3=O)C=C2",
                     "InChIKey" : "YUNQMQLWOOVHKI-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0381",
                  "PubChem CID" : "130939",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3678"
      },
      "BIOTID0228" : {
                                    "Substrate" : {
                     "Name" : "R-Ibuprofen",
                   "SMILES" : "OC(=O)[C@@H](C1=CC=C(C=C1)CC(C)C)C",
                 "InChIKey" : "HEFNNWSXXWATRW-SNVBAGLBSA-N",
                 "BTMDB_ID" : "BTM0382",
              "PubChem CID" : "114864",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8; CYP2C9",
                                "Reaction Type" : "Hydroxylation of terminal methyl",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1061",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "R,S-3-Hydroxyibuprofen",
                       "SMILES" : "C(C)(CO)CC1=CC=C(C=C1)[C@@H](C)C(O)=O",
                     "InChIKey" : "HFAIHLSDLUYLQA-QVDQXJPCSA-N",
                     "BTMDB_ID" : "BTM0383",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0229" : {
                                    "Substrate" : {
                     "Name" : "Lansoprazole",
                   "SMILES" : "N1C(=NC2=CC=CC=C12)[S@](=O)CC3=NC(C)=CC(OCC(F)(F)F)=C3C",
                 "InChIKey" : "DQJZOUNZNYHEBV-AREMUKBSSA-N",
                 "BTMDB_ID" : "BTM0384",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C19; CYP2C9; CYP3A4",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Hydroxylansoprazole",
                       "SMILES" : "N1C(=NC2=C(O)C=CC=C12)[S@](=O)CC3=NC(C)=CC(OCC(F)(F)F)=C3C",
                     "InChIKey" : "GJTJOZQYAJLAKN-HHHXNRCGSA-N",
                     "BTMDB_ID" : "BTM0385",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0230" : {
                                    "Substrate" : {
                     "Name" : "Lithocholic Acid",
                   "SMILES" : "OC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C",
                 "InChIKey" : "SMEROWZSTRWXGI-HVATVPOCSA-N",
                 "BTMDB_ID" : "BTM0386",
              "PubChem CID" : "9903",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6α-Hydroxylithocholic acid",
                       "SMILES" : "OC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C",
                     "InChIKey" : "DGABKXLVXPYZII-SIBKNCMHSA-N",
                     "BTMDB_ID" : "BTM0387",
                  "PubChem CID" : "5283820",
                  "DrugBank ID" : "DB11789",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0231" : {
                                    "Substrate" : {
                     "Name" : "M5",
                   "SMILES" : "N1N=NC(=N1)C2=CC=CC=C2C3=CC=C(C=C3)CN4C(=O)C5(N=C4CCCC)CCC(O)C5",
                 "InChIKey" : "SGLAKMDXJPVHBY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0187",
              "PubChem CID" : "101944494",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1067",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "M1",
                       "SMILES" : "N1N=NC(=N1)C2=CC=CC=C2C3=CC=C(C=C3)CN4C(=NC5(C4=O)CCC(O)C5)CCC(O)C",
                     "InChIKey" : "LIDZWACDVHJFLD-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0388",
                  "PubChem CID" : "101944491",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
      },
      "BIOTID0232" : {
                                    "Substrate" : {
                     "Name" : "Mianserine",
                   "SMILES" : "C1=CC=C2C(=C1)N3CCN(C)CC3C4=CC=CC=C4C2",
                 "InChIKey" : "UEQUQVLFIPOEMF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0389",
              "PubChem CID" : "4184",
              "DrugBank ID" : "DB06148",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2B6 (R>S); CYP3A4 (R>S); CYP2C19 (R>S); CYP1A2 (R≈S)",
                                "Reaction Type" : "N-dealkylation of alicyclic tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1144",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Desmethylmianserin",
                       "SMILES" : "C1=CC=C2C(=C1)N3CCNCC3C4=CC=CC=C4C2",
                     "InChIKey" : "ZBILSSSEXRZGKS-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0390",
                  "PubChem CID" : "115194",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0233" : {
                                    "Substrate" : {
                     "Name" : "Mirtazapine",
                   "SMILES" : "C1=NC2=C(C=C1)CC3=CC=CC=C3C4N2CCN(C)C4",
                 "InChIKey" : "RONZAEMNMFQXRA-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0391",
              "PubChem CID" : "4205",
              "DrugBank ID" : "DB00370",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2D6; CYP3A4",
                                "Reaction Type" : "N-dealkylation of mixed tertiary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1145",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Desmethylmirtazapine",
                       "SMILES" : "C1=NC2=C(C=C1)CC3=CC=CC=C3C4N2CCNC4",
                     "InChIKey" : "FGLAMNFOHWVQOH-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0392",
                  "PubChem CID" : "10467350",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754424"
      },
      "BIOTID0234" : {
                                    "Substrate" : {
                     "Name" : "Mestranol",
                   "SMILES" : "O[C@@]1(C#C)CC[C@H]2[C@@H]3CCC4=C(C=CC(OC)=C4)[C@H]3CC[C@]12C",
                 "InChIKey" : "IMSSROKUHAOUJS-MJCUULBUSA-N",
                 "BTMDB_ID" : "BTM0393",
              "PubChem CID" : "6291",
              "DrugBank ID" : "DB01357",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Ethinylestradiol",
                       "SMILES" : "O[C@@]1(C#C)CC[C@H]2[C@@H]3CCC4=C(C=CC(O)=C4)[C@H]3CC[C@]12C",
                     "InChIKey" : "BFPYWIDHMRZLRN-SLHNCBLASA-N",
                     "BTMDB_ID" : "BTM0394",
                  "PubChem CID" : "5991",
                  "DrugBank ID" : "DB00977",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
      },
      "BIOTID0235" : {
                                    "Substrate" : {
                     "Name" : "Mono-OH-methoxychlor",
                   "SMILES" : "OC1=CC=C(C=C1)[C@@H](C2=CC=C(OC)C=C2)C(Cl)(Cl)Cl",
                 "InChIKey" : "BUZUQNXGKRJIJT-AWEZNQCLSA-N",
                 "BTMDB_ID" : "BTM0395",
              "PubChem CID" : "13590210",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2C8; CYP2C19; CYP2D6",
                                "Reaction Type" : "O-aryl dealkylation not adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1132",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Bis-OH-methoxychlor",
                       "SMILES" : "OC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl",
                     "InChIKey" : "IUGDILGOLSSKNE-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0396",
                  "PubChem CID" : "76302",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Hu, Y. and Kupfer, D. (2002); Metabolism of the Endocrine Disruptor Pesticide-Methoxychlor by Human P450s: Pathways Involving a Novel Catechol Metabolite; Drug Metab Dispos. 2002 Sep;30(9):1035-42."
      },
      "BIOTID0236" : {
                                    "Substrate" : {
                     "Name" : "N-Desmethyldiphenhydramine",
                   "SMILES" : "C1=CC=C(C=C1)C(OCCNC)C2=CC=CC=C2",
                 "InChIKey" : "AGSLYHYWLYGAOU-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0397",
              "PubChem CID" : "40791",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP1A2; CYP2C9; CYP2C19",
                                "Reaction Type" : "N-dealkylation of acyclic secondary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1140",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N,N-Didesmethyldiphenhydramine",
                       "SMILES" : "C1=CC=C(C=C1)C(OCCN)C2=CC=CC=C2",
                     "InChIKey" : "NFJFUDGBWGXTHS-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0398",
                  "PubChem CID" : "36060",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0237" : {
                                    "Substrate" : {
                     "Name" : "N-Desmethyltamoxifen",
                   "SMILES" : "C1=CC=C(C=C1)\\C(=C(\\C2=CC=CC=C2)/CC)\\C3=CC=C(OCCNC)C=C3",
                 "InChIKey" : "NYDCDZSEEAUOHN-IZHYLOQSSA-N",
                 "BTMDB_ID" : "BTM0399",
              "PubChem CID" : "6378383",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "p-Hydroxylation of monosubstituted benzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1035",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Endoxifen",
                       "SMILES" : "C1=CC=C(C=C1)\\C(=C(\\C2=CC=C(O)C=C2)/C3=CC=C(OCCNC)C=C3)\\CC",
                     "InChIKey" : "MHJBZVSGOZTKRH-IZHYLOQSSA-N",
                     "BTMDB_ID" : "BTM0400",
                  "PubChem CID" : "10090750",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985 || (R2) Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423 || (R3) Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987 || (R4) Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
      },
      "BIOTID0238" : {
                                    "Substrate" : {
                     "Name" : "1-Naphtaldehyde",
                   "SMILES" : "C(=O)C1=CC=CC2=CC=CC=C12",
                 "InChIKey" : "SQAINHDHICKHLX-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0264",
              "PubChem CID" : "6195",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Reduction of aldehyde to alcohol",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1172",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "1-Nahthalenethanol",
                       "SMILES" : "OCC1=CC=CC2=CC=CC=C12",
                     "InChIKey" : "PBLNHHSDYFYZNC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0401",
                  "PubChem CID" : "20908",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0239" : {
                                    "Substrate" : {
                     "Name" : "Nateglinide",
                   "SMILES" : "OC(=O)C(NC(=O)C1CCC(CC1)C(C)C)CC2=CC=CC=C2",
                 "InChIKey" : "OELFLUMRDSZNSF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0402",
              "PubChem CID" : "4443",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP3A4",
                                "Reaction Type" : "Hydroxylation of penultimate aliphatic tertiary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1075",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2‐{[4‐(2‐hydroxypropan‐2‐yl)cyclohexyl]formamido}‐3‐phenylpropanoic acid",
                       "SMILES" : "OC(=O)C(NC(=O)C1CCC(CC1)C(O)(C)C)CC2=CC=CC=C2",
                     "InChIKey" : "IUMHIIXPABZGRF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0403",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
      },
      "BIOTID0240" : {
                                    "Substrate" : {
                     "Name" : "Nateglinide",
                   "SMILES" : "OC(=O)C(NC(=O)C1CCC(CC1)C(C)C)CC2=CC=CC=C2",
                 "InChIKey" : "OELFLUMRDSZNSF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0402",
              "PubChem CID" : "4443",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP3A4",
                                "Reaction Type" : "Hydroxylation of alkyl methine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0053",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2‐{[4‐(2‐hydroxypropan‐2‐yl)cyclohexyl]formamido}‐3‐phenylpropanoic acid",
                       "SMILES" : "OC(=O)C(NC(=O)C1CCC(CC1)C(O)(C)C)CC2=CC=CC=C2",
                     "InChIKey" : "IUMHIIXPABZGRF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0403",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
      },
      "BIOTID0241" : {
                                    "Substrate" : {
                     "Name" : "Nordoxepin",
                   "SMILES" : "C(=C/1\\C2=CC=CC=C2OCC3=CC=CC=C13)\\CCNC",
                 "InChIKey" : "HVKCEFHNSNZIHO-YBEGLDIGSA-N",
                 "BTMDB_ID" : "BTM0404",
              "PubChem CID" : "5353833",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1030",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-Hydroxynordoxepin",
                       "SMILES" : "C(=C/1\\C2=CC=CC=C2OCC3=CC=C(O)C=C13)\\CCNC",
                     "InChIKey" : "VOSZEQAEJIINHX-GIDUJCDVSA-N",
                     "BTMDB_ID" : "BTM0405",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Musshoff F. et al. (2010); Pharmacogenetics and forensic toxicology; Forensic Sci Int.; 203, 53-62. doi: doi:10.1016/j.forsciint.2010.07.011"
      },
      "BIOTID0242" : {
                                    "Substrate" : {
                     "Name" : "omeprazole",
                   "SMILES" : "N1C(=NC2=C1C=CC(OC)=C2)S(=O)CC3=NC=C(C(OC)=C3C)C",
                 "InChIKey" : "SUBDBMMJDZJVOS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0406",
              "PubChem CID" : "4594",
              "DrugBank ID" : "DB00338",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-Hydroxyomeprazole",
                       "SMILES" : "N1C(=NC2=C1C=CC(OC)=C2)S(=O)CC3=NC=C(C(OC)=C3CO)C",
                     "InChIKey" : "IGVYIWUGJPECAJ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0407",
                  "PubChem CID" : "71587579",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
      },
      "BIOTID0243" : {
                                    "Substrate" : {
                     "Name" : "omeprazole",
                   "SMILES" : "N1C(=NC2=C1C=CC(OC)=C2)S(=O)CC3=NC=C(C(OC)=C3C)C",
                 "InChIKey" : "SUBDBMMJDZJVOS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0406",
              "PubChem CID" : "4594",
              "DrugBank ID" : "DB00338",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "S-oxidation of sulfoxide to sulfone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0060",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Omeprazole sulfone",
                       "SMILES" : "N1C2=C(N=C1S(=O)(=O)CC3=NC=C(C(OC)=C3C)C)C=CC(OC)=C2",
                     "InChIKey" : "IXEQEYRTSRFZEO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0152",
                  "PubChem CID" : "145900",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
      },
      "BIOTID0244" : {
                                    "Substrate" : {
                     "Name" : "Ondansetron",
                   "SMILES" : "C1=CN(C(=N1)C)CC2C(=O)C3=C(N(C4=CC=CC=C34)C)CC2",
                 "InChIKey" : "FELGMEQIXOGIFQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0408",
              "PubChem CID" : "4595",
              "DrugBank ID" : "DB00904",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2D6; CYP3A4",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "8-OH-ondansetron",
                       "SMILES" : "C1=CN(C(=N1)C)CC2C(=O)C3=C(N(C4=C(O)C=CC=C34)C)CC2",
                     "InChIKey" : "XVDKMEPUFIAQFH-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0409",
                  "PubChem CID" : "19734439",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754424"
      },
      "BIOTID0245" : {
                                    "Substrate" : {
                     "Name" : "Pioglitazone",
                   "SMILES" : "N1C(=O)SC(C1=O)CC2=CC=C(OCCC3=NC=C(C=C3)CC)C=C2",
                 "InChIKey" : "HYAFETHFCAUJAY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0410",
              "PubChem CID" : "4829",
              "DrugBank ID" : "DB01132",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8; CYP3A4",
                                "Reaction Type" : "Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1077",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5‐({4‐[2‐(5‐ethylpyridin‐2‐yl)‐2‐hydroxyethoxy]phenyl}methyl)‐1,3‐thiazolidine‐2,4‐dione",
                       "SMILES" : "N1C(=O)SC(C1=O)CC2=CC=C(OCC(O)C3=NC=C(C=C3)CC)C=C2",
                     "InChIKey" : "RMTFRGFLVHAYCI-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0411",
                  "PubChem CID" : "9864268",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
      },
      "BIOTID0246" : {
                                    "Substrate" : {
                     "Name" : "Pranidipine",
                   "SMILES" : "COC(=O)C1=C(C)NC(C)=C(C1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC/C=C/C3=CC=CC=C3",
                 "InChIKey" : "XTFPDGZNWTZCMF-DHZHZOJOSA-N",
                 "BTMDB_ID" : "BTM0412",
              "PubChem CID" : "6436048",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4",
                                "Reaction Type" : "Dehydrogenation of 4-aryl substituted 1,4-dihydropyridine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1196",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dehydrogenated pranidipine",
                       "SMILES" : "COC(=O)C1=C(C)N=C(C)C(C(=O)OC/C=C/C2=CC=CC=C2)=C1C3=CC=CC(=C3)[N+]([O-])=O",
                     "InChIKey" : "UZYMZRZCYLNXQU-DHZHZOJOSA-N",
                     "BTMDB_ID" : "BTM0413",
                  "PubChem CID" : "10003684",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0247" : {
                                    "Substrate" : {
                     "Name" : "Propafenone",
                   "SMILES" : "OC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)CNCCC",
                 "InChIKey" : "JWHAUXFOSRPERK-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0414",
              "PubChem CID" : "4932",
              "DrugBank ID" : "DB01182",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP3A4",
                                "Reaction Type" : "N-dealkylation of acyclic secondary amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1140",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Despropylpropafenone",
                       "SMILES" : "NCC(O)COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2",
                     "InChIKey" : "HIGKMVIPYOFHBP-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0415",
                  "PubChem CID" : "128820",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0248" : {
                                    "Substrate" : {
                     "Name" : "(+)-limonene",
                   "SMILES" : "C=C(C)[C@H]1CC=C(C)CC1",
                 "InChIKey" : "XMGQYMWWDOXHJM-JTQLQIEISA-N",
                 "BTMDB_ID" : "BTM0416",
              "PubChem CID" : "440917",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19; CYP3A4",
                                "Reaction Type" : "Hydroxlation of methyl carbon adjacent to an aliphatic ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0054",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Perillyl alcohol",
                       "SMILES" : "CC(=C)C1CCC(CO)=CC1",
                     "InChIKey" : "NDTYTMIUWGWIMO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0417",
                  "PubChem CID" : "10819",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Jäger, W. and Höferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253–279."
      },
      "BIOTID0249" : {
                                    "Substrate" : {
                     "Name" : "(+)-limonene",
                   "SMILES" : "C=C(C)[C@H]1CC=C(C)CC1",
                 "InChIKey" : "XMGQYMWWDOXHJM-JTQLQIEISA-N",
                 "BTMDB_ID" : "BTM0416",
              "PubChem CID" : "440917",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9; CYP2C19; CYP3A4",
                                "Reaction Type" : "Allylic hydroxylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0071",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Perillyl alcohol",
                       "SMILES" : "CC(=C)C1CCC(CO)=CC1",
                     "InChIKey" : "NDTYTMIUWGWIMO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0417",
                  "PubChem CID" : "10819",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Jäger, W. and Höferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253–279."
      },
      "BIOTID0250" : {
                                    "Substrate" : {
                     "Name" : "silybin",
                   "SMILES" : "COC1=C(O)C=CC(=C1)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O",
                 "InChIKey" : "SEBFKMXJBCUCAI-HKTJVKLFSA-N",
                 "BTMDB_ID" : "BTM0418",
              "PubChem CID" : "31553",
              "DrugBank ID" : "DB09298",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C8",
                                "Reaction Type" : "O-aryl dealkylation adjacent to substituted carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1131",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "O-demethylated-silybin",
                       "SMILES" : "OC1=C(O)C=CC(=C1)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O",
                     "InChIKey" : "RAWNDNZPLHPBEN-OYYPCOLYSA-N",
                     "BTMDB_ID" : "BTM0419",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3687"
      },
      "BIOTID0251" : {
                                    "Substrate" : {
                     "Name" : "Sulfinpyrazone",
                   "SMILES" : "C1=CC=C(C=C1)N2N(C(=O)C(C2=O)CCS(=O)C3=CC=CC=C3)C4=CC=CC=C4",
                 "InChIKey" : "MBGGBVCUIVRRBF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0420",
              "PubChem CID" : "5342",
              "DrugBank ID" : "DB01138",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP3A4; CYP2C9",
                                "Reaction Type" : "S-oxidation of sulfoxide to sulfone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0060",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Sulfinpyrazone sulfone",
                       "SMILES" : "C1=CC=C(C=C1)N2N(C(=O)C(C2=O)CCS(=O)(=O)C3=CC=CC=C3)C4=CC=CC=C4",
                     "InChIKey" : "DQUYGWDNTAETLI-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0421",
                  "PubChem CID" : "70676",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
      },
      "BIOTID0252" : {
                                    "Substrate" : {
                     "Name" : "suprofen",
                   "SMILES" : "CC(C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2",
                 "InChIKey" : "MDKGKXOCJGEUJW-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0422",
              "PubChem CID" : "5359",
              "DrugBank ID" : "DB00870",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "Epoxidation of thiophene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0131",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Thiophene-4,5-epoxide",
                       "SMILES" : "OC(=O)C(C1=CC=C(C=C1)C(=O)C2=CC3OC3S2)C",
                     "InChIKey" : "SDGBIPHZPNRUFG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0423",
                  "PubChem CID" : "131769994",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
      },
      "BIOTID0253" : {
                                    "Substrate" : {
                     "Name" : "Thioridazine",
                   "SMILES" : "CSC1=CC2=C(SC3=CC=CC=C3N2CCC4CCCCN4C)C=C1",
                 "InChIKey" : "KLBQZWRITKRQQV-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0424",
              "PubChem CID" : "5452",
              "DrugBank ID" : "DB00679",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2D6; CYP3A4",
                                "Reaction Type" : "S-oxidation of alkylarylthioether to sulfoxide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0058",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Thioridazine 2-sulfoxide",
                       "SMILES" : "C1=CC=C2N(C3=C(SC2=C1)C=CC(=C3)S(=O)C)CCC4N(C)CCCC4",
                     "InChIKey" : "SLVMESMUVMCQIY-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0425",
                  "PubChem CID" : "4078",
                  "DrugBank ID" : "DB00933",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754425"
      },
      "BIOTID0254" : {
                                    "Substrate" : {
                     "Name" : "Thymol",
                   "SMILES" : "OC1=CC(=CC=C1C(C)C)C",
                 "InChIKey" : "MGSRCZKZVOBKFT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0426",
              "PubChem CID" : "6989",
              "DrugBank ID" : "DB02513",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2; CYP2A6; CYP2D6",
                                "Reaction Type" : "o-Hydroxylation of phenol",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1037",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "p-Cymene-2,3-diol",
                       "SMILES" : "CC(C)C1=CC=C(C)C(O)=C1O",
                     "InChIKey" : "LYUBXLHGANLIMX-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0427",
                  "PubChem CID" : "95873",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Jäger, W. and Höferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253–279."
      },
      "BIOTID0255" : {
                                    "Substrate" : {
                     "Name" : "Tizanidine",
                   "SMILES" : "N(C1=NCCN1)C2=C(Cl)C=CC3=NSN=C23",
                 "InChIKey" : "XFYDIVBRZNQMJC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0428",
              "PubChem CID" : "5487",
              "DrugBank ID" : "DB00697",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "Hydroxylation of heteroalicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1070",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2‐[(5‐chloro‐2,1,3‐benzothiadiazol‐4‐yl)amino]‐4,5‐dihydro‐1H‐imidazol‐4‐ol",
                       "SMILES" : "N(C1=NC(O)CN1)C2=C(Cl)C=CC3=NSN=C23",
                     "InChIKey" : "LURMELDQBVJARZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0429",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0256" : {
                                    "Substrate" : {
                     "Name" : "TSU-68",
                   "SMILES" : "OC(=O)CCC1=C(NC(/C=C/2\\C(=O)NC3=CC=CC=C23)=C1C)C",
                 "InChIKey" : "NHFDRBXTEDBWCZ-ZROIWOOFSA-N",
                 "BTMDB_ID" : "BTM0430",
              "PubChem CID" : "5329099",
              "DrugBank ID" : "DB12072",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A1; CYP1A2; CYP2C8",
                                "Reaction Type" : "Aromatic hydroxylation of fused benzene ring",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1031",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "TSU-68 metabolite 2",
                       "SMILES" : "OC(=O)CCC1=C(NC(/C=C/2\\C(=O)NC3=C(O)C=CC=C23)=C1C)C",
                     "InChIKey" : "NTSFCHHACMZKEA-JYRVWZFOSA-N",
                     "BTMDB_ID" : "BTM0431",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
      },
      "BIOTID0257" : {
                                    "Substrate" : {
                     "Name" : "YM-64227",
                   "SMILES" : "CCN1C(=O)N=C(C2CCCCC2)C3=CC=C(CC)N=C13",
                 "InChIKey" : "QFBNONLZWZUQCN-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0432",
              "PubChem CID" : "9925883",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP1A2",
                                "Reaction Type" : "Hydroxylation of alicyclic secondary carbon",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1068",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "M-2 (1,3-cis)",
                       "SMILES" : "CCN1C(=O)N=C(C2CCCC(O)C2)C3=CC=C(CC)N=C13",
                     "InChIKey" : "MJELJBCAAHPYTL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0433",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
      },
      "BIOTID0258" : {
                                    "Substrate" : {
                     "Name" : "Zaltoprofen",
                   "SMILES" : "OC(=O)C(C1=CC2=C(SC3=CC=CC=C3C(=O)C2)C=C1)C",
                 "InChIKey" : "MUXFZBHBYYYLTH-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0434",
              "PubChem CID" : "5720",
              "DrugBank ID" : "DB06737",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2C9",
                                "Reaction Type" : "S-oxidation of dialkylthioether to sulfoxide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0057",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Zaltoprofen S-oxide",
                       "SMILES" : "OC(=O)C(C1=CC2=C(C=C1)S(=O)C3=CC=CC=C3C(=O)C2)C",
                     "InChIKey" : "BMXFBJRSBWVAIU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0435",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3683"
      },
      "BIOTID0259" : {
                                    "Substrate" : {
                     "Name" : "4-VINYLCYCLOHEXENE",
                   "SMILES" : "C=CC1CCC=CC1",
                 "InChIKey" : "BBDKZWKEPDTENS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0436",
              "PubChem CID" : "7499",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2B6; CYP2E1",
                                "Reaction Type" : "Epxodation of alkene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0109",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "VCH-7,8-epoxide",
                       "SMILES" : "C1OC1C2CCC=CC2",
                     "InChIKey" : "OLKHRYQRCJLWLL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0437",
                  "PubChem CID" : "114431",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) S. M. FONTAINE et al. (2001); ROLE OF INDUCTION OF SPECIFIC HEPATIC CYTOCHROME P450 ISOFORMS IN EPOXIDATION OF 4-VINYLCYCLOHEXENE; DRUG METABOLISM AND DISPOSITION; Vol. 29, No. 9"
      },
      "BIOTID0260" : {
                                    "Substrate" : {
                     "Name" : "VCH-7,8-epoxide",
                   "SMILES" : "C=CC1CCC2OC2C1",
                 "InChIKey" : "SLJFKNONPLNAPF-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0438",
              "PubChem CID" : "7832",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "CYP2B6; CYP2E1",
                                "Reaction Type" : "Epxodation of alkene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0110",
                       "Biotransformation type" : "Human Phase I",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "VCH-diepoxide",
                       "SMILES" : "C1OC1C2CCC3OC3C2",
                     "InChIKey" : "OECTYKWYRCHAKR-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0439",
                  "PubChem CID" : "7833",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) S. M. FONTAINE et al. (2001); ROLE OF INDUCTION OF SPECIFIC HEPATIC CYTOCHROME P450 ISOFORMS IN EPOXIDATION OF 4-VINYLCYCLOHEXENE; DRUG METABOLISM AND DISPOSITION; Vol. 29, No. 9"
      },
      "BIOTID0261" : {
                                    "Substrate" : {
                     "Name" : "(-)-Epigallocatechin gallate",
                   "SMILES" : "OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC2=C1)C4=CC(O)=C(O)C(O)=C4",
                 "InChIKey" : "WMBWREPUVVBILR-WIYYLYMNSA-N",
                 "BTMDB_ID" : "BTM0440",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "(-)-Epigallocatechin gallate, 4p-OH-glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)[C@H](OC2=C(O)C=C(C=C2O)[C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3OC(=O)C5=CC(O)=C(O)C(O)=C5)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "DBWSOVOTCKCPCB-XNLIHRAISA-N",
                     "BTMDB_ID" : "BTM0441",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0262" : {
                                    "Substrate" : {
                     "Name" : "4-Hydroxychalcone",
                   "SMILES" : "OC1=CC=C(/C=C/C(=O)C2=CC=CC=C2)C=C1",
                 "InChIKey" : "PWWCDTYUYPOAIU-DHZHZOJOSA-N",
                 "BTMDB_ID" : "BTM0442",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4-Hydroxychalcone, 4-OH-glucuronide",
                       "SMILES" : "O[C@H]1[C@H](OC2=CC=C(/C=C/C(=O)C3=CC=CC=C3)C=C2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O",
                     "InChIKey" : "NFTLYQZAAUCPAS-BDOXZWLLSA-N",
                     "BTMDB_ID" : "BTM0443",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0263" : {
                                    "Substrate" : {
                     "Name" : "Phloretin",
                   "SMILES" : "OC1=CC=C(CCC(=O)C2=C(O)C=C(O)C=C2O)C=C1",
                 "InChIKey" : "VGEREEWJJVICBM-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0444",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Phloretin, 2p-OH-glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)[C@H](OC2=C(C(=O)CCC3=CC=C(O)C=C3)C(O)=CC(O)=C2)O[C@H](C=O)[C@H]1O",
                     "InChIKey" : "BQYYEYGIAKEJPL-QNDFHXLGSA-N",
                     "BTMDB_ID" : "BTM0445",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0264" : {
                                    "Substrate" : {
                     "Name" : "3,4-Diphenyl-7-hydroxycoumarin",
                   "SMILES" : "OC1=CC=C2C(OC(=O)C(C3=CC=CC=C3)=C2C4=CC=CC=C4)=C1",
                 "InChIKey" : "AABUKWVVUWBZCS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0446",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3,4-Diphenyl-7-hydroxycoumarin, 7-OH-glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)[C@H](OC2=CC=C3C(OC(=O)C(C4=CC=CC=C4)=C3C5=CC=CC=C5)=C2)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "QHFKYWZGVOSUJH-RTCYWULBSA-N",
                     "BTMDB_ID" : "BTM0447",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0265" : {
                                    "Substrate" : {
                     "Name" : "6-Hydroxy-7-methoxyl-4-phenylcoumarin",
                   "SMILES" : "COC1=C(O)C=C2C(OC(=O)C=C2C3=CC=CC=C3)=C1",
                 "InChIKey" : "AZELSOYQOIUPBZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0448",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "7-methoxyl-4-phenylcoumarin, 6-O-glucuronide",
                       "SMILES" : "COC1=C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)C=C3C(OC(=O)C=C3C4=CC=CC=C4)=C1",
                     "InChIKey" : "BUAGEPZSSIYTQL-SXFAUFNYSA-N",
                     "BTMDB_ID" : "BTM0449",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0266" : {
                                    "Substrate" : {
                     "Name" : "6-Hydroxywarfarin",
                   "SMILES" : "CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC(O)=CC=C3OC2=O",
                 "InChIKey" : "IQWPEJBUOJQPDE-AWEZNQCLSA-N",
                 "BTMDB_ID" : "BTM0450",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Warfarin 6-O-glucuronide",
                       "SMILES" : "CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)=CC=C3OC2=O",
                     "InChIKey" : "WVBVHLXQTOAFHW-AXCBLOFJSA-N",
                     "BTMDB_ID" : "BTM0451",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0267" : {
                                    "Substrate" : {
                     "Name" : "Demethoxycurcumin",
                   "SMILES" : "COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC=C(C=C2)O)O",
                 "InChIKey" : "HJTVQHVGMGKONQ-LUZURFALSA-N",
                 "BTMDB_ID" : "BTM0452",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Demethoxycurcumin O-glucuronide",
                       "SMILES" : "COC1=C(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)C=CC(/C=C/C(=O)CC(=O)/C=C/C3=CC=C(O)C=C3)=C1",
                     "InChIKey" : "YWKJMTRJZNWNFX-RMUOXEHGSA-N",
                     "BTMDB_ID" : "BTM0453",
                  "PubChem CID" : "90478404",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0268" : {
                                    "Substrate" : {
                     "Name" : "Endoxifen",
                   "SMILES" : "CC/C(=C(\\C1=CC=C(O)C=C1)/C2=CC=C(OCCNC)C=C2)/C3=CC=CC=C3",
                 "InChIKey" : "MHJBZVSGOZTKRH-IZHYLOQSSA-N",
                 "BTMDB_ID" : "BTM0454",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Endoxifen O-glucuronide",
                       "SMILES" : "CC/C(=C(/C1=CC=C(OCCNC)C=C1)\\C2=CC=C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C=C2)/C4=CC=CC=C4",
                     "InChIKey" : "HSQYCNXRYHIGKV-QXBBUDDSSA-N",
                     "BTMDB_ID" : "BTM0455",
                  "PubChem CID" : "71315759",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0269" : {
                                    "Substrate" : {
                     "Name" : "1-Naphthol",
                   "SMILES" : "OC1=CC=CC2=CC=CC=C12",
                 "InChIKey" : "KJCVRFUGPWSIIH-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0456",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "1-Naphthyl glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)[C@H](OC2=CC=CC3=CC=CC=C23)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "KEQWBZWOGRCILF-JHZZJYKESA-N",
                     "BTMDB_ID" : "BTM0457",
                  "PubChem CID" : "114851",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z || R(2) http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/4/1/17.html"
      },
      "BIOTID0270" : {
                                    "Substrate" : {
                     "Name" : "Tyrphostin B42",
                   "SMILES" : "C1=CC=C(C=C1)CNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N",
                 "InChIKey" : "TUCIOBMMDDOEMM-RIYZIHGNSA-N",
                 "BTMDB_ID" : "BTM0458",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Tyrphostin B42, 4-O-glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)[C@H](OC2=C(O)C=C(/C=C(\\C#N)/C(=O)NCC3=CC=CC=C3)C=C2)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "SSBVDYQLOOVCBF-DLYXBSSTSA-N",
                     "BTMDB_ID" : "BTM0459",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z || R(2) http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/4/1/17.html"
      },
      "BIOTID0271" : {
                                    "Substrate" : {
                     "Name" : "Hesperetin",
                   "SMILES" : "COC1=CC=C(C=C1O)[C@@H]2CC(=O)C3=C(O)C=C(O)C=C3O2",
                 "InChIKey" : "AIONOLUJZLIMTK-AWEZNQCLSA-N",
                 "BTMDB_ID" : "BTM0460",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Hesperetin 7-O-glucuronide",
                       "SMILES" : "COC1=CC=C(C=C1O)[C@@H]2CC(=O)C3=C(O)C=C(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C=C3O2",
                     "InChIKey" : "NEAWXAXVQDDFJL-QBUJOIIVSA-N",
                     "BTMDB_ID" : "BTM0461",
                  "PubChem CID" : "56598869",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z || R(2) http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/4/1/17.html"
      },
      "BIOTID0272" : {
                                    "Substrate" : {
                     "Name" : "2p-Hydroxyflavone",
                   "SMILES" : "OC1=C(C=CC=C1)C2=CC(=O)C3=CC=CC=C3O2",
                 "InChIKey" : "ZZLQHXCRRMUGQJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0462",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Flavone 2p-O-glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)[C@H](OC2=C(C=CC=C2)C3=CC(=O)C4=CC=CC=C4O3)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "FTGGCUZKPXEQLO-ZFORQUDYSA-N",
                     "BTMDB_ID" : "BTM0463",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z || R(2) http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/4/1/17.html"
      },
      "BIOTID0273" : {
                                    "Substrate" : {
                     "Name" : "3p-Hydroxyflavone",
                   "SMILES" : "OC1=CC(=CC=C1)C2=CC(=O)C3=CC=CC=C3O2",
                 "InChIKey" : "ISZWRZGKEWQACU-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0464",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Flavone 3p-O-glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)[C@H](OC2=CC(=CC=C2)C3=CC(=O)C4=CC=CC=C4O3)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "DHKTZCRUILGBGI-ZFORQUDYSA-N",
                     "BTMDB_ID" : "BTM0465",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z || R(2) http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/4/1/17.html"
      },
      "BIOTID0274" : {
                                    "Substrate" : {
                     "Name" : "2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",
                   "SMILES" : "CN1C(N)=NC2=NC=C(C=C12)C3=CC=CC=C3",
                 "InChIKey" : "UQVKZNNCIHJZLS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0466",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A1; UGT1A3; UGT1A4)",
                                "Reaction Type" : "Glucuronidation of primary aromatic amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0171",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, N2-glucuronide",
                       "SMILES" : "CN1C(N[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=NC3=NC=C(C=C13)C4=CC=CC=C4",
                     "InChIKey" : "SQVPGYDPSLNFET-KSXIZUIISA-N",
                     "BTMDB_ID" : "BTM0467",
                  "PubChem CID" : "71313317",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism; Slobodan Rendic, and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k || (R2) Walters DG et al. (2004); Carcinogenesis vol.25 no.9 pp.1659-1669; doi:10.1093/carcin/bgh164"
      },
      "BIOTID0275" : {
                                    "Substrate" : {
                     "Name" : "4'-OH-PhIP",
                   "SMILES" : "CN1C(N)=NC2=NC=C(C=C12)C3=CC=C(O)C=C3",
                 "InChIKey" : "UGJXOCBVCWTJFP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0468",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "PhIP 4'-O-sulfated",
                       "SMILES" : "CN1C(N)=NC2=NC=C(C=C12)C3=CC=C(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C=C3",
                     "InChIKey" : "UNVUNODRTHJKHH-PYOGLGTISA-N",
                     "BTMDB_ID" : "BTM0469",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k || (R2) Walters DG et al. (2004); Carcinogenesis vol.25 no.9 pp.1659-1669; doi:10.1093/carcin/bgh164"
      },
      "BIOTID0276" : {
                                    "Substrate" : {
                     "Name" : "2-hydroxyestradiol",
                   "SMILES" : "C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=C(O)C=C34)[C@@H]1CC[C@@H]2O",
                 "InChIKey" : "DILDHNKDVHLEQB-XSSYPUMDSA-N",
                 "BTMDB_ID" : "BTM0470",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "S-COMT",
                                "Reaction Type" : "METHYLATION",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-O-methoxyestradiol",
                       "SMILES" : "COC1=C(O)C=C2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2=C1",
                     "InChIKey" : "MMKYSUOJWFKECQ-SSTWWWIQSA-N",
                     "BTMDB_ID" : "BTM0471",
                  "PubChem CID" : "13267935",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k"
      },
      "BIOTID0277" : {
                                    "Substrate" : {
                     "Name" : "2-hydroxyestrone",
                   "SMILES" : "C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=C(O)C=C34)[C@@H]1CCC2=O",
                 "InChIKey" : "SWINWPBPEKHUOD-JPVZDGGYSA-N",
                 "BTMDB_ID" : "BTM0472",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A1; UGT1A7; UGT1A8; UGT1A10",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Estrone 2-O-glucuronide",
                       "SMILES" : "C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=C(O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C=C34)[C@@H]1CCC2=O",
                     "InChIKey" : "DQNRWYSYNOPGQY-FKYASPJISA-N",
                     "BTMDB_ID" : "BTM0473",
                  "PubChem CID" : "14016224",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k"
      },
      "BIOTID0278" : {
                                    "Substrate" : {
                     "Name" : "dibenzo[a,l]pyrene-11,12- diol",
                   "SMILES" : "OC1=CC=C2C(C=C3C=CC4=C5C(=CC=C4)C6=CC=CC=C6C2=C35)=C1O",
                 "InChIKey" : "MIKPSGCFJZJLRS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0474",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A1; UGT1A4",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "dibenzo[a,l]pyrene-11-ol, 12-O-glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)[C@H](OC2=CC=C3C(C=C4C=CC5=C6C(=CC=C5)C7=CC=CC=C7C3=C46)=C2O)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "VYNUATGPWOYQRU-NEOPOEGOSA-N",
                     "BTMDB_ID" : "BTM0475",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k"
      },
      "BIOTID0279" : {
                                    "Substrate" : {
                     "Name" : "4-hydroxytamoxifen",
                   "SMILES" : "CC/C(=C(\\C1=CC=C(O)C=C1)/C2=CC=C(OCCN(C)C)C=C2)/C3=CC=CC=C3",
                 "InChIKey" : "TXUZVZSFRXZGTL-QPLCGJKRSA-N",
                 "BTMDB_ID" : "BTM0476",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A1; UGT1A4; UGT1A6; UGT1A7; UGT1A8; UGT1A9; UGT1A10; UGT2B15; UGT2B17; UGT2B7",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Tamoxifen 4-O-glucuronide",
                       "SMILES" : "CC/C(=C(/C1=CC=C(OCCN(C)C)C=C1)\\C2=CC=C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C=C2)/C4=CC=CC=C4",
                     "InChIKey" : "SSRNQFUJUAOPJD-OFKVRPASSA-N",
                     "BTMDB_ID" : "BTM0477",
                  "PubChem CID" : "71749358",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k"
      },
      "BIOTID0280" : {
                                    "Substrate" : {
                     "Name" : "N’-nitrosoanabasine",
                   "SMILES" : "C1CCN(C(C1)C2=CN=CC=C2)N=O",
                 "InChIKey" : "BXYPVKMROLGXJI-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0478",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT2B10",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N’-nitrosoanabasine, N-glucuronide",
                       "SMILES" : "O[C@H]1[C@H](O)[C@H](OC([C@@H]1O)[N+]2=CC=CC(=C2)C3CCCCN3N=O)C(O)=O",
                     "InChIKey" : "CNFQJGRMFKQFEI-XRPMQRQJSA-O",
                     "BTMDB_ID" : "BTM0479",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k || (R2) Chen G et al. (2008); Glucuronidation of Tobacco-Specific Nitrosamines by UGT2B10; Drug Metab Dispos. 2008 May;36(5):824-30; PMID: 18238858; doi: 10.1124/dmd.107.019406"
      },
      "BIOTID0281" : {
                                    "Substrate" : {
                     "Name" : "Cotinine",
                   "SMILES" : "CN1[C@@H](CCC1=O)C2=CC=CN=C2",
                 "InChIKey" : "UIKROCXWUNQSPJ-VIFPVBQESA-N",
                 "BTMDB_ID" : "BTM0480",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A4; UGT1A9",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Cotinine N-glucuronide",
                       "SMILES" : "CN1[C@@H](CCC1=O)C2=CC=C[N+](=C2)C3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O",
                     "InChIKey" : "XWZCZWKUGIQPJD-QGVFRFOYSA-O",
                     "BTMDB_ID" : "BTM0481",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, and Zhou (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218"
      },
      "BIOTID0282" : {
                                    "Substrate" : {
                     "Name" : "4-hydroxy-2p,3,5-trichlorobiphenyl",
                   "SMILES" : "OC1=C(Cl)C=C(C=C1Cl)C2=C(Cl)C=CC=C2",
                 "InChIKey" : "XLRWQPVYQISORN-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0482",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "SULT1A2",
                                "Reaction Type" : "4-OH sulfonation of phenolic compound",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0197",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2p,3,5-trichlorobiphenyl, 4-sulfate",
                       "SMILES" : "OS(=O)(=O)OC1=C(Cl)C=C(C=C1Cl)C2=C(Cl)C=CC=C2",
                     "InChIKey" : "XWDRZEQZEVVMAL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0483",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Liu Y et al. (2006); Hydroxylated polychlorinated biphenyls are substrates and inhibitors of human hydroxysteroid sulfotransferase SULT2A1; Chem. Res. Toxicol. 19, 1420-1425"
      },
      "BIOTID0283" : {
                                    "Substrate" : {
                     "Name" : "Gavestinel",
                   "SMILES" : "OC(=O)C1=C(/C=C/C(=O)NC2=CC=CC=C2)C3=C(Cl)C=C(Cl)C=C3N1",
                 "InChIKey" : "WZBNEZWCNKUOSM-VOTSOKGWSA-N",
                 "BTMDB_ID" : "BTM0484",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "O-glucuronidation of aromatic acid",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0168",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "gavestinel 4-O-acyl glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)C(OC(=O)C2=C(/C=C/C(=O)NC3=CC=CC=C3)C4=C(Cl)C=C(Cl)C=C4N2)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "ITRQKRDZGOCGMA-COEUMGADSA-N",
                     "BTMDB_ID" : "BTM0485",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "https://www.drugbank.ca/drugs/DB06741"
      },
      "BIOTID0284" : {
                                    "Substrate" : {
                     "Name" : "3-hydroxyguanfacine",
                   "SMILES" : "NC(=N)NC(=O)CC1=C(Cl)C(O)=CC(O)=C1Cl",
                 "InChIKey" : "SHBGZECCBYCTEJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0486",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3-hydroxyguanfacine glucuronide",
                       "SMILES" : "NC(=N)NC(=O)CC1=C(Cl)C(OC2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=CC(O)=C1Cl",
                     "InChIKey" : "AUDUMKPECIWTMB-ZAOAHOKWSA-N",
                     "BTMDB_ID" : "BTM0487",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "https://www.drugbank.ca/drugs/DB01018"
      },
      "BIOTID0285" : {
                                    "Substrate" : {
                     "Name" : "8-Hydroxynevirapine",
                   "SMILES" : "CC1=CC=NC2=C1NC(=O)C3=C(N=CC(O)=C3)N2C4CC4",
                 "InChIKey" : "DZPVEPLRIKDBFC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0488",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "8-Hydroxynevirapine O-glucuronide",
                       "SMILES" : "CC1=CC=NC2=C1NC(=O)C3=C(N=CC(OC4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)=C3)N2C5CC5",
                     "InChIKey" : "IVZWGLRSSHUFTI-IQSUWLOCSA-N",
                     "BTMDB_ID" : "BTM0489",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675.|| (R2) http://www.hmdb.ca/metabolites/HMDB0061130"
      },
      "BIOTID0286" : {
                                    "Substrate" : {
                     "Name" : "2-Hydroxynevirapine",
                   "SMILES" : "CC1=CC(O)=NC2=C1N=C(O)C3=C(N=CC=C3)N2C4CC4",
                 "InChIKey" : "LFZSOJABLBVGRJ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0490",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2-Hydroxynevirapine glucuronide",
                       "SMILES" : "CC1=CC(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=NC3=C1N=C(O)C4=C(N=CC=C4)N3C5CC5",
                     "InChIKey" : "RNMZKTLILDCQOC-KUSYAZKWSA-N",
                     "BTMDB_ID" : "BTM0491",
                  "PubChem CID" : "131769929",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "http://www.hmdb.ca/metabolites/HMDB0060720"
      },
      "BIOTID0287" : {
                                    "Substrate" : {
                     "Name" : "Catechol",
                   "SMILES" : "OC1=CC=CC=C1O",
                 "InChIKey" : "YCIMNLLNPGFGHC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0492",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "SULT",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "catechol sulfate",
                       "SMILES" : "OC1=CC=CC=C1OS(O)(=O)=O",
                     "InChIKey" : "MZPWKJZDOCIALD-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0493",
                  "PubChem CID" : "3083879",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "http://www.hmdb.ca/metabolites/HMDB0061713"
      },
      "BIOTID0288" : {
                                    "Substrate" : {
                     "Name" : "Aminoflavone M-II",
                   "SMILES" : "CC1=C(F)C2=C(C(=O)C=C(O2)C3=CC=C(N)C(F)=C3)C(NO)=C1F",
                 "InChIKey" : "BGZUIZSBNOBPKP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0494",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Aminoflavone M-II O-glucuronide",
                       "SMILES" : "CC1=C(F)C2=C(C(=O)C=C(O2)C3=CC=C(N)C(F)=C3)C(NO[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)=C1F",
                     "InChIKey" : "QEXKIRZJZBQQPU-DCIOMXRHSA-N",
                     "BTMDB_ID" : "BTM0495",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, and Zhou (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218"
      },
      "BIOTID0289" : {
                                    "Substrate" : {
                     "Name" : "Aminoflavone M-IV",
                   "SMILES" : "CC1=C(F)C2=C(C(N)=C1F)C(=O)C(O)=C(O2)C3=CC=C(N)C(F)=C3",
                 "InChIKey" : "HUSFKTRIHYXGPZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0496",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "SULT",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Aminoflavone M-IV O-sulfate",
                       "SMILES" : "CC1=C(F)C2=C(C(N)=C1F)C(=O)C(OS(O)(=O)=O)=C(O2)C3=CC=C(N)C(F)=C3",
                     "InChIKey" : "SHPUPBLJTYTUDO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0497",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, and Zhou (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218"
      },
      "BIOTID0290" : {
                                    "Substrate" : {
                     "Name" : "8-OH-ondansetron",
                   "SMILES" : "CN1C2=C(C3=CC=CC(O)=C13)C(=O)C(CN4C=CN=C4C)CC2",
                 "InChIKey" : "XVDKMEPUFIAQFH-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0498",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "SULT",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "ondansetron 8-O-sulfate",
                       "SMILES" : "CN1C2=C(C3=CC=CC(OS(O)(=O)=O)=C13)C(=O)C(CN4C=CN=C4C)CC2",
                     "InChIKey" : "FKMUSAHZDJNPJY-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0499",
                  "PubChem CID" : "15700432",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, and Zhou (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218"
      },
      "BIOTID0291" : {
                                    "Substrate" : {
                     "Name" : "6-OH-ondansetron",
                   "SMILES" : "CN1C2=C(C3=CC(O)=CC=C13)C(=O)C(CN4C=CN=C4C)CC2",
                 "InChIKey" : "LMMFEGYKXLPLFC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0500",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "ondansetron 6-O-glucuronide",
                       "SMILES" : "CN1C2=C(C3=CC(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)=CC=C13)C(=O)C(CN5C=CN=C5C)CC2",
                     "InChIKey" : "BQFVWKTVJSIIOJ-DMBZKHIPSA-N",
                     "BTMDB_ID" : "BTM0501",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wang, and Zhou (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218"
      },
      "BIOTID0292" : {
                                    "Substrate" : {
                     "Name" : "All-trans-retinoic acid",
                   "SMILES" : "C\\C(\\C=C\\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O",
                 "InChIKey" : "SHGAZHPCJJPHSC-YCNIQYBTSA-N",
                 "BTMDB_ID" : "BTM0502",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "O-glucuronidation of aliphatic acid",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0167",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "All-trans-retinoyl glucuronide",
                       "SMILES" : "C/C(/C=C/C1=C(C)CCCC1(C)C)=C\\C=C\\C(\\C)=C\\C(=O)O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O",
                     "InChIKey" : "MTGFYEHKPMOVNE-NEFMKCFNSA-N",
                     "BTMDB_ID" : "BTM0503",
                  "PubChem CID" : "5281877",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rune Blomhoff and Heidi Kiil Blomhoff (2005); Overview of Retinoid Metabolism and Function; DOI 10.1002/neu.20242"
      },
      "BIOTID0293" : {
                                    "Substrate" : {
                     "Name" : "Epitestosterone",
                   "SMILES" : "C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@H]2O",
                 "InChIKey" : "MUMGGOZAMZWBJJ-KZYORJDKSA-N",
                 "BTMDB_ID" : "BTM0504",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "17-OH glucuronidation of sterol",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0163",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Epitestosterone O-glucuronide",
                       "SMILES" : "C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@H]2OC5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O",
                     "InChIKey" : "NIKZPECGCSUSBV-AUCSGLRSSA-N",
                     "BTMDB_ID" : "BTM0505",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) de Wildt, S.N. et al. (2012); Glucuronidation in Humans; Clinical Pharmacokinetics; June 1999, Volume 36, Issue 6, pp 439–452"
      },
      "BIOTID0294" : {
                                    "Substrate" : {
                     "Name" : "Resveratrol",
                   "SMILES" : "OC1=CC=C(/C=C/C2=CC(O)=CC(O)=C2)C=C1",
                 "InChIKey" : "LUKBXSAWLPMMSZ-OWOJBTEDSA-N",
                 "BTMDB_ID" : "BTM0506",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Resveratrol 3-O-glucuronide",
                       "SMILES" : "O[C@H]1[C@H](OC2=CC(O)=CC(/C=C/C3=CC=C(O)C=C3)=C2)O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O",
                     "InChIKey" : "QWSAYEBSTMCFKY-OTPOQTMVSA-N",
                     "BTMDB_ID" : "BTM0507",
                  "PubChem CID" : "5273285",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0295" : {
                                    "Substrate" : {
                     "Name" : "Mycophenolic Acid",
                   "SMILES" : "COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C/C=C(\\C)/CCC(O)=O",
                 "InChIKey" : "HPNSFSBZBAHARI-RUDMXATFSA-N",
                 "BTMDB_ID" : "BTM0508",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A9",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "",
                       "SMILES" : "COC1=C(C)C2=C(C(=O)OC2)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)=C1C/C=C(\\C)/CCC(O)=O",
                     "InChIKey" : "BYFGTSAYQQIUCN-HGIHDBQLSA-N",
                     "BTMDB_ID" : "BTM0509",
                  "PubChem CID" : "6442661",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Wu et al. 2011; Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches; Pharm Res (2012) 29:1544–1561; DOI 10.1007/s11095-012-0666-z"
      },
      "BIOTID0296" : {
                                    "Substrate" : {
                     "Name" : "1-hydroxymethylpyrene",
                   "SMILES" : "OCC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34",
                 "InChIKey" : "NGDMLQSGYUCLDC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0510",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "SULT1A1; SULT1B1, SULT2A1",
                                "Reaction Type" : "Sulfation of primary alcohol",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0501",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "",
                       "SMILES" : "OS(=O)(=O)OCC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34",
                     "InChIKey" : "JEHJDOIFMGNIQI-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0511",
                  "PubChem CID" : "131320",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k"
      },
      "BIOTID0297" : {
                                    "Substrate" : {
                     "Name" : "2-aminobenzylalcohol",
                   "SMILES" : "NC1=C(CO)C=CC=C1",
                 "InChIKey" : "VYFOAVADNIHPTR-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0512",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "SULT1A1",
                                "Reaction Type" : "Sulfation of primary alcohol",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0501",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "",
                       "SMILES" : "NC1=C(COS(O)(=O)=O)C=CC=C1",
                     "InChIKey" : "XBOBNEOJIDFIIU-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0513",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k"
      },
      "BIOTID0298" : {
                                    "Substrate" : {
                     "Name" : "5-hydroxymethylfurfural",
                   "SMILES" : "OCC1=CC=C(O1)C=O",
                 "InChIKey" : "NOEGNKMFWQHSLB-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0514",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "SULT1A1",
                                "Reaction Type" : "Sulfation of primary alcohol",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0501",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "",
                       "SMILES" : "OS(=O)(=O)OCC1=CC=C(O1)C=O",
                     "InChIKey" : "WVMJEBICTINBRO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0515",
                  "PubChem CID" : "154718",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k"
      },
      "BIOTID0299" : {
                                    "Substrate" : {
                     "Name" : "N-acetyl-N-hydroxy-3-aminobenzanthrone",
                   "SMILES" : "CC(=O)N(O)C1C=CC2=C3C1C=CC=C3C(=O)C4=CC=CC=C24",
                 "InChIKey" : "HKNUZKJRYBXLDZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0516",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "SULT1A1",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "",
                       "SMILES" : "CC(=O)N(OS(O)(=O)=O)C1C=CC2=C3C1C=CC=C3C(=O)C4=CC=CC=C24",
                     "InChIKey" : "NZSGZHDOQBDCEL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0517",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Rendic, S. et al. 2012; Contributions of Human Enzymes in Carcinogen Metabolism Slobodan Rendic1,* and F. Peter Guengerich; Chem Res Toxicol. 2012 July 16; 25(7): 1316–1383. doi:10.1021/tx300132k"
      },
      "BIOTID0300" : {
                                    "Substrate" : {
                     "Name" : "N-hydroxy-aminophenylnorharman",
                   "SMILES" : "ONC1=CC=C(C=C1)N2C3=CN=CC=C3C4=C2C=CC=C4",
                 "InChIKey" : "LECLBYWFRKFHIQ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0518",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "NAT1; NAT2",
                                "Reaction Type" : "O-acetylation of N-hydroxylarylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0441",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "",
                       "SMILES" : "CC(=O)ONC1=CC=C(C=C1)N2C3=CN=CC=C3C4=C2C=CC=C4",
                     "InChIKey" : "DJMGXUFTFWIYEZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0519",
                  "PubChem CID" : "71366829",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Oda, Y. et al. (2006); Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains; Mutagenesis, Volume 21, Issue 6, 1 November 2006, Pages 411–416"
      },
      "BIOTID0301" : {
                                    "Substrate" : {
                     "Name" : "N-hydroxy-2-aminofluorene",
                   "SMILES" : "ONC1=CC=C2C(CC3=CC=CC=C23)=C1",
                 "InChIKey" : "JJCLXJPUTJMRTM-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0520",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "NAT1",
                                "Reaction Type" : "O-acetylation of N-hydroxylarylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0441",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-hydroxy-2-aminofluorene, O-acetyl",
                       "SMILES" : "CC(=O)ONC1=CC=C2C(CC3=CC=CC=C23)=C1",
                     "InChIKey" : "DAJPHRKDAWYAJZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0521",
                  "PubChem CID" : "149047",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Murata, M. et al. (2005); Carcinogenic 3-nitrobenzanthrone induces oxidative damage to isolated and cellular DNA; Free Radical Biology & Medicine 40 (2006) 1242–1249"
      },
      "BIOTID0302" : {
                                    "Substrate" : {
                     "Name" : "isoniazid",
                   "SMILES" : "NNC(=O)C1=CC=NC=C1",
                 "InChIKey" : "QRXWMOHMRWLFEY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0522",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "NAT2",
                                "Reaction Type" : "N-acetylation of Hydrazine derivative",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0191",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "isoniazid N-acetyl",
                       "SMILES" : "CC(=O)NNC(=O)C1=CC=NC=C1",
                     "InChIKey" : "CVBGNAKQQUWBQV-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0523",
                  "PubChem CID" : "71602",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) https://www.pharmgkb.org/pathway/PA166151813"
      },
      "BIOTID0303" : {
                                    "Substrate" : {
                     "Name" : "Sulfapyridine",
                   "SMILES" : "NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2",
                 "InChIKey" : "GECHUMIMRBOMGK-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0524",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "NAT",
                                "Reaction Type" : "N-acetylation of arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0187",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Sulfapyridine, N-acetyl",
                       "SMILES" : "CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2",
                     "InChIKey" : "CYLYVXPHAQLXFG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0525",
                  "PubChem CID" : "58638",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Taggart, A.J. et al. (1992); The Effect of Age and Acetylator Phenotype on the Pharmacokinetics of Sulfasalazine in Patients with Rheumatoid Arthritis; Clinical Pharmacokinetics; October 1992, Volume 23, Issue 4, pp 311–320"
      },
      "BIOTID0304" : {
                                    "Substrate" : {
                     "Name" : "2,3-dimethylaniline",
                   "SMILES" : "CC1=CC=CC(N)=C1C",
                 "InChIKey" : "VVAKEQGKZNKUSU-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0526",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "NAT1; NAT2",
                                "Reaction Type" : "N-acetylation of arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0187",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "2,3‐dimethylacetanilide",
                       "SMILES" : "CC(=O)NC1=C(C)C(C)=CC=C1",
                     "InChIKey" : "SRSHEJADOPNDDF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0527",
                  "PubChem CID" : "8656",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) PMID:686074 || (R2) http://www.brenda-enzymes.org/enzyme.php?ecno=2.3.1.5&Suchword=&reference=&UniProtAcc=&organism%5B%5D=Homo+sapiens&show_tm=0"
      },
      "BIOTID0305" : {
                                    "Substrate" : {
                     "Name" : "2-(4-aminobenzamido)pyridine",
                   "SMILES" : "NC1=CC=C(C=C1)C(=O)NC2=NC=CC=C2",
                 "InChIKey" : "GBYNWLIJDNPFRH-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0528",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "GST",
                                "Reaction Type" : "N-acetylation of arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0187",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "4‐acetamido‐N‐(pyridin‐2‐yl)benzamide",
                       "SMILES" : "CC(=O)NC1=CC=C(C=C1)C(=O)NC2=NC=CC=C2",
                     "InChIKey" : "GDKVDCDNGVWBCW-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0529",
                  "PubChem CID" : "215925",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) PMID:487114 || (R2) http://www.brenda-enzymes.org/enzyme.php?ecno=2.3.1.5&Suchword=&reference=&UniProtAcc=&organism%5B%5D=Homo+sapiens&show_tm=0"
      },
      "BIOTID0306" : {
                                    "Substrate" : {
                     "Name" : "1,3,5-trinitrobenzene",
                   "SMILES" : "[O-][N+](=O)C1=CC(=CC(=C1)[N+]([O-])=O)[N+]([O-])=O",
                 "InChIKey" : "UATJOMSPNYCXIX-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0530",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "GSTA1",
                                "Reaction Type" : "GSH-conjugation of benzene substituted with an electron donating group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0237",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "S-(2,4,6-trinitrocyclohexa-2,5-dien-1-yl)glutathione",
                       "SMILES" : "N[C@@H](CCC(=O)N[C@@H](CSC1C(=CC(C=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)C(=O)NCC(O)=O)C(O)=O",
                     "InChIKey" : "VQUXYLXGOSJDJJ-SBPVCVGVSA-N",
                     "BTMDB_ID" : "BTM0531",
                  "PubChem CID" : "5288478",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Gildenhuys S et al. (2010); Arginine 15 stabilizes an S(N)Ar reaction transition state and the binding of anionic ligands at the active site of human glutathione transferase A1-1; Biophys. Chem. 146, 118-125"
      },
      "BIOTID0307" : {
                                    "Substrate" : {
                     "Name" : "Brodifacoum",
                   "SMILES" : "OC1=C(C2CC(CC3=CC=CC=C23)C4=CC=C(C=C4)C5=CC=C(Br)C=C5)C(=O)OC6=CC=CC=C16",
                 "InChIKey" : "VEUZZDOCACZPRY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0532",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "Aromatic -OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0166",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Brodifacoum O-glucuronide",
                       "SMILES" : "O[C@@H]1[C@@H](O)C(OC2=C(C3CC(CC4=CC=CC=C34)C5=CC=C(C=C5)C6=CC=C(Br)C=C6)C(=O)OC7=CC=CC=C27)O[C@@H]([C@H]1O)C(O)=O",
                     "InChIKey" : "UGNYAZFBDKONOJ-WMNBIHONSA-N",
                     "BTMDB_ID" : "BTM0533",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) USEPA; Reregistration Eligibility Decision Document - Rodenticide Cluster. Washington, DC: USEPA, Off Pest Prog. USEPA 738-R-98-007 p.36 July 1998. Available from, as of March 17, 2003"
      },
      "BIOTID0308" : {
                                    "Substrate" : {
                     "Name" : "Lumiracoxib",
                   "SMILES" : "CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(O)=O)=C1",
                 "InChIKey" : "KHPKQFYUPIUARC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0534",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "O-glucuronidation of aliphatic acid",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0167",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Lumiracoxib O-glucuronide",
                       "SMILES" : "CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)=C1",
                     "InChIKey" : "GEVZOJTWMGGTTK-DAZJWRSOSA-N",
                     "BTMDB_ID" : "BTM0535",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675."
      },
      "BIOTID0309" : {
                                    "Substrate" : {
                     "Name" : "Desogestrel",
                   "SMILES" : "[C@@H]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@@H]3[C@H]4CCCC=C4CC[C@@H]23",
                 "InChIKey" : "RPLCPCMSCLEKRS-BPIQYHPVSA-N",
                 "BTMDB_ID" : "BTM0536",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Desogestrel 17-O-glucuronide",
                       "SMILES" : "CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(OC5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C#C",
                     "InChIKey" : "ZUFUEHVHFQAYMH-BCARWAMXSA-N",
                     "BTMDB_ID" : "BTM0537",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675."
      },
      "BIOTID0310" : {
                                    "Substrate" : {
                     "Name" : "Oxoprenolol",
                   "SMILES" : "CC(C)NCC(COC1=CC=CC=C1OCC=C)O",
                 "InChIKey" : "CEMAWMOMDPGJMB-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0538",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "Alkyl-OH glucuronidation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0165",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Oxprenolol glucuronide",
                       "SMILES" : "CC(C)NCC(COC1=CC=CC=C1OCC=C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O",
                     "InChIKey" : "CJVSRVDYHNLUAN-DNPGXZAYSA-N",
                     "BTMDB_ID" : "BTM0539",
                  "PubChem CID" : "162729",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Laethem, ME et al. (1995); Clin Pharmacol Ther. 1995 Apr;57(4):419-24."
      },
      "BIOTID0311" : {
                                    "Substrate" : {
                     "Name" : "Quinotolast",
                   "SMILES" : "O=C(NC1=NNN=N1)C2=CC(OC3=CC=CC=C3)=C4C=CC=CN4C2=O",
                 "InChIKey" : "ZUPLNRDTYQWUHP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0540",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Quinotolast N-glucuronide",
                       "SMILES" : "C1=CC=C(C=C1)OC2=C3C=CC=CN3C(=O)C(=C2)C(=O)NC4=NN(N=N4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O",
                     "InChIKey" : "ZRRIOSTWOXCBKN-ARNOYJHMSA-N",
                     "BTMDB_ID" : "BTM0541",
                  "PubChem CID" : "101661861",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Terakawa M. et al. (1993); Steady-State Pharmacokinetics of Quinotolast Sodium in Man; Drug Metabolism and Pharmacokinetics; Vol. 8 (1993) No. 5 P 1029-1040"
      },
      "BIOTID0312" : {
                                    "Substrate" : {
                     "Name" : "RG12525",
                   "SMILES" : "C(OC1=CC=C(OCC2=CC=CC=C2C3=NN=NN3)C=C1)C4=NC5=CC=CC=C5C=C4",
                 "InChIKey" : "SOMUITKIBMREBL-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0542",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A1; UGT2B7",
                                "Reaction Type" : "N-glucuronidation of azole",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1303",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "RG12525 N2-glucuronide",
                       "SMILES" : "O[C@H]1[C@H](O)[C@H](OC([C@@H]1O)[N+]2=NN=C(N2)C3=CC=CC=C3COC4=CC=C(OCC5=NC6=CC=CC=C6C=C5)C=C4)C(O)=O",
                     "InChIKey" : "KXRLQRIPSYPFMG-FENBJSOMSA-O",
                     "BTMDB_ID" : "BTM0543",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kaivosaari, S. et al. (2011); N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.; Xenobiotica. 2011 Aug;41(8):652-69. doi: 10.3109/00498254.2011.563327"
      },
      "BIOTID0313" : {
                                    "Substrate" : {
                     "Name" : "JNJ-10198409",
                   "SMILES" : "COC1=C(C=C2C(=C1)CC3=C2NN=C3NC4=CC(=CC=C4)F)OC",
                 "InChIKey" : "ZDNURMVOKAERHZ-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0544",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A4; UGT1A9",
                                "Reaction Type" : "N-glucuronidation of azole",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "JNJ-10198409 N-glucuronide C",
                       "SMILES" : "COC1=C(OC)C=C2C(CC3=C2NN=C3N(C4OC(C(O)C(O)C4O)C(O)=O)C5=CC(F)=CC=C5)=C1",
                     "InChIKey" : "SEOXPQXQARYLQL-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0545",
                  "PubChem CID" : "18445712",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kaivosaari, S. et al. (2011); N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.; Xenobiotica. 2011 Aug;41(8):652-69. doi: 10.3109/00498254.2011.563327"
      },
      "BIOTID0314" : {
                                    "Substrate" : {
                     "Name" : "N-Acetylbenzidine",
                   "SMILES" : "CC(=O)NC1=CC=C(C=C1)C2=CC=C(N)C=C2",
                 "InChIKey" : "DZQXBXZZSKPMDV-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0546",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A1; UGT1A4; UGT1A9",
                                "Reaction Type" : "Glucuronidation of primary aromatic amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0171",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Acetylbenzidine, N-glucuronide",
                       "SMILES" : "CC(=O)NC1=CC=C(C=C1)C2=CC=C(NC3OC(C(O)C(O)C3O)C(O)=O)C=C2",
                     "InChIKey" : "FOSFMZROUHWIBO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0547",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kaivosaari, S. et al. (2011); N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.; Xenobiotica. 2011 Aug;41(8):652-69. doi: 10.3109/00498254.2011.563327"
      },
      "BIOTID0315" : {
                                    "Substrate" : {
                     "Name" : "Amitriptyline",
                   "SMILES" : "CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C13",
                 "InChIKey" : "KRMDCWKBEZIMAB-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0548",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT2B10; UGT1A4",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Amitriptyline N-glucuronide",
                       "SMILES" : "C[N+](C)(CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O",
                     "InChIKey" : "WXMXRAPAGYPAJI-ARXROMJUSA-O",
                     "BTMDB_ID" : "BTM0549",
                  "PubChem CID" : "62982",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kaivosaari, S. et al. (2011); N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.; Xenobiotica. 2011 Aug;41(8):652-69. doi: 10.3109/00498254.2011.563327"
      },
      "BIOTID0316" : {
                                    "Substrate" : {
                     "Name" : "Diphenylamine",
                   "SMILES" : "N(C1=CC=CC=C1)C2=CC=CC=C2",
                 "InChIKey" : "DMBHHRLKUKUOEG-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0550",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A3",
                                "Reaction Type" : "N-Glucuronidation of diaryl or alkylarylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1306",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Diphenylamine N-glucuronide",
                       "SMILES" : "OC1C(O)C(OC(C1O)C(O)=O)N(C2=CC=CC=C2)C3=CC=CC=C3",
                     "InChIKey" : "IJMCZAXZUZCSEO-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0551",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Green MD et al. (1998); Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3; Drug Metab Dispos.;26(6):507-12; PMID:9616184"
      },
      "BIOTID0317" : {
                                    "Substrate" : {
                     "Name" : "Loxepine",
                   "SMILES" : "CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=CC=C(Cl)C=C24",
                 "InChIKey" : "XJGVXQDUIWGIRW-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0552",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A3",
                                "Reaction Type" : "N-glucuronidation of tertiary aliphatic amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0244",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Loxepine N-glucuronide",
                       "SMILES" : "C[N+]1(CCN(CC1)C2=NC3=CC=CC=C3OC4=CC=C(Cl)C=C24)C5OC(C(O)C(O)C5O)C(O)=O",
                     "InChIKey" : "LQIYQWUFVYHRTJ-UHFFFAOYSA-O",
                     "BTMDB_ID" : "BTM0553",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Green MD et al. (1998); Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3; Drug Metab Dispos.;26(6):507-12; PMID:9616184"
      },
      "BIOTID0318" : {
                                    "Substrate" : {
                     "Name" : "Chlorpromazine",
                   "SMILES" : "CN(C)CCCN1C2=CC=CC=C2SC3=CC=C(Cl)C=C13",
                 "InChIKey" : "ZPEIMTDSQAKGNT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0554",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A3",
                                "Reaction Type" : "N-glucuronidation of tertiary aliphatic amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0244",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Chlorpromazine N-glucuronide",
                       "SMILES" : "C[N+](C)(CCCN1C2=CC=CC=C2SC3=CC=C(Cl)C=C13)C4OC(C(O)C(O)C4O)C(O)=O",
                     "InChIKey" : "WOWWOPLXFLBDAN-UHFFFAOYSA-O",
                     "BTMDB_ID" : "BTM0555",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Green MD et al. (1998); Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3; Drug Metab Dispos.;26(6):507-12; PMID:9616184"
      },
      "BIOTID0319" : {
                                    "Substrate" : {
                     "Name" : "Cyproheptadine",
                   "SMILES" : "CN1CCC(CC1)=C2C3=CC=CC=C3C=CC4=CC=CC=C24",
                 "InChIKey" : "JJCFRYNCJDLXIK-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0556",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT1A3",
                                "Reaction Type" : "N-glucuronidation of tertiary aliphatic amine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0244",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Cyproheptadine N-glucuronide",
                       "SMILES" : "C[N+]1(CCC(CC1)=C2C3=CC=CC=C3C=CC4=CC=CC=C24)C5OC(C(O)C(O)C5O)C(O)=O",
                     "InChIKey" : "CQLKKFODLDAYGC-UHFFFAOYSA-O",
                     "BTMDB_ID" : "BTM0557",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Green MD et al. (1998); Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3; Drug Metab Dispos.;26(6):507-12; PMID:9616184"
      },
      "BIOTID0320" : {
                                    "Substrate" : {
                     "Name" : "Isonicotinoylhydrazine",
                   "SMILES" : "NNC(=O)C1=CC=NC=C1",
                 "InChIKey" : "QRXWMOHMRWLFEY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0558",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "UGT",
                                "Reaction Type" : "",
          "BioTransformer Reaction ID (BTMRID)" : "",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "",
                       "SMILES" : "OC1C(NNC(=O)C2=CC=NC=C2)OC(C(O)C1O)C(O)=O",
                     "InChIKey" : "QVJOLLPKYFYTIH-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0559",
                  "PubChem CID" : "3768",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ]
      },
      "BIOTID0321" : {
                                    "Substrate" : {
                     "Name" : "chlorofluoroacetic acid",
                   "SMILES" : "OC(=O)C(F)Cl",
                 "InChIKey" : "JBIKZDFUXGHTHD-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0560",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "GST",
                                "Reaction Type" : "GSH-conjugation of organohalide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0224",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "chloroacetyl-S-glutathione",
                       "SMILES" : "NC(CCC(=O)NC(CSC(Cl)C(O)=O)C(=O)NCC(O)=O)C(O)=O",
                     "InChIKey" : "QSJWCVDVLJSMFK-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0561",
                  "PubChem CID" : "54244650",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Board PG et al. (2003); Clarification of the role of key active site residues of glutathione transferase zeta/maleylacetoacetate isomerase by a new spectrophotometric technique; Biochem. J. 374, 731-737; PMID:12852784; PMCID:PMC1223650; DOI:10.1042/BJ20030625"
      },
      "BIOTID0322" : {
                                    "Substrate" : {
                     "Name" : "monochlorobimane",
                   "SMILES" : "CC1=C(C)C(=O)N2N1C(CCl)=C(C)C2=O",
                 "InChIKey" : "SUIPVTCEECPFIB-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0562",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "",
                                "Reaction Type" : "GSH-conjugation of organohalide",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0224",
                       "Biotransformation type" : "Human Phase II",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Bimane-glutathione",
                       "SMILES" : "CC1=C(N2C(=C(C(=O)N2C1=O)C)CSCC(C(=O)CNC(=O)O)NC(=O)CCC(C(=O)O)N)C",
                     "InChIKey" : "ZTZDOPADIRRVJM-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0563",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Mukanganyama S et al. (2011); The evaluation of novel natural products as inhibitors of human glutathione transferase P1-1; J. Enzyme Inhib. Med. Chem. 26, 460-467; PMID:21028940; DOI:10.3109/14756366.2010.526769"
      },
      "BIOTID0323" : {
                                    "Substrate" : {
                     "Name" : "Sulfasalazine",
                   "SMILES" : "OC(=O)C1=CC(=CC=C1O)/N=N/C2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3",
                 "InChIKey" : "NCEXYHBECQHGNR-QZQOTICOSA-N",
                 "BTMDB_ID" : "BTM0564",
              "PubChem CID" : "NULL",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Azobenzene reductase",
                                "Reaction Type" : "Reduction of Azobenzene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1254",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Sulfapyridine",
                       "SMILES" : "NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2",
                     "InChIKey" : "GECHUMIMRBOMGK-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0524",
                  "PubChem CID" : "NULL",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Sousa T et al. (2008); The gastrointestinal microbiota as a site for the biotransformation of drugs; Int J Pharm.;363(1-2):1-25; doi:10.1016/j.ijpharm.2008.07.009; PMID:18682282"
      },
      "BIOTID0324" : {
                                    "Substrate" : {
                     "Name" : "Nitrazepam",
                   "SMILES" : "[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1",
                 "InChIKey" : "KJONHKAYOJNZEC-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0566",
              "PubChem CID" : "4506",
              "DrugBank ID" : "DB01595",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Bacterial oxygen-insensitive NADPH nitroreductase",
                                "Reaction Type" : "Nitroreduction of nitroarene to nitrosoarene",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1293",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5-Phenyl-7-nitroso-1H-1,4-benzodiazepine-2(3H)-one",
                       "SMILES" : "O=NC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1",
                     "InChIKey" : "AOMIVOOSFGGVGQ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0567",
                  "PubChem CID" : "101057825",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Sousa T et al. (2008); The gastrointestinal microbiota as a site for the biotransformation of drugs; Int J Pharm.;363(1-2):1-25; doi:10.1016/j.ijpharm.2008.07.009; PMID:18682282"
      },
      "BIOTID0325" : {
                                    "Substrate" : {
                     "Name" : "omeprazole",
                   "SMILES" : "N1C(=NC2=C1C=CC(OC)=C2)S(=O)CC3=NC=C(C(OC)=C3C)C",
                 "InChIKey" : "SUBDBMMJDZJVOS-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0406",
              "PubChem CID" : "4594",
              "DrugBank ID" : "DB00338",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified bacterial sulfoxide reductase",
                                "Reaction Type" : "Reduction of sulfoxide to thioether",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0152",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "5‐methoxy‐2‐{[(4‐methoxy‐3,5‐dimethylpyridin‐2‐yl)methyl]sulfanyl}‐3H‐1,3‐benzodiazole",
                       "SMILES" : "COC1=CC=C2N=C(NC2=C1)SCC3=NC=C(C)C(OC)=C3C",
                     "InChIKey" : "XURCIPRUUASYLR-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0568",
                  "PubChem CID" : "155794",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Sousa T et al. (2008); The gastrointestinal microbiota as a site for the biotransformation of drugs; Int J Pharm.;363(1-2):1-25; doi:10.1016/j.ijpharm.2008.07.009; PMID:18682282"
      },
      "BIOTID0326" : {
                                    "Substrate" : {
                     "Name" : "5-Aminosalicylic acid",
                   "SMILES" : "NC1=CC=C(O)C(=C1)C(O)=O",
                 "InChIKey" : "KBOPZPXVLCULAV-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0565",
              "PubChem CID" : "4075",
              "DrugBank ID" : "DB00244",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Arylamine N-acetyltransferase",
                                "Reaction Type" : "N-acetylation of arylamine",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0187",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "N-Acetyl-5-aminosalicylic acid",
                       "SMILES" : "CC(=O)NC1=CC=C(O)C(=C1)C(O)=O",
                     "InChIKey" : "GEFDRROBUCULOD-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0569",
                  "PubChem CID" : "65512",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Sousa T et al. (2008); The gastrointestinal microbiota as a site for the biotransformation of drugs; Int J Pharm.;363(1-2):1-25; doi:10.1016/j.ijpharm.2008.07.009; PMID:18682282"
      },
      "BIOTID0327" : {
                                    "Substrate" : {
                     "Name" : "5-OH-7-methoxyflavone",
                   "SMILES" : "COC1=CC(O)=C2C(=O)C=C(OC2=C1)C3=CC=CC=C3",
                 "InChIKey" : "IRZVHDLBAYNPCT-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0570",
              "PubChem CID" : "5281954",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified bacterial demethylase",
                                "Reaction Type" : "5-O-demethylation of flavone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0077",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Chrysin",
                       "SMILES" : "OC1=CC(O)=C2C(=O)C=C(OC2=C1)C3=CC=CC=C3",
                     "InChIKey" : "RTIXKCRFFJGDFG-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0571",
                  "PubChem CID" : "5281607",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Kim M et al. (2014); Metabolism of Kaempferia parviflora Polymethoxyflavones by Human Intestinal Bacterium Bautia sp. MRG-PMF1; J. Agric. Food Chem.; 62;12377−12383; PMID:25437273; DOI:10.1021/jf504074n"
      },
      "BIOTID0328" : {
                                    "Substrate" : {
                     "Name" : "Quercetin",
                   "SMILES" : "OC1=CC2=C(C(O)=C1)C(=O)C(O)=C(O2)C3=CC(O)=C(O)C=C3",
                 "InChIKey" : "REFJWTPEDVJJIY-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0572",
              "PubChem CID" : "5280343",
              "DrugBank ID" : "DB04216",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified gut bacterial enzyme",
                                "Reaction Type" : "Flavonoid C-ring reduction",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0255",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dihydroquercetin",
                       "SMILES" : "OC1C(OC2=C(C(O)=CC(O)=C2)C1=O)C3=CC(O)=C(O)C=C3",
                     "InChIKey" : "CXQWRCVTCMQVQX-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0573",
                  "PubChem CID" : "471",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Aura AM. et al.(2002), J. Agric. Food Chem., 50, 1725–1730 || (R2) Walle, T, Walle UK, and Halushka PV (2001); J. Nutr., 131, 2684–2652"
      },
      "BIOTID0329" : {
                                    "Substrate" : {
                     "Name" : "Cyanidin",
                   "SMILES" : "OC1=CC(O)=C2C=C(O)C(=[O+]C2=C1)C3=CC=C(O)C(O)=C3",
                 "InChIKey" : "VEVZSMAEJFVWIL-UHFFFAOYSA-O",
                 "BTMDB_ID" : "BTM0574",
              "PubChem CID" : "128861",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified gut bacterial enzyme",
                                "Reaction Type" : "Anthocyanidin C-ring fission",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0269",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "3,4-Dihydroxyphenylacetic acid",
                       "SMILES" : "OC(=O)CC1=CC=C(O)C(O)=C1",
                     "InChIKey" : "CFFZDZCDUFSOFZ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0576",
                  "PubChem CID" : "547",
                  "DrugBank ID" : "DB01702",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Aura AM. et al.(2002), J. Agric. Food Chem., 50, 1725–1730 || (R2) Fleschhut J et al. (2006); Eur. J. Nutr.; 45; 7–15"
      },
      "BIOTID0330" : {
                                    "Substrate" : {
                     "Name" : "Dihydrodaidzein",
                   "SMILES" : "OC1=CC=C(C=C1)C2COC3=CC(O)=CC=C3C2=O",
                 "InChIKey" : "JHYXBPPMXZIHKG-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0577",
              "PubChem CID" : "176907",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified gut bacterial enzyme",
                                "Reaction Type" : "Dehydration of isoflavanone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0295",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Tetrahydrodaidzein",
                       "SMILES" : "OC1C(COC2=CC(O)=CC=C12)C3=CC=C(O)C=C3",
                     "InChIKey" : "YOSDNAMJVOLJKI-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0578",
                  "PubChem CID" : "6430026",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Joannou GE et al. (1995); J. Steroid Biochem. Mol. Biol.; 54; 167–184 || (R2) Setchell KD, Brown NM, and Lydeking-Olsen E (2003); J. Nutr.; 132; 3577–3584"
      },
      "BIOTID0331" : {
                                    "Substrate" : {
                     "Name" : "Tetrahydrodaidzein",
                   "SMILES" : "OC1C(COC2=CC(O)=CC=C12)C3=CC=C(O)C=C3",
                 "InChIKey" : "YOSDNAMJVOLJKI-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0578",
              "PubChem CID" : "6430026",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified gut bacterial enzyme",
                                "Reaction Type" : "Isoflavan-4-ol dehydroxylation",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0299",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Equol",
                       "SMILES" : "OC1=CC=C(C=C1)C2COC3=CC(O)=CC=C3C2",
                     "InChIKey" : "ADFCQWZHKCXPAJ-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0579",
                  "PubChem CID" : "382975",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Joannou GE et al. (1995); J. Steroid Biochem. Mol. Biol.; 54; 167–184 || (R2) Setchell KD, Brown NM, and Lydeking-Olsen E (2003); J. Nutr.; 132; 3577–3584"
      },
      "BIOTID0332" : {
                                    "Substrate" : {
                     "Name" : "2‐(4‐hydroxyphenyl)‐1‐(2,4,6‐trihydroxyphenyl)prop‐2‐en‐1‐one",
                   "SMILES" : "OC1=CC=C(C=C1)C(=C)C(=O)C2=C(O)C=C(O)C=C2O",
                 "InChIKey" : "YQJWBMJVIIHDFM-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0580",
              "PubChem CID" : "59846969",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "NADPH dehydrogenase",
                                "Reaction Type" : "Reduction of alpha,beta unsaturated carbon-carbon double bond adjacent to an electron withdrawing group",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR1209",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "6'-Hydroxy-O-desmethylangolensin",
                       "SMILES" : "CC(C(=O)C1=C(O)C=C(O)C=C1O)C2=CC=C(O)C=C2",
                     "InChIKey" : "IEFUAUZFJJOQMC-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0581",
                  "PubChem CID" : "20601635",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Joannou GE et al. (1995); J. Steroid Biochem. Mol. Biol.; 54; 167–184 || (R2) Coldham NG et al. (2002); Xenobiotica; 32; 45–62"
      },
      "BIOTID0333" : {
                                    "Substrate" : {
                     "Name" : "formononetin",
                   "SMILES" : "C12=C(C(C(=CO1)C=3C=CC(=CC3)OC)=O)C=CC(=C2)O",
                 "InChIKey" : "HKQYGTCOTHHOMP-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0174",
              "PubChem CID" : "5280378",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified gut bacterial enzyme",
                                "Reaction Type" : "Reduction of isoflavone to isoflavanone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0294",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dihydroformononetin",
                       "SMILES" : "COC1=CC=C(C=C1)C2COC3=CC(O)=CC=C3C2=O",
                     "InChIKey" : "INYISIYHXQDCPK-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0582",
                  "PubChem CID" : "14730796",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Heinonen SM, Wähälä K, and Adlercreutz H (2004); J. Agric. Food Chem.; 52; 6802–6809"
      },
      "BIOTID0334" : {
                                    "Substrate" : {
                     "Name" : "Biochanin A",
                   "SMILES" : "COC1=CC=C(C=C1)C2=COC3=CC(O)=CC(O)=C3C2=O",
                 "InChIKey" : "WUADCCWRTIWANL-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0583",
              "PubChem CID" : "5280373",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified bacterial demethylase",
                                "Reaction Type" : "4p-Demethylation of 4p-methoxyisoflavone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0296",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Genistein",
                       "SMILES" : "OC1=CC=C(C=C1)C2=COC3=CC(O)=CC(O)=C3C2=O",
                     "InChIKey" : "TZBJGXHYKVUXJN-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0584",
                  "PubChem CID" : "5280961",
                  "DrugBank ID" : "DB01645",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Heinonen SM, Wähälä K, and Adlercreutz H (2004); J. Agric. Food Chem.; 52; 6802–6809"
      },
      "BIOTID0335" : {
                                    "Substrate" : {
                     "Name" : "3-(4-Hydroxy-3-methoxyphenyl)propanoic acid",
                   "SMILES" : "COC1=CC(CCC(O)=O)=CC=C1O",
                 "InChIKey" : "BOLQJTPHPSDZHR-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0585",
              "PubChem CID" : "14340",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified bacterial demethylase",
                                "Reaction Type" : "Demethylation of methoxyphenyl, or methoxybenzoic acid",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0280",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Dihydrocaffeic acid",
                       "SMILES" : "OC(=O)CCC1=CC=C(O)C(O)=C1",
                     "InChIKey" : "DZAUWHJDUNRCTF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0586",
                  "PubChem CID" : "348154",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Gonthier MP et al. (2006), Biomed. Pharmacotherapy; 60; 536–540 || (R2) Braune A. et al. (2009); J. Agric. Food Chem.; 57; 3356–3362 || (R3) Mateo Anson N et al. (2009); J. Agric Food Chem.; 57; 6148–6155"
      },
      "BIOTID0336" : {
                                    "Substrate" : {
                     "Name" : "Pentahydroxy-urolithin",
                   "SMILES" : "OC1=C(O)C2=C(C=C1)C3=C(O)C(O)=C(O)C=C3C(=O)O2",
                 "InChIKey" : "ZELMDXUEWHBWPN-UHFFFAOYSA-N",
                 "BTMDB_ID" : "BTM0587",
              "PubChem CID" : "18504424",
              "DrugBank ID" : "NULL",
                  "HMDB_ID" : "NULL"
          },
                                    "Enzyme(s)" : "Unspecified bacterial dehydroxylase",
                                "Reaction Type" : "Dehydroxylation of dibenzopyranone",
          "BioTransformer Reaction ID (BTMRID)" : "BTMR0289",
                       "Biotransformation type" : "Human Gut Microbial",
                                    "Biosystem" : "Human",
                                     "Products" : [
              {
                         "Name" : "Urolithin E",
                       "SMILES" : "OC1=CC(O)=C2C(=C1)C(=O)OC3=C2C=CC(O)=C3O",
                     "InChIKey" : "UAOUKWCOBPGDDF-UHFFFAOYSA-N",
                     "BTMDB_ID" : "BTM0588",
                  "PubChem CID" : "102435041",
                  "DrugBank ID" : "NULL",
                      "HMDB_ID" : "NULL"
              }
          ],
                                   "References" : "(R1) Piu Saha et al. (2016); Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases; PLoS One. 2016; 11(6): e0156811; PMCID:PMC4890745; doi:10.1371/journal.pone.0156811"
      }
  }
}